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ABSTRACT

PATHOLOGICAL UPREGULATION OF THE CALCIUM STIMULATED
PHOSPHATASE, CALCINEURIN, IN TWO MODELS OF NEURONAL INJURY
A dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2006
Director: Severn B. Churn, Ph.D.
Associate Professor, Departments of Neurology;
Anatomy and Neurobiology; Pharmacology and Toxicology;
and Physiology

Excitotoxic calcium influx and activation of calcium-regulated systems is a
common event in several types of neuronal injury. This mechanism has been the
focus of intense research, with the hope that a more complete understanding of
how neuronal injury affects calcium-regulated systems will provide effective
treatment options. This study examines one such calcium-stimulated enzyme,
calcineurin, in the context of two common neurological pathologies, status
epilepticus and traumatic brain injury.
Status epilepticus was induced by pilocarpine injection. NMDA-dependent
increases in calcineurin activity were observed in cortical and hippocampal
homogenates. Upon closer examination, the most profound increases in activity
were found to be present in crude synaptoplasmic membrane fractions isolated

x

from cortex and hippocampus. A concurrent status epilepticus-induced increase
in calcineurin concentration was observed in membrane fractions from cortex and
hippocampus. Immunohistochemical analysis revealed an increase in calcineurin
immunoreactivity in apical dendrites of hippocampal pyramidal neurons. We
examined a cellular effect of increased dendritic calcineurin activity by
characterizing a calcineurin-dependent loss of dendritic spines. Increased
dendritic calcineurin led to increased dephosphorylation and activation of cofilin,
an actin-depolymerizing factor. Calcineurin-activated cofilin induced an increase
in actin depolymerization, a mechanism shown to cause spine loss in other
models. Finally, via Golgi impregnation, we demonstrated that status epilepticusinduced spine loss is blocked by calcineurin inhibitors.
To demonstrate that the increase in dendritic calcineurin activity was not
model-specific, we examined a moderate fluid-percussion model of brain injury.
Calcineurin activity was significantly increased in hippocampal and cortical
homogenates. This increased activity persisted for several weeks post-injury, and
may be involved in injury-induced neuronal pathologies. Also similar to the SE
model,

calcineurin

immunoreactivity

was

dramatically

increased

in

synaptoplasmic membrane fractions from cortex and hippocampus, and
immunohistochemistry revealed increased calcineurin content in dendrites of
hippocampal CA1-3 pyramidal neurons. These changes in calcineurin distribution
also persisted for several weeks post-injury.

xi

These studies demonstrate a novel, cellular mechanism of calciummediated pathology in two models of neuronal injury. Elucidation of cellular
events involved in the acute and chronic effects of brain trauma is essential for
the development of more effective treatment options.

INTRODUCTION

Excitotoxic calcium influx and the subsequent activation of calciumregulated systems is a common event in several types of neuronal injury [1]. This
pathological mechanism has been the focus of intense research, with the hope
that a more complete understanding of how neuronal injury affects calciumregulated systems will eventually provide effective neuroprotective and
therapeutic treatment options. The present study examines one such calciumstimulated enzyme, calcineurin, in the context of two common neurological
pathologies, status epilepticus and traumatic brain injury.

Calcineurin – Structure, Function, Regulation, and Neuronal Substrates:
Structure and Function:
Calcineurin (CaN) was first discovered as a calmodulin-dependent
inhibitor of CaM Kinase II that was highly enriched in neuronal tissue [2]. CaN
was subsequently identified as a calcium-calmodulin dependent serine-threonine
phosphatase [3, 4]. As one of the few serine-threonine phosphatases directly
regulated by a second messenger, CaN plays an important role in many cellular
functions, including regulation of other phosphatases and kinases, regulation of
apoptosis, modulation of neurotransmitter release and receptor function,
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modulation of learning and memory [5], regulation of gene transcription, and
activation of immune cells [6]. CaN’s involvement in numerous essential cellular
properties, coupled to its neuronal enrichment, have made the enzyme an
intriguing subject of research into the mechanisms underlying neuronal injury and
disease states.
CaN is composed of two subunits: the catalytic “A” subunit, and the
regulatory “B” subunit. Each of these subunits is subject to a number of
regulatory mechanisms. The 58-64 kDa catalytic A subunit consists of catalytic,
calmodulin-binding, autoinhibitory, and calcineurin-B binding domains [7, 8]. In
the presence of 20 micromolar calmodulin, calcineurin has a Km of 0.6 µM for
calcium. Calcium-calmodulin binding to CaN is highly cooperative, with a Hill
coefficient of 2.5-3 [8, 9]. Binding of calcium/calmodulin to the calmodulin binding
domain releases the catalytic domain from the influence of the autoinhibitory
domain, permitting the enzyme’s phosphatase activity [10, 11]. The existence of
these functional domains is supported by proteolysis studies. Partial proteolytic
cleavage of the A subunit by the calcium-stimulated protease calpain (as well as
members of the caspase family) can result in the removal of both the
autoinhibitory and calmodulin-binding domains, resulting in a constitutively active
enzyme with greatly increased phosphatase activity [12-15].
The CaN A subunit exists in several isoforms, including Aα1, Aα2,
Aβ1, and Aβ2 [8]. CaN A α and A β are both broadly expressed (including in most
neurons and glia), although expression levels of the two isoforms vary between
different cell types [16], and the α isoforms tend to be more strongly expressed in
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neural tissue [16]. A testis-specific splice variant of CaN (CaN Aγ) exists in both
rodents and humans [8], and may play a role in sperm maturation [17]. From a
practical standpoint, no functional difference has been demonstrated between
the various CaN A isoforms, and all are highly homologous [8].
CaN B, the 19 kDa regulatory subunit of the enzyme, is a member of the
EF-hand superfamily of calcium-binding proteins [18]. CaN B is tightly bound to
CaN A, even in very low (nanomolar) calcium concentrations [8]. CaN B can bind
4 calcium ions with high (Kd = 10-7M) affinity, and several more with micromolar
(Kd = 0.5 to 1 micromolar) affinity [18]. Binding of calcium to the high affinity sites
appears to be structural, while binding of calcium to the low-affinity sites causes
a small, calmodulin-independent activation of the enzyme. The presence of CaN
B is also essential for the calcium/calmodulin-dependent activation of the
enzyme; it has been suggested that binding of calcium to the low-affinity sites on
CaN B induces a conformational change in the catalytic A subunit, facilitating
calmodulin binding [19]. Mammalian CaN B exists in 2 isoforms, CaN B1, found in
all tissues, and CaN B2, which is testis-specific. The structure of CaN B is highly
conserved from yeast to man, and both isoforms are typically myristoylated on
the N-terminal glycine, a post-translational modification that is not essential for
function [20].

Regulation:
In addition to its regulation by calcium/calmodulin, CaN is also activated
by other divalent cations, including nickel, magnesium and manganese [21], with
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the most potent activation by Ni and the least by Mg. There is some debate about
the physiological relevance of this activation, with some early studies suggesting
that CaN requires one of these cations in addition to Ca for activity [22], while
other researchers have not found any tightly associated Ni or Mn ions [23].
Calcineurin is sensitive to oxidation, and prolonged activation by calcium can
result in inactivation of the enzyme through an oxidative mechanism [24]. Activity
lost in this manner can be restored by ascorbate or another mild reducing agent
in enzyme assays.
Various endogenous peptides have been identified that act as
physiological inhibitors of CaN activity. One such peptide (calcineurin
autoinhibitory peptide, referred to in the literature as CAIN or CAP) binds to the
autoinhibitory domain of CaN [25]. This peptide has been shown to negatively
modulate

CaN-mediated

endocytosis,

demonstrating

that

it

has

some

physiological function [26]. More research remains to be done on this topic. In
addition to the autoinhibitory peptide, other endogenous CaN inhibitory proteins
have been recently identified. These include the calcineurin B homologous
protein (CHP) and calcipressin 1. CHP (and a highly similar protein, tescalcin,
expressed during the development of mouse testes [27]) is highly homologous
with both calcineurin B and calmodulin and is capable of calcium binding [28]. It
has been shown to potently inhibit calcineurin when overexpressed in cultured
cells or when added in purified form to calcineurin assays [28]. Calcipressin 1 is
the peptide product of the DSCR1 gene, located in a region thought to be critical
to the defects associated with Down’s Syndrome [29, 30]. Calcipressin 1 is a
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potent inhibitor of calcineurin [30, 31], through a mechanism that likely involves
direct binding to the enzyme [30] and may involve competition with CaN
substrates [32]. A final potential peptide regulator of CaN activity is the astrocyte
calcium binding protein S100B, which seems to increase CaN activity [33],
although this effect still requires further study.
Regulation

of CaN by

phosphorylation of

the

enzyme remains

controversial. For example, CaN can be phosphorylated at the same site (Ser
411) by CaM kinase II and PKC [34-37]. While early research suggested that this
phosphorylation modulated CaN activity [35], the effects were generally small
and differed between activation and inhibition depending on the substrate and
assay protocol used [38]. This site is rapidly autodephosphorylated by CaN itself
[35]. CaN can also be phosphorylated at two sites by casein kinase I, no effect
on CaN enzymatic activity has yet been attributed to this phosphorylation, and
further research is required to determine its functional significance [39].
Finally, CaN is also regulated by its binding to the scaffolding protein
AKAP79/150. In general, the AKAP family of proteins anchor protein kinase A
near its substrates. Specifically, the AKAP79/150 molecule anchors PKA, CaN
and PKC in the vicinity of AMPA receptors. Binding of CaN to the AKAP molecule
results in an inhibition of CaN phosphatase activity [40].

Substrates and Potential Role in Disease States:
Calcineurin is highly enriched in neurons, and modulates a number of
neuronal systems that are of interest in disease states. These systems include
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management of neuronal calcium homeostasis, modulation of neurotransmitter
function, and regulation of the neuronal cytoskeleton. An understanding of the
role of CaN in these systems is essential to determining its role in clinical
disease.
Maintenance of a low level of free intracellular calcium is essential to the
proper function of neurons and allows calcium ions to work effectively as a
second messenger in several key steps of neurotransmission. Due to its high
affinity for calcium ions and relatively low dissociation constant for Ca2+ [2], CaN
is one of the first post-synaptic enzymes activated after a calcium influx [41].
Thus CaN is ideally placed for the regulation of intracellular free calcium via
negative feedback on several systems, including several types of voltage-gated
ion channels, NMDA receptor-associated channels, and endoplasmic reticulum
calcium stores.
Calcineurin has been shown to exhibit negative feedback on calcium entry
through both L [42-44] and N [44, 45] type voltage-gated calcium channels
(VGCC). In L-type channels, CaN overexpression reduced channel availability
and increased the rate of channel inactivation in a cell line derived from rat
neuroblastoma cells [42, 44]. These effects on L-type calcium currents were
reversed by the inclusion of FK506 in the patch pipette, further implicating CaN in
the effect [42]. A similar negative modulation of L-type channels has been seen
in other, non-neuronal cell types, such as smooth muscle [46]. The precise
mechanism for this effect has not yet been described, however the authors
suggested that it was not G-protein mediated. This is in contrast to the regulation

7

of N-type calcium channels by CaN, which does appear to be G-protein
mediated. In rat sympathetic neurons, CaN was shown to positively modulate the
binding of an inhibitory G-protein to the N-type channel, enhancing channel
inhibition. Addition of cyclosporin A in this study enhanced N-type calcium
currents [45]. Some controversy exists over the CaN-dependent regulation of
VGCC’s. For example, one study has suggested that calcineurin increases Ltype calcium channel activity in hippocampal neurons in culture [47]. The authors
state that since VGCC regulation often varies greatly between cell types and
even with the age of the neuron, it is possible for CaN to negatively modulate
voltage sensitive calcium entry in some neurons while positively modulating it in
others. If true, this hypothesis adds another layer of complexity to the role of CaN
in regulating calcium entry.
In addition to its ability to retard calcium entry through some types of
calcium channels, CaN also regulates intracellular calcium storage, particularly
that of the endoplasmic reticulum. The ER is capable of sequestering calcium
ions via a Mg/ATP-ase pump, then releasing this calcium in response to second
messengers, including IP3 and calcium itself (through the ryanodine receptor).
CaN has been shown to downregulate both the IP3 and ryanodine receptors
through

dephosphorylation

of

a

PKC-dependent

site

[48,

49].

This

dephosphorylation reduces the affinity of both receptors for their respective
ligands, thus preventing excessive calcium discharge from the ER. CaN also
regulates intracellular calcium dynamics on a transcriptional level. For example,
CaN-mediated dephosphorylation of the transcription factor NF-ATc4 has been
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shown to upregulate IP3 expression [50, 51]. CaN has also been shown (in some
neuronal populations) to modulate expression of the plasma membrane calcium
ATP-ase pump [52, 53] and the Na/Ca exchanger [54].
With the few exceptions noted above, the net effect of CaN is to provide
negative feedback on calcium influx and ER calcium release, preventing
excessive intracellular calcium levels in response to neuronal stimuli, and
possibly downregulating downstream neurotransmission.
In excitatory neurons, CaN is highly enriched in the post-synaptic density.
This places the enzyme in an ideal location for the regulation of neurotransmitter
receptors. Indeed, several classes of receptors have been identified as either
direct CaN substrates or indirectly regulated by CaN. These receptors include the
NMDA-associated receptor, the AMPA/kainate glutamate receptor, and the
GABAA receptor. In the PSD, CaN is highly bound to scaffolding proteins,
including AKAP 79/150 [55, 56] and MAP-2. This interaction of CaN with these
molecules serves several purposes. First, binding of CaN to specific molecular
scaffolds aids in the compartmentalization of CaN substrates and downstream
effectors, increasing the efficiency with which CaN regulates target mechanisms.
For example, AKAP 79/150 holds CaN in a complex with PKA near AMPA
receptors, facilitating the regulation of these receptors [55]. Additionally, binding
of CaN to AKAP 79/150 directly regulates CaN activity. CaN activity has been
shown to be decreased by approximately 25% when bound to the AKAP 79/150
molecule [40]. Finally, molecular scaffolds can recruit further neurotransmitter
receptors and other PSD proteins in response to neuronal activity.
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The anchoring of CaN near AMPA receptors by AKAP 79/150 suggests
strongly that the enzyme may regulate these receptors. Recent research has
demonstrated that this is, in fact, the case. CaN has been shown to negatively
modulate these ligand-gated ion channels by several mechanisms. First, CaN
appears to directly dephosphorylate the AMPA receptor GluR1 subunit at Ser
845 [57]. Phosphorylation at this serine site potentiates the response of AMPA
receptors to glutamate [58], thus CaN-mediated dephosphorylation of this site
depotentiates the receptor. Further evidence for CaN-mediated negative
modulation of AMPA receptors is provided by a study where the calcineurin
autoinhibitory peptide was diffused into neurons via patch pipette. Under the
influence of the autoinhibitory peptide, the amplitude of glutamate-induced fast
EPSC’s increased [59]. Finally, some recent evidence suggests that CaN plays a
role in NMDA receptor-triggered endocytosis of AMPA receptors, thus indirectly
limiting AMPA receptor activity [60]. These mechanisms have all been proposed
as a possible explanation of CaN’s effects on LTP and LTD.
Calcineurin also appears to negatively modulate the other major class of
glutamate-gated ion channels, NMDA receptors. Lieberman and Mody
discovered that FK506 prolonged NMDA receptor channel open time in granule
cells of the dentate gyrus [61], although they did not determine if this was due to
a direct dephosphorylation of the receptor protein. A later study discovered that
calcineurin was involved in glycine-insensitive desensitization of the NMDA
receptor in outside-out patches from hippocampal neurons (a type of
desensitization in which the NMDA receptor becomes desensitized to glutamate

10

due to extended binding of ligand to the receptor) [62]. Inhibition of CaN with an
autoinhibitory

peptide reduced

subsequently

discovered

that

desensitization
this effect of

of

the

CaN on

receptor.

It

was

NMDA receptor

desensitization was due to a direct dephosphorylation of the receptor on the Cterminus of the NR2A subunit [63]. This densensitization of NMDA receptors was
observed under more physiological conditions (and found again to be CaNdependent) using synaptic NMDA receptors in hippocampal cell culture. Synaptic
NMDA receptors were stimulated by causing glutamate release from presynaptic
neurons.

Desensitization

was

observed

under

these

conditions,

and

desensitization was blocked through the use of CaN inhibitors [64].
GABAA receptors are the primary receptor responsible for the fast
inhibitory response in neuronal tissue [65]. Several recent studies have
demonstrated a down-regulation of GABAA receptor function by CaN [66-68].
This modulation of GABAA receptor function may occur through direct
dephosphorylation of receptor subunits. For example, a recent study described a
direct interaction of CaN with the gamma 2 subunit of GABA receptors. CaNmediated dephosphorylation of this subunit was shown to produce long-term
depression (LTD) of inhibitory synapses [69].
Finally, CaN also regulates a number of cytoskeletal elements. CaN has
been shown to dephosphorylate several microtubule-associated proteins,
including MAP2 and tau [70]. MAP2 is a protein that co-purifies with tubulin and
is present in neuronal cell bodies, axons and dendrites, and is important for the
crosslinking of microtubules to one another and to other cytoskeletal elements.
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MAP2 is highly phosphorylated in vivo, and this phosphorylation seems to be
involved in the crosslinking and assembly of microtubules. A number of studies
have demonstrated a CaN-dependent dephosphorylation of MAP2. This
dephosphorylation was induced by activation of the NMDA receptor in several
studies, suggesting that CaN may regulate the microtubule structure in response
to neuronal excitation. Like MAP2, tau has also been shown to crosslink
microtubules to one another [71] and CaN has been shown to dephosphorylate
tau [72]. In fact, exogenous CaN added to cultured neurons resulted in
dephosphorylation of at least four tau phosphorylation sites [73], while reduction
of

CaN

expression

by

antisense

oligonucleotides

resulted

in

hyperphosphorylation of tau at two sites [74]. Loss of CaN-mediated tau
dephosphorylation has been a topic of intense interest in Alzheimer’s disease, as
hyperphosphorylated tau is a major component of the neurofibrillary tangles that
are a hallmark of the disease [75]. In a more normal physiological role, CaNmediated tau dephosphorylation has also been shown to be involved in the
acquisition of polarity in cultured neurons [76]. Finally, in addition to its actions on
microtubule-associated proteins, CaN is also capable of modulating actin
stability. Calcineurin has been shown to be involved in extension of neuronal
growth cones by encouraging actin depolymerization and turnover, likely by
dephosphorylating a number of factors [77, 78]. CaN has also been observed to
alter dendritic spine morphology, both in neuronal cultures and in a hippocampal
slice model of LTD [79, 80]. Finally, CaN has been shown to regulate several
actin-associated proteins, including cofilin and calponin [81]. Cofilin acts as an

12

actin-depolymerizing

factor,

and

is

stimulated

by

CaN-mediated

dephosphorylation, while calponin is an actin binding protein that is associated
with smooth muscle contraction. Both proteins have been identified in neurons
and have been implicated in dendritic spine plasticity [82, 83].
Given its essential role in modulating neuronal excitability and its ability to
regulate the architecture of the neuronal cytoskeleton, alterations in CaN
expression or activity by disease states have a great deal of pathological
potential. The present study investigates the role of CaN in two such conditions,
traumatic brain injury and status epilepticus.

Traumatic Brain Injury:
Traumatic brain injury is a major cause of death and disability in the
United States, particularly among young adults and the elderly [84], has been
associated with a number of long-term neurological pathologies, including
cognitive deficits and the development of post-traumatic epilepsy [85]. Limiting
the mortality and long-term neurological pathology associated with these injuries
has been a major focus of research for many years. A number of delayed
processes are thought to contribute to the neuronal pathology associated with
these injuries. The current hope is that a better understanding of these
secondary processes will help provide neuroprotective clinical treatments for the
brain-injured patient. Preventing this secondary damage of brain tissue may
allow for better post-injury outcomes, especially in patients with mild to moderate
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injuries, where the area of primary damage may be small. One pathological
mechanism that has been of great interest is excitotoxic neuronal damage.
Following TBI, widespread neuronal depolarization leads to excessive
release of glutamate [86]. The presence of such large amounts of excitatory
neurotransmitter leads to toxic activation of post-synaptic receptors, influx of
calcium ions, and pathological overactivation of calcium-stimulated systems.
These calcium-stimulated enzymes and transcription factors are then thought to
lead to a number of pathological changes in neurons, including axonal sprouting
and synaptic reorganization, dendritic pull-back, neuronal hyperexcitability and
cell death. This excessive glutamate release has been observed both in several
animal models of injury and clinically (via the use of microdialysis probes) [8789]. Interestingly, the rise in glutamate levels can be delayed anywhere from
several hours to a day after the initial brain injury. Ideally, this presents a clinical
window for the administration of neuroprotective agents. Unfortunately, efforts at
pharmacological treatments that focus on this pathway, while promising in animal
models, have been unsuccessful clinically [90]. A more complete understanding
of the calcium-regulated mechanisms that are activated by this post-traumatic
glutamate release may help with the development of more focused and effective
treatment options.
A mounting body of evidence suggests that CaN may be one such TBImodulated system. CaN activation has been observed in vitro in several studies
of glutamate excitotoxicity [91, 92]. Additionally, both of the immunosuppressive
CaN inhibitors, cyclosporin A and FK506 (tacrolimus), have been shown to be
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neuroprotective in several animal models of TBI. Singleton and colleagues
demonstrated protection by FK506 against diffuse axonal injury [93], this
protection was shown to be a result of FK506 preventing TBI-induced impairment
of axonal transport [93]. Some controversy exists over the mechanism of action
of these inhibitors in TBI, as cyclosporin in particular has other actions in addition
to inhibition of CaN, and may be providing neuroprotection through more than
one pathway. Cyclosporin blocks the mitochondrial permeability transition pore,
thought to be a key step in both the induction of apoptosis and axonal injury [94].
However, the efficacy of FK506 (which is more specific in its effects) in
preventing a number of pathological processes tends to argue for a CaNdependent mechanism. Further research is required to accurately determine the
involvement of CaN in TBI-associated neuronal pathology.

Status Epilepticus:
Epilepsy and other seizure disorders are one of the most common
neurological conditions in the United States today. These disorders can have a
negative impact on quality of life for a number of reasons [95]. Depending on the
patient’s seizure frequency and severity, seizure disorders can limit cognitive
development in children [96], prevent daily activities such as driving a car or
working [97], and may require a lifetime of medication, often with unpleasant side
effects [98, 99]. In spite of this, in most seizure disorders the seizures themselves
are self-limiting – lasting a few minutes at most – and thus are not life threatening
on their own. However, seizures that do not self-terminate after a few minutes
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are life threatening and merit aggressive treatment. This condition of continuous
seizure activity is known as status epilepticus (SE).
SE, affecting over 100,000 people annually [100], is defined as continuous
seizure activity that exceeds thirty minutes in duration, or a number of individual
seizures that total more than thirty minutes and between which the patient does
not regain consciousness. SE can be subdivided into convulsive and nonconvulsive SE (NCSE). Convulsive SE, which can be generalized (GCSE) or
patrial manifests both behavioral and electrographic seizures, and is associated
with a higher acute mortality. On the other hand, NCSE is characterized by
electrographic

seizures

without

convulsions

and

has

several

possible

presentations, ranging from mild confusion to coma [101]. NCSE requires
electroencephalography (EEG) for definitive diagnosis. Both subtypes of SE
represent a severe neurological emergency associated with significant morbidity
and mortality [102, 103]. SE is of particular concern in the elderly population, with
a higher incidence among these patients. SE also has a markedly higher
mortality rate among elderly patients, partly due to the greater incidence of other
complicating conditions in this population [104].
Many of these cases of SE may be attributed to a causative event, such
as an injury or illness. Underlying epilepsy is perhaps the most common cause of
SE, especially in patients without adequate antiepileptic drug therapy [105].
Traumatic brain injury is also associated with the development of SE [106, 107].
The onset of continuous seizures often greatly complicates the treatment of
traumatic brain injury and is associated with lower rates of recovery [108]. Other
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causes of SE include brain neoplasms, drug overdose or withdrawal, infection,
fever (especially in children) and stroke [105]. However, in many cases a
causative event cannot be identified.
Regardless of the cause, SE requires urgent treatment to prevent longterm injury or mortality. Unfortunately, common anti-epileptics are not effective in
some cases of SE, especially as the duration of the seizure activity increases
[109]. As a result, SE often requires aggressive treatment with general
anesthetics, placing the patient in a drug-induced coma to reduce or eliminate
electrographic seizure activity. Additionally, patients require cardiovascular and
respiratory support to help them survive the SE episode [110]. While termination
of the seizure activity is essential for patient survival (particularly in GCSE), these
treatments are not without risks and are not always optimally effective.
Understanding why SE becomes refractory to first- and second-line treatments
and devising new treatment options are currently major focuses of a number of
research studies.
Even

among

patients

that

survive

SE,

long-term

neurological

complications are a common consequence of a prolonged seizure episode.
Potential consequences of SE include cognitive deficits and the development of
spontaneous recurrent seizures (i.e. epileptogenesis) [105, 111]. Developmental
delay has been associated with SE in children, especially in non-febrile, nonidiopathic cases [96]. A more complete understanding of the cellular mechanisms
underlying these pathologies may help limit the morbidity currently associated
with continuous seizure activity.
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As with TBI, glutamate-mediated excitotoxicity and calcium-mediated
injury are thought to be a major cause of SE-mediated neuronal damage [1, 112].
Acutely, blockade of the NMDA receptor has been shown to preserve
benzodiazepine efficacy well into SE, suggesting that calcium-regulated systems
may be partially responsible for refractoriness to anti-epileptic drugs [113].
Additionally, blockade of glutamate receptors limits neuronal death in SE.
Chronically, excitotoxic/calcium-mediated mechanisms are important in the
development of several SE-associated pathologies. For example, in the
pilocarpine model of SE, several studies have demonstrated that post-SE
cognitive dysfunction and epileptogenesis were dependent on NMDA-receptor
mediated calcium influx [114-116].
NMDA-mediated calcium influx leads to toxically high levels of calcium
inside of neurons during the seizure event. However, this acute spike in free
calcium is not the only source of excessive intracellular calcium implicated in the
pathology of SE. It appears that calcium levels remain chronically high in neurons
well after SE, due to a reset of the neuron’s normal resting calcium levels [117,
118]. Additionally, after SE neurons respond more slowly to a calcium challenge,
requiring more time to remove calcium once it has entered the neuron [119].
Since calcium is such a pervasive second messenger in cellular processes, this
SE-induced increase in resting calcium concentrations can lead to chronic
activation of calcium-stimulated enzymes and subsequent disregulation of
synaptic function. Neuronal free calcium levels are normally maintained in at
nanomolar concentrations through the actions of several calcium sinks, including
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plasma membrane calcium pumps, calcium-binding proteins, and calcium
sequestration by the mitochondria and smooth endoplasmic reticulum. Recent
research has implicated at least one of these mechanisms in SE-induced altered
calcium handling. Parsons et al [120] demonstrated that the ATP-dependent
calcium pumps of the smooth ER are damaged by SE, resulting in an uncoupling
of their ATP usage from their calcium pumping activity and a loss of efficiency in
ER calcium sequestration. These calcium-related pathological mechanisms have
made calcium-regulated systems an intriguing area of research in SE. One such
calcium-regulated system that may play a role in the pathology of SE is CaN.
Some evidence points to a role for CaN in SE. As with TBI, CaN inhibitors
have proven neuroptotective in some seizure models. Moriwaki et al
demonstrated that CaN inhibitors prevented epileptogenesis and behavioral
deficits after kainite-induced SE, although no effect was observed on the acute
seizure activity of SE, suggesting that CaN may be important for the
development of SE-associated chronic pathologies [121]. However, the
mechanism underlying this neuroprotective effect has not been elucidated. Moia
and colleagues observed a similar anti-epileptogenic effect in a kindling model,
with administration of FK506 or cyclosporin A preventing electrical-stimulation
kindling in rats [122]. In the same study, CaN was shown to translocate into postsynaptic membrane fractions as a result of kindling, possibly indicating that CaN
modulates

neuronal

excitability

post-synaptically

during

epileptogenesis.

Sanchez et al. [123] suggested one potential seizure-induced post-synaptic effect
of CaN in a model of hypoxic seizures in immature rats. In this study, CaN
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activity was increased post-seizure, and this increase in CaN activity appeared to
modulate the activity of the GABAA receptor. In spite of these intriguing results in
other seizure models, no study has yet examined the effects of SE on CaN
activity, or demonstrated the role of CaN in SE-associated pathology.

The present study characterizes the effects of two different models of
neuronal injury on the activity and subcellular distribution of CaN. In chapter one,
we examine basal and maximal CaN activity in forebrain homogenates after a
one-hour SE event. In this chapter, we also describe SE-induced changes in
CaN substrate kinetics. Finally, chapter one also examines the NMDA receptordependence of these changes in CaN activity, and determines whether the
observed SE-induced changes in CaN activity are due to an overall increase in
enzyme concentration. In chapter two, through the use of western and
immunohistochemical analysis, we show an SE-dependent increase in the
amount of CaN present in the post-synaptic region of hippocampal and cortical
neurons. This SE-induced increase in synaptoplasmic CaN concentration is
accompanied by a dramatic increase in CaN activity in this fraction. Chapter two
also presents data on SE-induced changes in CaN enzyme activity in subcellular
fractions taken from cortex and hippocampus. Taken together, the results
presented in the first two chapters of this study describe a profound increase in
post-synaptic CaN concentration and activity after one hour of SE, changes that
could have major implications in the pathology of SE. In chapters three and four
we present TBI-induced changes in CaN activity and post-synaptic concentration
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in the moderate fluid percussion model of traumatic brain injury. These changes
in CaN activity and subcellular distribution persist for several weeks post-injury, a
time-course which corresponds to a number of TBI-associated pathologies.
Finally, in chapter five, we discuss a major physiological consequence of SEinduced increases in post-synaptic CaN activity and concentration: loss of
dendritic spines. CaN was shown to be part of a cellular mechanism of SEinduced dendritic spine loss, possibly implicating the enzyme in SE-induced
chronic neurological pathology. Altogether, the results presented in this study
provide compelling evidence that CaN is involved in neuronal damage in two
disparate models of injury, and support the hypothesis that SE-induced increases
in CaN activity lead to decreased dendritic spine density. Ideally, further research
in this topic will provide a basis for future neuroprotective and therapeutic
treatments.

CHAPTER I
A SIGNIFICANT INCREASE IN BOTH BASAL AND MAXIMAL
CALCINEURIN ACTIVITY IN THE RAT PILOCARPINE MODEL OF
STATUS EPILEPTICUS

INTRODUCTION
Status epilepticus (SE) is a severe medical condition, affecting 102,000 to
152,000 people per year in the United States [100, 103]. Defined as continuous
seizure activity lasting thirty minutes or greater, SE is a life-threatening medical
emergency, associated with significant mortality rates [103, 105, 124]. According
to recent studies, status epilepticus results in between 22,000 and 42,000
fatalities every year in the U.S. [100, 103]. In addition, SE is also associated with
physiological and neurochemical changes which take place during the seizure
activity [105, 125, 126]. These cellular changes may later manifest themselves as
spontaneous recurrent seizure activity (i.e. epilepsy), through a process known
as epileptogenesis [105, 111]. Therefore, victims of status epilepticus incur both
an immediate, serious risk of death, and another, long-term risk of developing
recurrent seizure activity.
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Modulation of intracellular calcium levels is important in a number of
normal neuronal processes including regulation of gene expression, development
of learning and memory, and neurotransmitter synthesis and release [127, 128].
However, alterations in calcium-regulated systems and loss of calcium
homeostasis have also been implicated in many pathological conditions, such as
ischemia [129-131], traumatic brain injury [132, 133], and SE [118, 120].
Specifically, influx of calcium through the NMDA subtype of glutamate receptor is
suspected to be important for physiological changes occurring after SE [116,
118, 126]. NMDA-linked increases in intracellular calcium affect a number of
calcium-controlled

cellular

mechanisms

and

enzymes

including

calcium/calmodulin-dependent kinase II (EC 2.7.1.123, CaM Kinase II) [127,
134], calpain I (EC 3.4.22.17) [135] and calcineurin (EC 3.1.3.16 CaN) [136].
Calcineurin is a calcium/calmodulin-stimulated phosphatase enriched in
neural tissue [137]. CaN-mediated dephosphorylation is an important modulatory
factor in many cellular processes, including development of learning and memory
[138], regulation of LTP and LTD [139], and induction of apoptosis [140].
Additionally, CaN may depress the activity of the GABA receptor, an important
inhibitory receptor in the brain [67]. These characteristics make CaN an intriguing
enzyme for study in SE. In spite of this, no studies have yet focused on SEdependent changes in CaN activity.
This study was undertaken to characterize changes in calcineurin activity
in specific brain regions following status epilepticus. Basal and maximal CaN
activities were investigated, with an NMDA-receptor activation-dependent
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increase present in both. Since CaN regulates many important neuronal
processes, an increase in the activity of this important enzyme may be involved
in SE-induced alterations of neuronal function.
METHODS AND MATERIALS:
All materials were reagent grade and were purchased from Sigma
Chemical Co. (St. Louis, MO) unless otherwise noted. Bio-Rad protein assay
concentrate, sodium dodecyl sulfate (SDS), 2-mercaptoethanol, blotting grade
dry milk, and Mini-Protean II SDS-PAGE apparatus and power supplies were
purchased from Bio-Rad Laboratories (Richmond, CA). Okadaic Acid was
purchased from BioMol (Plymouth Meeting, PA). ABC reagents were obtained
from Vector Laboratories (Burlingame, CA). Absolute ethyl alcohol was
purchased from AAPER Alcohol and Chemical Co. (Shelbyville, KY). Adult male
Sprague-Dawley rats were obtained from Harlan Laboratories (Indianapolis, IN).

Pilocarpine model of status epilepticus:
All animal use procedures were in strict accordance with the Guide for the
Care and Use of Laboratory Animals described by the National Institutes of
Health and were approved by the Virginia Commonwealth University Animal Use
Committee. SE was induced in adult male Sprague-Dawley rats by the method
described in Mello et al [141]. Rats were handled regularly for approximately one
week to acclimate them to handling prior to drug administration. Adult rats
weighing

175-230g

were

injected

intraperitoneally (i.p.)

with 350mg/kg

pilocarpine HCl, a potent muscarinic agonist. 30 minutes prior to the pilocarpine
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injection,

all

rats

were

treated

i.p.

with

1mg/kg

methylscopolamine.

Methylscopolamine is a peripheral muscarinic antagonist; administering it prior to
pilocarpine injection minimizes adverse peripheral effects. Control rats received
all injections, except that pilocarpine was administered at 1/10th its seizureinducing dose. Control animals did not exhibit any behavioral seizure activity.
When appropriate, rats were injected with the non-competitive NMDA antagonist,
MK-801 (4 mg/kg, i.p.), 20 minutes before pilocarpine injection. All drugs were
dissolved in 0.9% saline.
Behavioral seizures typically began 20 minutes following pilocarpine
injection. Seizures were rated according to the scale described by Racine [142].
Only animals reaching stage 5 seizures were included in this study. Stage 5 was
classified as the most severe level of seizure activity, characterized by rearing
and falling. Rats not responding to the initial pilocarpine injection received a
second injection, often of a lower dose. Rats that still did not display stage 5
seizure activity following a second pilocarpine injection were excluded from the
SE group [134].

Isolation and homogenization of brain regions:
Rats were rapidly decapitated after 1 hour of SE. Brains were dissected
on a petri dish on ice to preserve post-mortem enzyme activity. Cortical,
hippocampal, and cerebellar brain regions were quickly isolated and immediately
homogenized with 10 strokes (up and down) at 12,000 rpm, using a motorized
homogenizer (TRI-R Instruments, Inc. Rockville Center, NY). Brain regions were

25

homogenized into ice-cold homogenization buffer containing 5mM HEPES (pH
7.0), 7mM EGTA, 5mM EDTA, 1mM dithiothreitol (DTT), 0.3mM PMSF, and
300mM sucrose. Cortical regions were homogenized into 7ml of buffer,
hippocampal regions into 3ml of buffer, and cerebellar regions into 5ml. All brain
homogenates were normalized for protein, separated into aliquots and stored at
–80°C until used.

pNPP assay of phosphatase activity:
Calcineurin activity was assayed using a modification of the procedure
detailed by Pallen and Wang [143]. All reaction tubes were prepared on ice and
contained the following: 25mM MOPS (pH 7.0), 1mM DTT, 2mM p-nitrophenol
phosphate (pNPP). Some basal tubes also contained 2mM EGTA and 2mM
EDTA. Maximal tubes contained the same reagents as basal reactions, with the
addition of 2mM MnCl2. Final reaction volumes were 1ml. Both Mn2+ and
Ca2+/calmodulin activate calcineurin in this assay; however, Mn2+ activates
calcineurin more strongly than calcium [21]. Therefore, Mn2+ was used instead of
calcium in maximal reactions to better visualize the cation-stimulated activity of
the enzyme. When called for, 150nM okadaic acid, 50µM okadaic acid (sodium
salt), or 100µM NaVO4 was added to both basal and maximal tubes. Prior to use,
the protein concentration of all homogenates was determined using the method
of Bradford et al. [144]. Reactions were initiated by the addition of 200 mg/ml
brain region homogenate. Unless otherwise specified, standard reactions were
incubated at 37°C for 15 minutes in a shaking water bath. Tubes were then
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removed from the water bath and placed in ice to stop the reaction. Absorbance
of

the

reaction

mixture

was

immediately

measured

at

405nm

in

a

spectrophotometer (UV-2101, Shimadzu Scientific Instruments, Inc. Columbia,
MD). Absorbance units were converted to nmol of pNP produced by comparison
to a pNP concentration standard absorption curve.

pNPP substrate kinetics:
Basal reaction tubes were prepared containing 25mM MOPS, 1mM DTT,
2mM EGTA, 2mM EDTA, and 150nM okadaic acid to minimize the influence of
other phosphatases on the results of the assay.

Maximal reaction tubes

contained 25mM MOPS, 1mM DTT, 2mM MnCl2, and 150nM okadaic acid. All
reaction tubes were prepared on ice. pNPP was added to the tubes for final
concentrations of 0, 0.1, 0.2, 0.5, 1, 2, 4, 8, 16 and 24mM. CaN reactions were
initiated by the addition of homogenate and assayed as described above. Values
for Km and Vmax were obtained via a non-linear regression analysis of the
substrate isotherm.

CaN protein level analysis:
Western analysis was performed essentially as described previously [145,
146]. Briefly, homogenates were resolved on SDS-PAGE and transferred to a
nitrocellulose membrane using the Geni blot system (Idea Scientific, Minneapolis,
MN). Nitrocellulose was then immersed for one hour in blocking solution
containing phosphate buffered saline (PBS, pH 7.4), 0.05% (v/v) polyoxyethylene
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sorbitan monolaurate (tween-20), 50 g/L Bio-Rad blotting grade dry milk, and
horse serum (Vector Laboratories Inc., diluted 50 µl/10ml). The nitrocellulose
membrane was then incubated with primary antibody in blocking solution for one
hour. Anti-CaN A antibody (clone CN-A1, mouse monoclonal IgG, Sigma
Chemical Co.) was diluted 1:10,000 for western analysis. Membranes were then
washed three times in a wash solution containing PBS, tween-20, and dry milk.
Nitrocellulose was then reacted with a secondary antibody in blocking solution for
45 minutes. The membrane was then washed three times and incubated with an
avidin-biotinylated horseradish peroxidase complex for 30 minutes. Nitrocellulose
was then washed three times in PBS for 10 minutes per wash. Blots were
developed with a solution containing 10 ml PBS, 0.025% (v/v) H2O2, and 8 mg 4chloro-1-napthol dissolved in 2ml of methanol. Specific immunoreactive bands
were quantified by computer-assisted densitometry (Inquiry, Loats Associates,
Westminster, MD).

Statistical analysis:
All statistical analysis of data was performed using GraphPad Prism 3.0
(GraphPad Software, San Diego, CA), or Sigma Stat 2.03 (SPSS Inc, Richmond,
CA). Levels of phosphatase activity were compared to control using the Student’s
t-test (two-tailed distribution, unpaired or paired where appropriate) or one-way
ANOVA with Tukey post analysis to control for type 1 errors in multiple
comparisons. Values for Vmax and Km were determined by a non-linear regression
curve for single-site substrate binding, included with the Prism software.

28

Computer assisted densitometric analysis was performed using Inquiry (Loats
Associates Inc, Westminster, MD).

RESULTS:
Status epilepticus results in an increase in calcineurin activity in specific
brain regions:
Calcineurin dephosphorylates the low molecular weight compound pnitrophenolphosphate (pNPP) with high affinity, producing p-nitrophenol (pNP)
[143]. It is possible to measure this dephosphorylation spectrophotmetricaly,
providing a simple and accurate method for quantifying calcineurin activity. In the
present study, CaN activity was measured via the pNPP assay in homogenates
obtained from the cortex, hippocampus, and cerebellum of SE and control rats.
Both basal and maximal CaN activity were measured in SE and control
animals (Figure 1). In every sample studied, SE caused an increase in
phosphatase activity above control levels in both the cortex and hippocampus,
but not the cerebellum. Average basal activity in control samples was 0.79 ± 0.10
µg pNP /min in cortical homogenates, and 0.86 ± 0.03 µg pNP/min in
hippocampal homogenates. Following SE, basal CaN activity was elevated 48.6
± 14.5% above control in the cortex (Figure 1A) (1.18 ± 0.04µg pNP/min, p <
0.01, n=6, two-tailed unpaired Student’s t-test) and 20.8 ± 4.9% in the
hippocampus (Figure 1B) (1.04±0.03µg pNP/min, p < 0.001, n=9). The elevated
activity was biological, and could be eliminated by boiling the homogenate prior
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to beginning the reaction. The increase was present in spite of the addition of ion
chelators to the reaction mix (see methods).
Unlike homogenates from the cortex and hippocampus, basal activity in
cerebellar homogenate was not significantly increased after SE. Basal activity in
cerebellar homogenates isolated from control animals was 0.92 ± 0.08µg
PNP/min. After SE, activity in the cerebellum was elevated to 1.00 ± 0.05µg
PNP/min, an increase of 8.0 ± 10.1% (Figure 1C). This was not a significant
increase (p > 0.05, n=7). The difference in the response of the cerebellum from
that of the forebrain suggests that different mechanisms are involved in the
expression of SE in the cerebellum from that of the forebrain.
Maximal activity, like basal activity, was increased after SE in both the
cortex and hippocampus, but not the cerebellum. In cortical homogenates
isolated from control animals, pNPP dephosphorylation was found to be 1.34 ±
0.18µg pNP/min. Following SE, maximal cortical dephosphorylation activity was
elevated to 1.80 ± 0.05µg pNP/min, an increase of 34.2 ± 10.2% (Figure 1A, p <
0.01, n=6). An increase in maximal activity was also observed in hippocampal
homogenates. Control maximal activity was 1.36 ± 0.05µg pNP/min. SE resulted
in a 13.7 ± 5.1% increase in activity, to a post-SE value of 1.55 ± 0.02µg
pNP/min. (Figure 1B, p < 0.05, n=9). No significant change in maximal activity
was observed in the cerebellum. Control maximal activity was 1.54 ± 0.12µg
pNP/min in cerebellar homogenates. After SE, maximal activity increased to 1.60
± 0.08µg pNP/min. This was an increase of 4.0 ± 3.4% over control, which was
not statistically significant (Figure 1C, p > 0.05, n=7).
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The SE-dependent increase in CaN activity is due to an alteration in
enzyme kinetics:
To further characterize the SE-dependent effect on calcineurin activity,
several experiments were conducted in cortical homogenate to examine the
effects of SE on CaN-mediated pNPP dephosphorylation kinetics. Figure 2
shows the linear regression analysis of the time course for pre-steady state
pNPP dephosphorylation under basal and maximal CaN conditions. The slope of
the linear regression for each condition was used to estimate the rate of pNPP
dephosphorylation. The rate of CaN-dependent dephosphorylation of pNPP in
cortical homogenates from control animals was estimated to be 0.26 µg/min
under basal conditions. SE resulted in a 36.7 ± 7.6% increase in the rate of
pNPP dephosphorylation, to 0.36 µg/min (Figure 2A, p < 0.001, n=3, unpaired
student’s t-test). The increase in pNPP dephosphorylation rate was also
observed in maximal CaN reactions (Figure 2B). The rate of control pNPP
dephosphorylation was 0.68 µg/min under maximal conditions. SE resulted in a
significant increase in pNPP dephosphorylation, to a value of 0.80 µg/min (17.6 ±
4.7%, p < 0.05, n=3, unpaired student’s t-test). The data demonstrate a
significant increase in both basal and maximal pNPP dephosphorylation rates in
cortical homogenate
To determine the effect of SE on CaN affinity for pNPP, cortical
homogenates from SE and control animals were tested in the presence of
specific pNPP concentrations. (Figure 3). Through non-linear regression analysis
of the data, maximal pNPP dephosphorylation (Vmax) and substrate affinity (Km)
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for the dephosphorylation of pNPP were calculated. The control value for Vmax
was 1.21 ± 0.06µg pNP/min under basal reaction conditions. Following SE, Vmax
increased to 1.46 ± 0.03µg pNP/min, an increase of 20.5 ± 5.3% above the
control value (p < 0.05, n=3, two-tailed unpaired Student’s t-test). Substrate
affinity was also increased under basal conditions. In homogenates isolated from
control animals, Km was found to have a value of 1.25 ± 0.22mM. Post-SE, Km
decreased to 0.54 ± 0.06mM. This decrease in Km corresponded to a 56.8 ±
14.5% increase in substrate affinity in SE homogenates when compared to
control (p < 0.05, n=3). Under maximal conditions, Vmax was also increased after
SE. In control homogenates, Vmax was determined to be 1.73 ± 0.05µg pNP/min.
Following SE, Vmax was elevated to 1.93 ± 0.04µg pNP/min, an increase of 12.8 ±
3.5% over control (p < 0.05, n=3). Substrate affinity appeared to increase in SE
homogenates under maximum conditions; however, this difference was not
statistically significant (p > 0.05, n=3).

The increase in both basal and maximal pNPP dephosphorylation is due to
CaN:
The enzyme activity observed in the various brain regions is consistent
with CaN activity: calcineurin dephosphorylates pNPP readily, is stimulated by
Mn2+, and is most active at pH 6.8 - 7.0 [21, 143]. However, pNPP is a versatile
substrate, and is also dephosphorylated by some tyrosine and alkaline
phosphatases [147]. All experiments were conducted at a neutral, rather than
alkaline, pH (see methods). Therefore, it would be expected that alkaline
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phosphatases

have

only

a

minimal

contribution

to

the

observed

dephosphorylation of pNPP. To rule out tyrosine phosphatases and other
serine/threonine

phosphatases,

the

phosphatase

inhibitors

sodium

orthovanadate and okadaic acid were tested.
Sodium orthovanadate (NaVO4) is a potent inhibitor of tyrosine
phosphatases (IC50 = 10µM) [148]. Additionally, orthovanadate is a strong
inhibitor of the Mn2+-stimulated activity of calcineurin (IC50 = 1µM) [149]. It does
not, however, inhibit any non-Mn2+ stimulated calcineurin activity [149].
Dephosphorylation reactions were carried out in cortical homogenates in the
presence of 100µM NaVO4 under both basal and maximal (Mn2+-stimulated)
conditions (Figure 4). The addition of orthovanadate did not cause any significant
change in basal pNPP dephosphorylation in either control or SE homogenates (p
> 0.05, n=4, one-way ANOVA). Therefore, even in the presence of NaVO4, basal
pNPP dephosphorylation in homogenates isolated from SE animals was still
significantly greater when compared to control homogenates (p < 0.001, n=4,
unpaired student’s t-test). Thus, SE induced a NaVO4-resistant increase in pNPP
dephosphorylation. The data support the hypothesis that the SE induced
dephosphorylation was not due to tyrosine phosphatases.
As expected, the inclusion of orthovanadate did have a significant effect
on maximal pNPP dephosphorylation. Orthovanadate reduced maximal enzyme
activity to basal levels in both SE and control homogenates. The addition of
NaVO4 reduced control maximal activity from 1.19µg pNP/min to 0.62µg
pNP/min, a decrease of 48.1 ± 4.6% (p < 0.001, n=4, two-tailed paired student’s
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t-test). In SE homogenates, maximal activity was reduced by 40.7 ± 8.9%, from
1.67µg pNP/min to 0.99µg pNP/min (p < 0.001, n=4). The NaVO4-inhibited
maximal activity was significantly greater in SE homogenates when compared to
control homogenates (p < 0.001, n=4, two-tailed unpaired student’s t-test). Since
orthovanadate specifically inhibits only Mn2+-stimulated CaN activity, the
observed inhibition of maximal activity, but not basal activity, is consistent with
CaN-dependent dephosphorylation.
To further characterize the CaN-dependent dephosphorylation of pNPP,
okadaic acid was utilized. Okadaic acid (OA) is a potent inhibitor of
serine/threonine phosphatases 1 and 2A [150], with an IC50 of 10-15 nM for PP1,
and an IC50 of 100 pM for PP2A. Okadaic acid is also an inhibitor of calcineurin,
although with a much lower affinity (IC50 =5mM) [150]. This difference in
sensitivity makes OA a valuable tool in differentiating between the activities of
these three phosphatases. CaN activity was first assayed in the presence of
150nM OA, a concentration sufficient to inhibit both PP1 and 2A, but not high
enough to significantly affect CaN activity. The inclusion of 150nM OA did not
significantly affect pNPP dephosphorylation in cortical homogenates (Fig. 5A).
The lack of OA-dependent inhibition was observed under both basal and
maximal conditions for CaN activation. SE basal activity in the presence of
150nM OA was 1.03µg pNP/min, only 1.7% lower than the 1.05µg pNP/min that
was measured in the absence of inhibitor. This difference was not significant (p >
0.05, n=4, two-tailed paired student’s t-test). SE maximal activity was 2.14µg
pNP/min in the absence of inhibitor, and 2.00µg pNP/min in the presence of
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150nM OA, a decrease of 8.3% that was not statistically significant (p > 0.05,
n=4). Similarly, control basal activity was not significantly modified by low
concentrations of OA (p > 0.05, n=4). Control basal activity in the absence of OA
was 0.62µg pNP/min, and in the presence of OA activity was 0.69µg pNP/min.
Control maximal activity was 1.61µg pNP/min without OA and 1.68µg pNP/min
with OA, a difference of 4.7% (p > 0.05, n=4). These results indicated that PP1
and 2A are not responsible for the SE-dependent increase in phosphatase
activity observed under either basal or maximal conditions.
Dephosphorylation of pNPP was also carried out at a higher concentration
(50µM) of OA. This concentration of OA was high enough to block the activity of
CaN, and was found to significantly decrease pNPP dephosphorylation in both
control and SE cortical homogenates (Fig. 5B). Maximal activity in control
homogenates was reduced from 1.29µg pNP/min to 1.20µg pNP/min by the
addition of inhibitor (a decrease of 8.8 ± 2.8%, p < 0.01, n=6). Similarly, maximal
activity was reduced in SE homogenates by 10.7 ± 4.2%, from a value of 1.57µg
pNP/min without inhibitor to a value of 1.40µg pNP/min in the presence of OA (p
< 0.01, n=6, two-tailed paired student’s t-test). However, basal activity was not
inhibited by 50µM OA in control homogenates (p>0.05, n=6). Under basal
reaction conditions, most of the required ions for CaN activation are either not
present or bound to chelators, and CaN activity in control basal reactions is
probably very limited. Therefore, it is not surprising that 50µM OA does not inhibit
the control basal pNPP dephosphorylation. However, it is interesting to note that
the SE basal activity, unlike the control basal activity, was inhibited by high-
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concentration OA. Basal activity in the SE homogenate was reduced from 1.06µg
pNP/min to 0.94 µg pNP/min by the addition of 50µM OA, a decrease of 11.2 ±
4.4% (p < 0.01, n=6). The data suggest that SE results in the production of a
Ca2+-independent form of CaN that is sensitive to inhibition by high
concentrations of OA. However, the activity in SE homogenates was not entirely
reduced to control levels by the addition of 50µM OA. This may be due to the
solubility or efficacy limits of OA as a CaN inhibitor under these conditions, or it
may suggest that another, OA-insensitive phosphatase is also contributing to the
observed SE-dependent increase in phosphatase activity.
The lack of response to low concentrations of OA, the significant inhibition
by high concentration OA, and the distinctive reaction of the homogenate to
orthovanadate, all strongly suggest that CaN is responsible for the observed
increase in activity. In addition, the response of the SE homogenate to high
concentration OA under basal conditions suggests that the observed increase in
basal activity is due to the presence of a calcium independent form of CaN.

The increase in enzyme activity is not due to an increase in protein:
A potential explanation for the observed SE-dependent changes in CaN
activity and kinetics is an increase in the amount of enzyme present in the cell.
To investigate this possibility, western blot analysis was performed on
homogenate isolated from the cortex and hippocampus (Figure 6). Cerebellar
homogenate was not tested since there was no SE-dependent change in CaN
activity in the cerebellum. Immunoreactivity of the catalytic A subunit was
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determined using a monoclonal antibody to CaN A (CN-1, Sigma, St. Louis, MO).
In both the cortex (Figure 6A) and hippocampus (Figure 6B), a single band with
molecular weight of 61kDa was resolved. This size corresponds with the size of
the CaN A subunit [8]. Computer assisted densitometric analysis was performed
on SE and control fractions (see methods and materials). Optical density of the
immunoreactive band in SE homogenate was found to be 93.62 ± 3.01% of
control in the cortex and 104.17 ± 14.57% of control in the hippocampus. No
significant difference in the density of the 61kDa band was found in either brain
region, indicating equal total amounts of the enzyme in both SE and control
animals in both regions (p>0.05, n=4, two-tailed unpaired student’s t-test). The
data suggest that the increase in enzyme activity was not due to increased
protein synthesis, but due to another mechanism, such as post-translational
modification of the enzyme, or increased Ca/CaM binding to the enzyme
following SE.

The increase in calcineurin activity occurs through an NMDA-dependent
mechanism:
Calcium influx through the NMDA subtype of glutamate receptor is
essential for the development of a number of SE-dependent alterations in
neurochemical and physiological processes [115, 120, 127, 134]. To investigate
the involvement of NMDA-regulated calcium influx on the SE-dependent increase
in calcineurin activity, MK-801 was used to block the NMDA receptor-associated
calcium channel during seizure activity. Pre-injection of MK-801 has been shown
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to prevent many of the NMDA-receptor dependent consequences of SE, but
does not prevent or inhibit the pilocarpine-induced seizures in this model [115].
Cortical (Figure 7A) and hippocampal (Figure 7B) homogenates from MK801 treated SE animals were assayed for phosphatase activity via the pNPP
assay as described. Injection of MK-801 alone (no SE) did not induce a
significant change in calcineurin activity. However, MK-801 injection did block the
SE-induced increase in calcineurin activity. In the cortex, basal calcineurin
activity in MK-801 animals was 0.88µg pNP/min, only slightly higher than the
control activity of 0.82µg pNP/min. The observed increase was not statistically
significant (7.2 ± 16.8% increase over control, p > 0.05, n=4, one-way ANOVA
with Tukey post-hoc analysis). Maximal activity of MK-801 and control animals
was also not significantly different: 1.38µg pNP/min for control homogenates and
1.48µg pNP/min for MK-801 homogenates (an increase of 7.1 ± 11.4%, p > 0.05,
n=4). Cortical calcineurin activity was significantly higher in pilo-SE animals than
in either control or MK-801 treated animals. SE basal CaN activity was 1.21µg
pNP/min, an increase of 37.8 ± 11.0% over the MK-801 group (p < 0.05, n=4).
Maximal activity was 1.86µg pNP/min, 26.0 ± 6.8% higher than that of the MK801 homogenates (p < 0.05, n=4). This data suggests that NMDA-dependent
calcium influx during SE is essential for the observed increase in calcineurin
activity in the cortex.
Hippocampal homogenates from MK-801 treated animals had significantly
lower basal and maximal CaN activity than hippocampal SE homogenates (p <
0.05, n=4, one-way ANOVA with Tukey post-hoc analysis). However, unlike the
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cortex, CaN activity was not entirely reduced to control levels by MK-801 preinjection. A significant increase in CaN activity was still found in MK-801
homogenates (Figure 7B). The MK-801 basal value of 1.23µg pNP/min was
elevated 19.1% above the control value of 1.03µg pNP/min, but still significantly
lower than the activity in SE homogenates, which was 1.35µg pNP/min, or a
31.1% increase over control (p < 0.05, n=4). Likewise, maximal activity was
elevated above control in the MK-801 group, with a value of 1.67µg pNP/min, a
24.6% increase over the control value of 1.34µg pNP/min. However, this increase
was not as large as the increase in activity found in SE homogenates. SE
maximal activity was 31.3% above control, with a value of 1.76µg pNP/min. This
suggests that either the MK-801 did not entirely block the NMDA receptor in
hippocampal neurons, or that the SE-dependent increase in calcineurin activity is
controlled by additional mechanisms in the hippocampus. Overall, NMDA
receptor activation was found to play a significant role in the SE-induced increase
in CaN activity in both brain regions.

DISCUSSION:
Understanding the cellular and molecular changes that take place during
SE is essential to understanding the physiological mechanisms that cause this
severe seizure activity. This study characterizes the changes in both basal and
Mn2+-stimulated CaN activity in specific brain regions following SE. The data
demonstrate a significant increase in CaN activity in cortical and hippocampal
homogenates. The increase in phosphatase activity in cortical homogenates was
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found to be OA-sensitive. SE did not significantly affect CaN activity in
homogenates isolated from the cerebellum. In addition, the SE-induced increase
in CaN activity was NMDA-receptor activation-dependent. The present study is
the first definitive investigation of SE-dependent modulation of calcineurin
activity. The data supports the hypothesis that SE results in an NMDA-dependent
increase in both basal and maximal calcineurin activity in the rat forebrain, but
not in the cerebellum.
There are several possible mechanisms that could account for the
increase

in

CaN-mediated

dephosphorylation.

Calcineurin

is

a

calcium/calmodulin-stimulated enzyme [8] and would be stimulated by increased
intracellular calcium concentrations. SE induces a loss of function of the
endoplasmic reticulum Mg2+/Ca2+ ATPase [120]. This enzyme sequesters
calcium ions into the microsomes of the smooth ER, providing a high-affinity
mechanism for regulating intracellular calcium concentration [151, 152]. After SE,
ATPase-mediated uptake of calcium into the microsomes is less efficient [120],
which

could

potentially

result

in

higher

than

normal

resting

calcium

concentrations inside the cell. In fact, an increase in intracellular free calcium has
been found during and after SE [118]. The increased intracellular calcium
associated with SE could be responsible for activating CaN above its normal
physiological level. However, it is unlikely that increased calcium observed in vivo
is directly responsible for the increase in CaN activity following SE observed in
this study. Increasing chelator concentrations did not effect the SE-induced
increase in CaN dephosphorylation (Data not shown). Additionally, no difference
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in free calcium between SE and control homogenates was present, as
determined by calcium-specific electrode measurements as described by
Parsons et al [130] (93-20 calcium electrode, Orion, Boston, MA). Thus, the
effects of any alterations in intracellular free calcium would be minimal under the
conditions used in the present study.
Another possible explanation for the observed increase in CaN activity is
an increase in the amount of enzyme present in the cell. This is unlikely, since it
would require translation of a significant amount of enzyme in a relatively short
amount of time (animals actively seized for slightly less than 1 hr). Western
analysis of SE and control homogenates further eliminated this possibility, as no
significant increase in total enzyme level was observed in any brain region
studied.
Another possible mechanism is post-translational modification of CaN,
producing a more active form of the enzyme. One such modification could be
limited proteolysis by the calcium-stimulated neutral protease, calpain I. Calpain
may be activated by the increased intracellular calcium concentrations present
during and after SE. Supporting this hypothesis, calpain is activated in other
neurotraumatic events that involve glutamate excitotoxicity, such as ischemia
[153] and traumatic brain injury [154]. Calpain proteolysis could account for the
increased Vmax, decreased Km, and increased enzyme activity observed post-SE
in this study. Calpain cleaves the catalytic CaN A subunit, removing the
calmodulin binding domain and creating a highly active, 43 kDa, calciumindependent form of the enzyme [12, 14]. Some researchers also surmise that
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calpain-mediated proteolysis removes the autoinhibitory domain present in the A
subunit [14], although other studies suggest that this may not be the case [155].
Significant proteolysis of CaN was not responsible for the observed
alteration in enzyme function, since no decrease in total enzyme was observed in
western analysis of the SE homogenate. Additionally, no degradation products
reacted with the anti-CaN A antibody. However, it is possible that the total
amount of enzyme broken down by calpain was too small to detect in the western
analysis that was used. Calpain-degraded CaN is reported to be 1100% more
active than normal enzyme, while SE produced only a 20-50% increase in
activity. The magnitude of this difference suggests that, if the calciumindependent 43 kDa fragment is present, it constitutes only a small amount (35%) of total enzyme. A difference in protein levels of this magnitude would be
difficult to detect through western blot analysis. It is also possible that the epitope
recognized by the antibody was no longer present following proteolysis,
explaining why no small fragments appeared on the western blot.
Finally, post-translational modification other than calpain proteolysis may
be taking place, activating CaN through another, unidentified mechanism. For
example, calcineurin is phosphorylated at the same location by both protein
kinase C and CaM kinase II, inhibiting the enzyme through a decrease in
substrate affinity [35, 37]. Calcineurin and CaM kinase II share a similar
distribution in the brain [156], and regulation of CaN by CaM kinase II is not
unlikely. However, long-lasting inhibition of CaM kinase II has been observed
following SE in multiple models [134, 157, 158]. It is possible that a decrease in
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the CaM kinase II-mediated phosphorylation of CaN produces a net increase in
the amount of active calcineurin. While this mechanism would account for the
observed increase in maximal calcineurin activity, it does not explain the SEdependent development of calcium-independent CaN activity.
Calcium influx through the NMDA receptor has been implicated in many of
the physiological changes that take place following SE [115, 134]. For this
reason, it was of interest to determine if the observed SE-dependent increase in
CaN activity was also NMDA-dependent. Blocking the NMDA receptorassociated Ca2+ channel with MK-801 completely prevented the SE-dependent
increase in CaN activity in the cortex, and significantly reduced the magnitude of
the increase in the hippocampus. This data suggests that calcium influx through
the NMDA-receptor associated channel is involved in the SE-induced increase in
calcineurin activity.
The increase in CaN activity described in this study was not observed in
the cerebellum. Although pilocarpine-induced seizure activity generalizes into the
cerebellum, many SE-induced physiological changes do not develop in this
region. For example, CaM kinase II activity is altered in the cortex and
hippocampus following SE, but not in the cerebellum [134]. Similarly, the
spontaneous recurrent seizures that develop following pilocarpine treatment do
not generalize into the cerebellum [141]. Considering this, it is not surprising that
SE-induced increase in calcineurin activity was not noted in the cerebellum. It is
possible that SE activates different mechanisms in the cerebellum than in the
forebrain, or that an enzyme or receptor necessary for the SE-dependent
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activation of CaN is not present in the cerebellum.
The observed SE-dependent increase in CaN activity has broad
physiological implications. Neuronal mechanisms which are regulated by CaN
dephosphorylation under normal conditions could be highly altered as a result of
elevated

enzyme

activity.

One

important

CaN-mediated

mechanism

is

modulation of the GABAA receptor. GABA receptors are the primary receptor
responsible for the fast inhibitory response in neuronal tissue [65], and play a
major role in preventing the neuronal hyperexcitability associated with epilepsy
and SE [124]. Several recent studies have demonstrated an inhibitory modulation
of GABAA receptor function by CaN [66-68, 159, 160]. A post-SE elevation in
CaN activity may result in increased dephosphorylation of GABAA receptors,
producing a net disinhibition of cellular excitability. This hypothesis is
strengthened by the fact that recent studies have described a post-SE decrease
in GABAA activity [161]. Chronic increases in CaN-mediated dephosphorylation,
could lead to a long-term loss of GABA receptor function, which may play a role
in epileptogenesis. The results of one kindling study already suggest that
calcineurin may have an epileptogenic role [122], and disinhibitory mechanisms
have been found to be epileptogenic in several studies.
This study is the first to detail an SE-dependent effect on calcineurin
activity. The results presented above describe an SE- induced increase in CaN
activity which has far-reaching implications, from possible avenues for SE
treatment to a potential role in development of epilepsy following SE. While this
study focused on the total enzyme pool contained in the homogenate, future
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studies will investigate the effect of SE on CaN activity in specific cellular
fractions, as well as on purified enzyme. A great deal of further research on this
topic is possible, offering exciting insight into the mechanisms underlying status
epilepticus.
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Figure 1. SE resulted in a significant increase in basal and maximal CaN
activity.

Basal (white) and maximal (black) calcineurin activity was assayed in

cortical, hippocampal, and cerebellar homogenates isolated immediately after 1
hour of SE. A) Cortical homogenates isolated from SE animals displayed a
significant increase in both basal and maximal CaN activity. (** p < 0.01, n=6,
two-tailed unpaired Student’s t-test). B) Basal and maximal CaN activity was also
elevated in the hippocampal homogenates isolated from SE animals when
compared to control animals (* p < 0.05, n=9; ** p < 0.01, n=9, two-tailed
unpaired Student’s t-test). C) No significant differences were observed in either
basal or maximal calcineurin activity in cerebellar homogenates.(p>0.1, n=7).
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Figure 2. SE modulates the rate of CaN-mediated dephosphorylation in rat
cortical homogenates.
CaN dephosphorylation reactions were performed in cortical homogenates
isolated from control (white circles) and SE (black circles) animals. Basal (A) and
maximal (B) CaN reactions were allowed to continue for specific time intervals,
and the corresponding activities plotted to determine reaction rate. The portion of
the reaction shown is during the linear (pre-steady state) portion of the reaction
A) Under basal conditions, the reaction rate (as indicated by linear regression
analysis of the data with time as the independent variable and µg pNP produced
as the dependent variable. r2 = 0.992) was 0.257µg/min in control homogenates
(white circles). CaN-mediated dephosphorylation in SE cortical homogenates
(black circles) occurred at a rate of 0.355µg/min. This represents an increase of
36.72 ± 7.6% when compared to the control rate. B) Maximal dephosphorylation
occurred at a rate of 0.684µg/min in control homogenates, as indicated by linear
regression analysis (r2 = 0.991). The maximal reaction rate in SE homogenates
was 0.804µg/min, an increase of 17.55 ± 4.74% over the control rate. Data
represents an average of three experiments.
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Figure 3. SE alters CaN substrate affinity in rat cortical homogenates.
Substrate affinity (Km) and maximal pNPP dephosphorylation (Vmax) for CaN
were determined under basal and maximal conditions for SE and control
cortical homogenates. A) SE increased both Km and Vmax for pNPP
dephosphorylation by CaN under basal conditions. A substrate concentration
isotherm was generated under basal dephosphorylation conditions in cortical
homogenates isolated from control animals (white circles) and SE animals
(black circles). Both Vmax and substrate affinity were increased in SE
homogenates when compared to control. Inset: Linweaver-Burk plots of data
from control and SE homogenates. SE resulted in an increase in maximal
dephosphorylation (Vmax) under basal conditions. Vmax for SE homogenates
(black circles) was higher than that of control homogenates (white circles) (p
< 0.05, n=3, student’s t-test). Km was increased after SE. (p < 0.05, n=3). B)
SE increased Vmax for pNPP dephosphorylation under conditions for maximal
CaN

activity.

Substrate

concentration

isotherms

under

maximal

dephosphorylation conditions were generated in cortical homogenates
isolated from control (white circles) and SE (black circles) animals. Maximal
dephosphorylation was increased in SE homogenates when compared to
control. However, substrate affinity in SE and control homogenates was not
significantly different under maximal conditions. Inset: Linweaver-Burk plot of
substrate isotherms from control and SE homogenates. Vmax was increased in
SE homogenates (p < 0.05, n=3). Substrate affinity appeared to increase,
however the change was small and not statistically significant (p > 0.05, n=3).
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Figure 4. The SE-induced increase in pNPP dephosphorylation was not
due to tyrosine phosphatase activity.
Cortical homogenates were isolated from control and SE rats and subjected to
basal (white bars) and maximal (black bars) reaction conditions. The reactions
were performed in the absence (-) or presence (+) or 100µM NaVO4. This level of
NaVO4 is sufficient to inhibit tyrosine phosphatases and Mn2+-stimulated CaN
activity. The inclusion of NaVO4 did not significantly affect basal pNPP
dephosphorylation, but resulted in complete inhibition of Mn2+-stimulated pNPP
dephosphorylation (*** p < 0.001, n=4, Student’s t-test)
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Figure 5. The SE-induced increase CaN activity was inhibited by okadaic
acid in a concentration-dependent manner.
A) Low concentration OA has no significant effect on pNPP dephosphorylation in
cortical homogenate. The addition of 150nM okadaic acid did not affect pNPP
dephosphorylation under either basal or maximal activity in homogenates
isolated from either SE or control animals (p > 0.05, n=4). This suggests that
neither PP1 (IC50 for OA: 10-15nM) nor PP2A (IC50: 100pM) is responsible for the
measured activity. B) High concentration of OA results in significant inhibition of
pNPP dephosphorylation. 50µM okadaic acid inhibited maximal activity in both
control and SE cortical homogenates (** p<0.01, n=6, two-tailed paired student’s
t-test). Maximal activity was inhibited by 10.65% in SE homogenates, and by
6.61% in homogenate isolated from control animals. High concentration OA also
inhibited basal activity by 11.17% in SE homogenates (** p<0.01, n=6, two-tailed
paired student’s t-test), but did not inhibit pNPP dephosphorylation in control
homogenates (p>0.05, n=6, two-tailed paired student’s t-test). The data suggests
that SE results in an OA-sensitive increase in pNPP dephosphorylation,
measured under both basal and maximal conditions for CaN activity.
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Figure 6. The post-SE increase in CaN activity was not due to a SE-induced
increase in CaN protein expression.
To determine if SE results in increased CaN enzyme levels, homogenates from
control and SE rats were subjected to western analysis. Cortical (A) and
hippocampal (B) homogenates were resolved on SDS-PAGE and blotted to
nitrocellulose (see methods). The resulting blots were reacted a monoclonal
antibody against the A subunit of CaN. SE did not result in a significant alteration
of CaN immunoreactivity in any brain region studied. A) Immunoreactivity was
93.62 ± 3.01% of control enzyme levels in cortical homogenates isolated from SE
animals. B) CaN immunoreactivity in hippocampal homogenates isolated from
SE animals was 104.17 ± 14.57% of the control enzyme level.
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Figure 7. MK-801 pretreatment prevented the SE-dependent increase in
CaN activity in cortical homogenates. A) Preinjection of animals with MK-801
(a non-competitive NMDA antagonist) completely prevented the SE-dependent
increase in CaN activity in cortical homogenates. CaN activity in MK-801 cortical
homogenates was not significantly different from that of control homogenates for
both basal (white) and maximal (black) activities (p > 0.05, n=4, one-way ANOVA
with Tukey post-hoc analysis). SE homogenates had significantly higher activity
than both MK-801 and control homogenates under both basal and maximal
conditions (*p < 0.05, n=4). B) MK-801 pre-treatment reduced, but did not
completely prevent, the SE-dependent increase in CaN activity in hippocampal
homogenates. MK-801 treated animals had significantly lower CaN activity than
SE animals under both basal (white) and maximal (black) conditions (p < 0.05,
n=4). However, both basal and maximal hippocampal CaN activity in MK-801
animals was significantly higher than that of control animals (p < 0.05).

CHAPTER II
STATUS EPILEPTICUS-INDUCED CHANGES IN THE
SUBCELLULAR DISTRIBUTION AND ACTIVITY OF
CALCINEURIN IN RAT FOREBRAIN

INTRODUCTION:
Status epilepticus (SE) is a severe medical emergency affecting more
than 100,000 people per year in the United States [100, 103]. Victims of SE are
at risk for both immediate mortality and long-term neurological pathologies
associated with the disorder [105, 111, 124]. Previous research has shown many
of these pathological consequences to be associated with calcium and calciumregulated systems [115, 126]. Calcium’s central role in the pathology of SE has
made characterization of calcium-regulated systems an important area for further
study in SE.
One calcium-regulated enzyme of particular interest is the calciumstimulated phosphatase, calcineurin (CaN). CaN’s enrichment in forebrain
neurons and its key role in the modulation of many neuronal processes make it
an intriguing enzyme for study. For example, CaN regulates gene transcription
through the NFAT family of molecules [6, 162], modulates the function of both the
GABA and NMDA receptors [63, 67, 68, 163, 164], affects cytoskeletal
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architecture through dephosphorylation of microtubules and associated proteins
[70-72], regulates neurotransmitter release [165], and may be involved in the
initiation of apoptosis [91, 166]. All of these processes may play a role in the
pathology of SE, warranting a closer look into any association between CaN and
SE.
Several recent studies have, in fact, suggested an association between
CaN and seizure activity. For instance, Kurz et al. [167] described an SEdependent increase in CaN activity in the forebrain, while Moia et al. [122]
suggested that CaN activity may be essential for the development of seizures in
a kindling model. While these findings suggest the involvement of CaN in the
development of seizure activity, more research is needed to elucidate the
physiological role of this enzyme in SE. For example, the ability to localize SEinduced changes in enzyme activity and concentration to specific subcellular
compartments would provide valuable clues to the role of CaN in the pathology of
SE.
The present study examined the effects of SE on enzyme activity and the
sub-cellular distribution of CaN in the cortex and hippocampus. CaN activity was
assayed in sub-cellular fractions isolated from both of these regions, and CaN
concentration in each fraction was determined by western analysis. Additionally,
immunohistochemical studies were conducted on hippocampal tissue from SE
and control animals. A significant SE-dependent increase in CaN activity was
observed in synaptosomal and crude nuclear fractions. This increase was
accompanied by a significant increase in CaN concentration in these fractions as
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demonstrated by western analysis. In addition, immunohistochemical studies
revealed an apparent increase in CaN levels in the apical dendrites of CA1
neurons in the hippocampus following SE.

METHODS AND MATERIALS:

Materials:
All materials were reagent grade and were purchased from Sigma
Chemical Co. (St. Louis, MO) unless otherwise noted. Bio-Rad protein assay
concentrate, sodium dodecyl sulfate (SDS), 2-mercaptoethanol, blotting grade
dry milk, and Mini-Protean II SDS-PAGE apparatus and power supplies were
purchased from Bio-Rad Laboratories (Richmond, CA). ABC reagents were
obtained from Vector Laboratories (Burlingame, CA). Absolute ethyl alcohol was
purchased from AAPER Alcohol and Chemical Co. (Shelbyville, KY). Adult male
Sprague-Dawley rats were obtained from Harlan Laboratories (Indianapolis, IN).

Pilocarpine model of status epilepticus:
All animal use procedures were in strict accordance with the Guide for the
Care and Use of Laboratory Animals described by the National Institutes of
Health and were approved by the Virginia Commonwealth University Animal Use
Committee. SE was induced in adult male Sprague-Dawley rats by the method
described in Mello et al [141]. Rats were handled regularly for approximately one
week to acclimate them to handling prior to drug administration. Adult rats
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weighing

175-230g

were

injected

intraperitoneally (i.p.)

with 350mg/kg

pilocarpine HCl, a potent muscarinic agonist. 30 minutes prior to the pilocarpine
injection,

all

rats

were

treated

i.p.

with

1mg/kg

methylscopolamine.

Methylscopolamine is a peripheral muscarinic antagonist; administering it prior to
pilocarpine injection minimizes adverse peripheral effects. Control rats received
all injections, except that pilocarpine was administered at 1/10th its seizureinducing dose. Control animals did not exhibit any behavioral seizure activity. All
drugs were dissolved in 0.9% saline.
Behavioral seizures typically began 20 minutes following pilocarpine
injection. Seizures were rated according to the scale described by Racine [142].
Only animals reaching stage 5 seizures were included in this study. Stage 5 was
classified as the most severe level of seizure activity, characterized by rearing
and falling. Rats not responding to the initial pilocarpine injection received a
second injection at on half of the initial dose (175 mg/kg). Rats that still did not
display stage 5 seizure activity following a second pilocarpine injection were
excluded from the SE group.

Isolation and homogenization of brain regions:
Rats were rapidly decapitated after 1 hour of SE. Brains were dissected
on a petri dish on ice to preserve post-mortem enzyme activity. Cortical,
hippocampal, and cerebellar brain regions were quickly isolated and immediately
homogenized with 10 strokes (up and down) at 12,000 rpm, using a motorized
homogenizer (TRI-R Instruments, Inc. Rockville Center, NY). Brain regions were
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homogenized into ice-cold homogenization buffer containing 5mM HEPES (pH
7.0), 7mM EGTA, 5mM EDTA, 1mM dithiothreitol (DTT), 0.3mM PMSF, and
300mM sucrose. Cortical regions were homogenized into 7ml of buffer,
hippocampal regions into 3ml of buffer, and cerebellar regions into 5ml. All brain
homogenates were either separated into aliquots and stored for later use, or
subjected to the differential centrifugation procedure described below.

Isolation of sub-cellular fractions:
Sub-cellular fractions were isolated by a differential centrifugation
procedure as modified from Edelman et al [168]. Brain region homogenate was
first centrifuged at 5000g for 10 minutes, to produce a crude nuclear pellet (P1)
and a supernatant (S1). The P1 pellet was resuspended in homogenization
buffer, separated into aliquots, and stored at -80°C until used. The S1 was
centrifuged for 30 minutes at 18,000g to produce the crude synaptoplasmic
membrane/mitochondiral pellet (P2) and a supernatant (S2). The P2 pellet was
resuspended in ½ the original volume of the homogenate (3.5mL for cortex,
2.5mL for cerebellum, 1.5mL for hippocampus), then separated into aliquots and
stored at -80°C until used. The S2 was subjected to another centrifugation, at
100,000g for 60 minutes. The resulting supernatant (S3) was separated into
aliquots and stored for later use. The P3 pellet was resuspended in
homogenization buffer (700µL for cortex, 500µL for cerebellum, 300µL for
hippocampus), and likewise separated into aliquots and stored at -80°C for later
use.
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pNPP assay of phosphatase activity:
Calcineurin activity was assayed using the procedure detailed by Pallen
and Wang [143] as modified by Kurz et al. [167]. All reaction tubes were
prepared on ice and contained the following: 25mM MOPS (pH 7.0), 1mM DTT,
2mM p-nitrophenol phosphate (pNPP). Some basal tubes also contained 2mM
EGTA and 2mM EDTA. Maximal tubes contained the same reagents as basal
reactions, with the addition of 2mM MnCl2. Where appropriate, 120µM gossypol,
50µM okadaic acid (sodium salt), or 100µM sodium orthovanadate was added to
the reaction mixture. Final reaction volumes were 1ml. Both Mn2+ and
Ca2+/calmodulin activate calcineurin in this assay; however, Mn2+ activates
calcineurin more strongly than calcium [21]. Therefore, Mn2+ was used instead of
calcium in maximal reactions to better visualize the cation-stimulated activity of
the enzyme. Prior to use, the protein concentration of all homogenates was
determined using the method of Bradford et al. [144]. Reactions were initiated by
the addition of 200 µg/ml of homogenate or the appropriate subcellular fraction.
Reactions were incubated at 37°C for 15 minutes in a shaking water bath. Tubes
were then removed from the water bath and placed in ice to stop the reaction.
Absorbance of the reaction mixture was immediately measured at 405nm in a
spectrophotometer (UV-2101, Shimadzu Scientific Instruments, Inc. Columbia,
MD). Absorbance units were converted to nmol of pNP produced by comparison
to a pNP concentration standard absorption curve.
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CaN immunoblotting procedure:
Western analysis was performed essentially as described previously [145].
Briefly, homogenates were resolved on SDS-PAGE and transferred to a
nitrocellulose membrane using the Geni blot system (Idea Scientific, Minneapolis,
MN). Nitrocellulose was then immersed for one hour in blocking solution
containing phosphate buffered saline (PBS, pH 7.4), 0.05% (v/v) polyoxyethylene
sorbitan monolaurate (tween-20), 50 g/L Bio-Rad blotting grade dry milk, and
horse serum (Vector Laboratories Inc., diluted 50 µl/10ml). The nitrocellulose
membrane was then incubated with primary antibody in blocking solution for one
hour. Anti-CaN A antibody (clone CN-A1, mouse monoclonal IgG, Sigma
Chemical Co.) was diluted 1:10,000 for western analysis. Membranes were then
washed three times in a wash solution containing PBS, tween-20, and dry milk.
Nitrocellulose was then reacted with a secondary antibody in blocking solution for
45 minutes. The membrane was then washed three times and incubated with an
avidin-biotinylated horseradish peroxidase complex for 30 minutes. Nitrocellulose
was then washed three times in PBS for 10 minutes per wash. Blots were
developed with a solution containing 10 ml PBS, 0.025% (v/v) H2O2, and 8 mg 4chloro-1-napthol dissolved in 2ml of methanol. Specific immunoreactive bands
were quantified by computer-assisted densitometry (Inquiry, Loats Associates,
Westminster, MD).
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Immunohistochemical analysis:
SE was induced in male Sprague-Dawley rats as described above. After
one hour of SE, rats were anesthetized with halothane and transcardially
perfused

with

a

solution

containing

4%

paraformaldehyde

and

0.1%

glutaraldehyde. Brains were then removed and allowed to post-fix in the
perfusion fixative for 24hr. Brains were then blocked to allow sectioning of the
dorsal hippocampus, embedded in agar and coronally sectioned into serial 40 µm
sections on a Leica VT1000S vibratome (Leica Microsystems, Bannockburn, IL).
Sections were stored in 12 well culture plates until used.
For immunohistochemical staining, sections were incubated for 30
minutes in normal serum at 37°C. Sections were then incubated overnight with a
polyclonal anti-CaN A antibody at a dilution of 1:50,000. Following incubation
with the primary antibody, sections were then washed 4X with phosphatebuffered saline (PBS, pH 7.4) for 15 minutes per wash. The tissue was then
incubated in secondary antibody for 1 hour at 37°C. Sections were washed 3X in
PBS, then placed in Vectastain ABC reagent for 2 hours. The first hour of
incubation in ABC was performed at 37°C, the second hour at room temperature.
Sections were then washed 2X in PBS for 10 minutes per wash, and 1X in TrisBase (pH 7.6) It was essential to wash in Tris-Base at this step because the
staining procedure requires most of the phosphate to be washed out of the tissue
to work properly. The tissue was then stained with a glucose oxidase-DAB-nickel
preparation.
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Statistical analysis:
All statistical analysis of data was performed using GraphPad Prism 3.0
(GraphPad Software, San Diego, CA). Levels of phosphatase activity or
concentration were compared to control using the Student’s t-test (two-tailed
distribution, unpaired or paired where appropriate), or using one-way ANOVA
with Tukey post-test to control for type one errors in multiple comparisons.
Computer assisted densitometric analysis was performed using Inquiry (Loats
Associates Inc, Westminster, MD).

RESULTS:

CaN-mediated dephosphorylation of pNPP:
Fractions were isolated from the cortex and hippocampus of control and
SE animals. In both the hippocampal and cortical homogenates, overall post-SE
CaN activity was significantly increased. In hippocampal homogenates, SE
resulted in a 21.2 ± 4.7% increase in basal CaN activity, and a 20.8 ± 5.0%
increase in maximal activity when compared to control animals. Similarly, in
cortical homogenates isolated from SE animals, basal CaN activity was 49.3 ±
13.6% of control, and maximal activity was elevated 34.3 ± 13.9% above control
values. This overall increase in CaN activity in the homogenate is consistent with
the findings of previous studies [167] and establishes a baseline to which the
activities of individual fractions may be compared.
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The effects of several inhibitors were tested to confirm that the observed
increase in pNPP dephosphorylation was due to an increase in CaN activity and
not due to contamination from other phosphatases (Figure 8). The results
obtained are consistent with a previous characterization of the pNPP assay [167].
The addition of okadaic acid (a potent inhibitor of PP1 and PP2A) did not effect
either basal or maximal pNPP dephosphorylation, suggesting PP1 and PP2A are
not responsible for the observed increase in activity. The effects of sodium
orthovanadate (NaVO4) on pNPP dephosphorylation were also tested. NaVO4 is
a potent inhibitor of tyrosine phosphatases; however, it also inhibits the Mn2+
stimulated activity of CaN. In this study, sodium orthovanadate did not affect the
SE-induced increase in basal activity; however, under maximal reaction
conditions, NaVO4 blocked pNPP dephosphorylation down to basal levels in
homogenates isolated from both control and SE animals. These results are
consistent with CaN activity, and suggest that tyrosine phosphatases are not
involved in the SE-dependent increase in enzyme activity. Finally, gossypol (120
µM), a specific CaN inhibitor [169], was tested. Co-incubation with gossypol
blocked the SE-induced increase in both basal and maximal CaN activity
(p<0.05, n=3), suggesting CaN is responsible for the increase. The data
demonstrate that the SE-induced increase in pNPP dephosphorylation is due to
CaN and not due to another phosphatase.
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Selective modulation of CaN by SE in specific subcellular fractions:
An SE-dependent increase in CaN activity was observed in the P1 pellet
from both cortical and hippocampal tissue. The P1, or crude nuclear pellet,
contains nuclei and other large molecular weight fractions. In hippocampal P1
isolated from control animals, basal CaN activity was 3.8 ± 0.01 µg pNP/min/mg.
Following SE, this value increased by 13.1 ± 4.7%, to 4.3 ± 0.2 µg pNP/min/mg
(p < 0.05, n=3). Under maximal conditions, CaN activity in control hippocampal
P1 was 6.1 ± 0.1 µg pNP/min/mg. SE induced a 10.6 ± 2.9% increase in the
maximal CaN activity, to a value of 6.8 ± 0.2 µg pNP/min/mg (p < 0.05, n=3).
SE also induced a significant increase in basal and maximal enzyme
activity in cortical P1 fractions (Figure 9). Under basal reaction conditions, CaN
activity in control P1 was 3.1 ± 0.9 µg pNP/min/mg. Following SE, basal activity
increased 29.4 ± 11.9 % to 4.1 ± 0.6 µg pNP/min/mg (p < 0.05, n = 9). Maximal
activity in cortical P1 isolated from control animals was 6.2 ± 0.1 µg pNP/min/mg.
Following SE, maximal CaN activity increased by 14.88 ± 3.3 % to a value of 7.1
± 0.2 µg pNP/min/mg (p < 0.001, n = 9). The increase in activity in both the
hippocampus and cortical P1 was similar to that observed in homogenate.
In crude synaptoplasmic membrane (P2) fractions isolated from forebrain
homogenates, SE resulted in a significant increase in both basal and maximal
CaN activity (Figure 9). Average basal CaN activity measured in control
hippocampal P2 was 2.7 ± 0.7 µg pNP/min/mg. Following SE, this value was
elevated to 4.8 ± 0.3 µg pNP/min/mg, an increase of 77.8 ± 25.9% (p < 0.05, n=3,
Student’s t-test). Control maximal activity in hippocampal P2 was 7.0 ± 0.8 µg
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pNP/min/mg. After SE, activity increased 56.4 ± 16.3% over control, to a value of
10.9 ± 0.8 µg pNP/min/mg (p < 0.05, n=3). This increase is more than double the
overall increase observed in hippocampal homogenate.
In cortical P2, a large, SE-dependent increase in CaN activity was
observed under both basal and maximal reaction conditions (Figure 9). Average
basal CaN activity in control samples was 2.7 ± 0.4 µg pNP produced/ min/ mg of
protein. Following SE, this value increased to 5.6 ± 0.7 µg pNP/min/mg, an
increase of 107.4 ± 29.6% (p < 0.01, n=6).

Maximal activity in cortical P2

isolated from control animals was 7.4 ± 0.6 µg pNP/min/mg. In SE animals, this
value was increased by 54.0 ± 10.7%, to a value of 11.4 ± 0.6 µg pNP/min/mg (p
< 0.01, n=6). This increase was also more than twice the overall increase
observed in cortical homogenates in this study.
Unlike the other membrane-rich fractions, cortical P3 did not display any
significant, SE-dependent change in CaN activity (Figure 9). In cortical P3
isolated from control animals, basal activity was 1.8 ± 0.2 µg PNP/min/mg. After
SE, activity in the P3 decreased to 1.7 ± 0.1 µg PNP/min/mg, an increase of 5.5
± 4.1% which was not statistically significant (p > 0.05, n=3). Maximal activity in
control cortical P3 was 3.4 ± 0.1 µg PNP/min/mg, while in SE P3 this value was
3.1 ± 0.1 µg PNP/min/mg. This difference was also not statistically significant (p
> 0.05, n=3). It was not possible to test hippocampal P3 due to the extremely low
protein yield present in this fraction. The lack of an SE-dependent increase in
activity in this fraction indicated that the post-SE increase in activity observed in
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the P1 and P2 fractions was not due to a nonselective precipitation of CaN during
SE.
No significant SE-induced change in CaN activity was observed in the
cytosolic (S3) fraction isolated from either hippocampus or cortex. However, it is
interesting to note that under both basal and maximal conditions, CaN activity
appeared to decrease slightly (Figure 9). This is particularly interesting
considering that overall CaN activity increased by 35-50% in the cortical
homogenate. In S3 isolated from control hippocampi, basal CaN activity was 1.3
± 0.1 µg PNP/min/mg. Following SE, this value decreased by 10.8 ± 18.5% to 1.1
± 0.2 µg PNP/min/mg (p > 0.05, n=4). Under maximal reaction conditions, CaN
activity in S3 isolated from control animals was 4.4 ± 0.4 µg PNP/min/mg. In S3
from SE animals, CaN activity was 3.8 ± 0.1 µg PNP/min/mg, a decrease of 13.6
± 13.4% from control (p > 0.05, n=4). Similarly, in cortical S3, control CaN activity
was 2.3 ± 0.2 µg PNP/min/mg under basal conditions. Following SE, this value
decreased by 8.6 ± 8.8% to a value of 2.1 ± 0.1 µg PNP/min/mg (p > 0.05, n=8).
Under maximal conditions, control CaN activity was 9.1 ± 0.3 µg PNP/min/mg in
the cytosol. In cytosolic fractions isolated from SE animals, this value decreased
14.4 ± 9.8% to 7.8 ± 0.9 µg PNP/min/mg (p > 0.05, n=8).

SE resulted in increased synaptoplasmic CaN in both the hippocampus and
cortex.
The increase in activity observed in the P2 fraction in both the
hippocampus and cortex was far larger than that observed in any other fraction
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or the homogenate. This increase in activity could be accounted for by an
increase in the amount of enzyme present in this fraction, either through new
synthesis of CaN or by translocation from other areas of the cell. To examine this
hypothesis, western analysis of homogenate from all fractions and brain regions
was performed, using an antibody directed against the catalytic A-subunit of the
enzyme (CN-1, Sigma, St. Louis, MO). In all fractions, a band with molecular
weight of approximately 61kDa was resolved. This corresponds with the size of
the CaN A subunit [8].

In P2 isolated from cortical homogenates, two other

bands were sometimes observed. Both of these bands were determined to be
due to non-specific binding of the secondary antibody (anti-mouse IgG), as they
were also observed when the primary antibody was omitted from the reactions.
In the P2 fraction, a large increase in CaN A immunoreactivity was
observed in both the hippocampus and cortex (Figure 10). Optical density of the
61kDa band in fractions from SE animals was 194.9 ± 31.04% of control in the
hippocampus (p < 0.05, n=5), and 207.2 ± 22.3% of control in the cortex (p <
0.001, n=6). No significant difference in immunoreactivity was detected in any
other sub-cellular fraction.

SE results in increased CaN A immunoreactivity in apical dendrites of
hippocampal CA1 neurons.
To further characterize the SE-dependent increase in CaN activity and
concentration observed in the P2 fraction, immunohistochemical studies were
performed on paraformaldehyde-fixed coronal sections from SE and control
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animals. Hippocampal sections from control animals demonstrated diffuse
staining throughout the pyramidal cell layer, with the exception of the pyramidal
cell nuclei (Fig. 11A, C). Faint CaN immunoreactivity was observed in the
surrounding cortex (data not shown). This diffuse staining remained unchanged
following SE. Therefore, the intensity of cortical staining was used as a
background value to compare control and SE images. When viewed under 400X
magnification, individual pyramidal neurons could be visualized (Fig. 11E). The
cytoplasm of these cells demonstrated very diffuse CaN-reactive staining. The
darkest staining was seen around the plasma membrane of these neurons.
Occasional dendritic processes demonstrated CaN immunoreactivity; however,
many apical dendrites could not be individually visualized in control sections.
These

histological

findings

were

in

agreement

with

previous

studies

demonstrating the presence of CaN in the hippocampal formation, particularly in
the plasma membrane and in neurites [170, 171].
Hippocampal sections from SE animals demonstrated several qualitative
changes when compared to control sections (Fig. 11B). Similar to the control
sections, diffuse CaN-reactive staining was present throughout CA1-3. However,
this staining was noticeably more intense in the SE sections. Staining was still
relatively poor in the surrounding cortex in the SE sections. In addition to the
increased level of staining in the pyramidal neurons, an intensely stained band
could be seen near the pyramidal cell layer of the hippocampus in SE sections.
At 400X magnification this intense staining was found to be present around the
plasma membranes and throughout the apical dendrites of pyramidal neurons
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(Fig. 11F). Unlike the control sections, CaN immunoreactivity was absent from
the nuclei of pyramidal neurons from SE animals as well as those from control
animals. It was not possible to visualize any axonal processes leading from the
pyramidal cells, nor were any darkly stained processes observed in axonal layers
of the hippocampus, suggesting that the increased CaN immunoreactivity was
post- rather than presynaptic. Finally, no interneurons were detected in control or
SE sections, suggesting an absence of CaN in these neurons which is in
agreement with previous research [172].

DISCUSSION:
Recent research suggests a physiological role for CaN in the pathology of
seizure disorders [122, 167]. However, much remains to be discovered about the
effects of SE on CaN and the physiological ramifications of these effects. Since
CaN regulates many neuronal processes [67, 70, 164-166], understanding how
SE effects the activity of specific subcellular pools of CaN is warranted. The
present study demonstrated a significant, SE-dependent increase in CaN activity
in the synaptosomal (P2) and nuclear (P1) fractions isolated from rat cortex and
hippocampus. Additionally, a significant, SE-dependent increase in CaN
concentration was observed in P2 fractions isolated from hippocampal and
cortical tissue. No significant increase in CaN activity or concentration was
observed in the cortical P3 fraction, confirming that the observed increase was
not due to nonspecific precipitation of CaN protein during SE. Can activity in the
hippocampal P3 was not assessed due to low protein yield in this fraction.
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Immunohistochemical staining of hippocampal tissue revealed increased CaN
staining in apical dendrites of the CA1 region. These data suggest that SE
induces a translocation of CaN into specific subcellular compartments, where it
may play an important role in the pathophysiology of SE.
A significant increase in CaN activity was observed in the nuclear (P1)
pellet fraction. While this is a relatively crude fraction, the observed increase in
activity may represent translocation of enzyme into the nucleus or cell
membrane. There are precedents for nuclear translocation of calcineurin. For
example, CaN is capable of dephosphorylating the NFAT family of molecules.
Although originally described in the immune system [6], several members of the
NFAT family have been identified in neuronal tissue [173, 174]. Following
dephosphorylation by CaN, both the enzyme and NFAT move to the nucleus of
the cell, where the NFAT molecule regulates gene transcription. Previous studies
have shown alteration of gene transcription to be an important pathological
mechanism in SE and epileptogenesis [175-177]. CaN-regulated mechanisms,
similar to the NFAT mechanism described above, may play an important role in
this modulation of gene expression.
A large, significant increase in both CaN activity and enzyme
concentration was observed in the P2 fraction. The P2 fraction is highly enriched
in both crude synaptoplasmic membrane and mitochondria [168]. Previous
studies have not detected significant amounts of CaN in purified mitochondrial
preparations [171]; however, it is possible that SE induces a translocation of
enzyme to these organelles. CaN plays an essential role in several apoptotic
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pathways [91, 166]. Movement of the enzyme to the mitochondria would likely
facilitate these apoptotic mechanisms, resulting in increased cell death.
An alternative hypothesis on the apparent increase in enzyme
concentration observed in both western and immunohistochemical studies is that
prolonged SE modulates the immunoreactivity of CaN. Pathological changes in
protein immunoreactivity have been observed before [146]. The changes in
enzyme immunoreactivity would have to be a primary structural change, since it
is observed in both western and immunohistochemical analyses. The altered
immunoreactivity would also explain why a significant increase in CaN
concentration is observed in the P1 and P2 fractions without a significant loss of
enzyme in the other subcellular fractions studied.
On the other hand, the increase in CaN concentration in the P2 fraction
may represent a true increase of enzyme at the synaptoplasmic membrane.
Immunohistochemical data demonstrated a significant increase in CaN staining
in the pyramidal cell layers, particularly the CA1 region, of hippocampus isolated
from SE animals. The observation that the increased staining is confined to
hippocampal pyramidal neurons suggests that SE may induce a unique
mechanism in these cells that is not present in other hippocampal neurons. The
histochemical data also suggest that the increase in CaN concentration is
occurring primarily post-synaptically, in the dendrites of affected cells. This
increase in enzyme concentration places approximately double the control
amount of enzyme in the post-synaptic region of neurons, where it may modulate
neurotransmitter receptors.
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The GABAA receptor is a particularly important CaN-regulated system in
the study of SE. GABA receptors are the primary receptor responsible for the fast
inhibitory response in neuronal tissue [65], and play a major role in preventing
the neuronal hyperexcitability associated with epilepsy and SE [124]. Several
recent studies have demonstrated an inhibitory modulation of GABAA receptor
function by CaN [66-68, 159, 160]. This modulation of GABAA receptor function
may occur through direct dephosphorylation of receptor subunits. GABAA
receptors have a critical phosphorylation level required for optimal function. A
post-SE elevation in CaN concentration in the dendrites could result in highly
increased dephosphorylation of GABAA receptors, producing a net disinhibition of
cellular excitability. An increase in CaN activity during and immediately after SE,
such as the one described in this study, could lead to short-term loss of GABAA
receptor function. This acute loss of inhibitory tone could lead to increased
seizure propagation, failure of seizure termination, or resistance to antiepileptic
drug treatment.
Additionally, high levels of CaN in the synaptic region of neurons may
have several other pathological effects. CaN indirectly modulates the activities of
the serine/ threonine phosphatases PP1 and PP2A through dephosphorylation of
their respective inhibitors [178-180]. Thus, an increase in CaN activity could
result in an accompanying increase in the activity of PP1 and 2A in neurons, with
numerous downstream effects. CaN also is capable of dephosphorylating
microtubules [70, 181], altering dendritic stability [79] and affecting the outgrowth
of developing neurites [78].
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The observed SE-dependent change in CaN concentration and activity
could result from either increased synthesis of CaN or translocation of the
enzyme from other cellular compartments. Several previous studies have
observed that there is no significant, post-SE increase in the concentration of
CaN in whole cell homogenate [167, 182], nor has any post-seizure increase in
CaN mRNA been detected [182]. The lack of a SE-dependent net increase in
CaN protein concentration or mRNA expression strongly suggests that SE does
not induce synthesis of the enzyme. Indeed, it seems unlikely that animals
undergoing the high physiological stress of SE, and studied at an acute post-SE
time point, would have the necessary time and capacity to synthesize the amount
of CaN represented by the increase.
Translocation of the enzyme may account for the increased levels of CaN
detected in the P2 fraction. Movement of CaN to the synaptosomal fraction from
other cellular compartments would suggest that a concurrent decrease in CaN
concentration should be detected in other sub-cellular fractions. However, no
significant decrease in CaN concentration was detected in any of the fractions
isolated in this study, although the slight decrease in CaN activity observed in the
cortical cytosol may suggest some loss of enzyme. This discrepancy may be due
to the relatively small volume of the P2 fraction when compared to the cytosol;
the effect of the translocation to the synaptosomes may simply be diluted by the
large volume of the cytosolic compartment.
This study is the first to demonstrate a post-SE increase in CaN
concentration and activity in specific subcellular compartments. The increase in

78

CaN activity in the nuclear-enriched P1 fraction suggests that CaN may alter
gene expression. Alterations in gene expression may be responsible for many of
the long-term effects of SE, such as the post-SE development of spontaneous
seizure activity (epileptogenesis). On the other hand, the large increase in CaN
activity and concentration in the synaptosomal P2 fraction suggests a CaNmodulated alteration in neurotransmitter receptor function. This mechanism could
be responsible for many of the acute effects of SE, as well as playing a role in
the resistance to anti-epileptic drugs seen in some instances of SE. Further
research into these topics may help to clarify the pathological mechanisms of SE,
and may help to develop more effective anti-epileptic drugs, ultimately leading to
more effective treatment of this life-threatening and debilitating condition.
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Figure 8. Prolonged SE resulted in increased CaN activity in cortical
homogenates.
SE induced a significant increase in both basal and maximal pNPP
dephosphorylation. (A) Basal (white) and maximal (black) CaN activity was
determined in cortical homogenates isolated from both control and SE animals.
SE resulted in an approximately 50% increase in basal activity and a 34%
increase in maximal pNPP deposphorylation when compared to homogenate
protein isolated from control animals. (B) The prolonged SE-induced increase in
pNPP dephosphorylation was due to CaN activity. Basal (white) and maximal
CaN reactions were performed in the presence of okadaic acid (OA; 50 µM),
sodium orthovanadate (NaVO4; 100 µM) and the CaN-selective inhibitor,
gossypol (Goss.; 120 µM). OA did not affect either basal or maximal pNPP
dephosphorylation, suggesting that PP1 and PP2A did not significantly contribute
to the observed dephosphorylation of pNPP. As expected, the tyrosine and
activated CaN inhibitor NaVO4 blocked maximal pNPP dephosphorylation.
However,

NaVO4

did

not

affect

the

SE-induced

increase

in

basal

dephosphorylation of pNPP. In addition, the CaN-selective inhibitor, gossypol,
blocked both basal and maximal increased pNPP dephosphorylation. *P < 0.05
different from no drug homogenate; **P < 0.01 different from no drug
homogenate; ***P < 0.001, paired Student's t test, n = 3 each group.
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Figure 9. The SE-induced increase in CaN activity was observed in specific
subcellular fractions.
SE-induced a significant increase in hippocampal CaN activity. Basal (A)
and maximal (B) CaN activity was determined in specific subcellular fractions
isolated from hippocampal homogenates. Significant increases in CaN activity
were observed in the nuclear-enriched P1 fraction, as well as the mitochondrial
and SPM-enriched P2 fractions. No significant change in CaN activity was
observed in the cytosolic fraction (S3). Additionally, no change was observed in
the endoplasmic reticulum-enriched P3 fraction isolated from cortical tissue. The
lack of increase in the P3 fraction suggests that the increased CaN activity in the
nuclear and SPM fractions was not due to nonspecific precipitation of the
enzyme subunits. CaN activity was not assessed in hippocampal P3 due to low
protein yield in this fraction. SE also resulted in increased CaN activity in specific
subcellular fractions isolated from cortical homogenates. Basal (C) and maximal
(D) CaN activity was determined in specific subcellular fractions isolated from
cortical homogenate. SE resulted in a significant increase in nuclear and
synaptoplasmic membrane fractions but not in endoplasmic reticulum or cytosolic
fractions when compared to control fractions. No changes were observed in any
fraction isolated from the cerebellum (data not shown). *P < 0.05 different from
control, Student's t t test. **P < 0.01 different from control, Student's t test. See
text for specific n values.
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Figure 10. SE resulted in a significant increase in CaN protein levels in the
SPM-enriched P2 fraction. (A) SPM-enriched hippocampal protein isolated from
control (C) and SE (SE) rats was subjected to Western analysis and tested with a
specific antibody directed against the A subunit of CaN. There was a selective
increase in immunoreactivity toward CaN observed in the SPM-enriched fraction.
(B) SE resulted in an almost 2-fold increase in CaN immunoreactivity in the SPMenriched P2 subfraction. Immunoreactivity was quantified by computer-assisted
densitometry (see Materials and methods). SE resulted in a significant, 95%
increase in CaN immunoreactivity. *P < 0.05, n = 5, Student's t test. (C) SPMenriched cortical protein isolated from control (C) and SE (SE) rats was subjected
to Western analysis and tested with a specific antibody directed against the A
subunit of CaN. There was a selective increase in immunoreactivity toward CaN
observed in the SPM-enriched fraction. (D) SE resulted in a significant, 107%
increase in CaN immunoreactivity (n = 6) in the SPM-enriched P2 subfraction. *P
< 0.05, Student's t test. ***P < 0.001, Student's t test.
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Figure 11. SE resulted in increased immunoreactivity of CaN in the
dendritic processes of hippocampal CA1 neurons. Animals were subjected to
prolonged SE or sham protocols, perfused, and studied for CaN immunoreactivity
(see Materials and methods). (A) low magnification (40× original magnification) of
dorsal hippocampus from control animal. Hippocampi from control animals
displayed a nondescript, evenly distributed CaN immunoreactivity. (B) Low
magnification of dorsal hippocampi isolated from an animal subjected to
prolonged SE. Overall, an increase in immunoreactivity is observed in the
hippocampal pyramidal region (both A and B are balanced for CaN
immunoreactivity observed in nearby entorhinal cortex). (C) 100x original
magnifaction and (E) 400x magnification, of CA1 pyramidal neurons in A. The
CaN immunoreactivity appeared evenly distributed with the only substantial
staining being cytosolic. (D) and (F) Higher magnification of CA1 pyramidal
neurons isolated from animals subjected to prolonged SE displayed increased
immunoreactivity, especially in the apical dendritic areas. Together with the data
in Fig 2.3 the data suggest that SE induced a translocation of CaN into
postsynaptic processes in CA1 pyramidal neurons.

CHAPTER III
A SIGNIFICANT INCREASE IN BOTH BASAL AND MAXIMAL
CALCINEURIN ACTIVITY FOLLOWING FLUID PERCUSSION
INJURY IN THE RAT

INTRODUCTION:
Traumatic brain injury is one of the major causes of death and disability in
the United States today [183]. The initial traumatic insult to neuronal tissue can
lead to significant pathology; however, much of the pathology associated with
TBI also involves secondary damage to the tissue surrounding the primary injury
site [183, 184]. Multiple cellular signals and mechanisms trigger significant
physiological changes in neuronal tissue in the hours and days after TBI. These
events occur in tissue not directly damaged by the primary insult, and result in
such diverse effects as the formation of reactive astrocytes, alterations in
neuronal excitability and receptor function, and induction of apoptosis [184]. It is
this secondary phase of TBI that offers the most promise for treatment in the
clinical setting; presumably a window exists following the initial injury during
which much of this secondary damage could be prevented by pharmacological
agents. Prevention of this later and more widespread stage of injury would
drastically reduce the long-term consequences of severe TBI. Unfortunately,
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clinical and laboratory testing of many neuroprotective agents up to this point has
proven disappointing [90]. Clearly, more research into the cellular mechanisms
occurring following TBI is needed to further our understanding of secondary
neuronal damage and death.
Calcium and calcium-regulated systems play a central role in the spread
of neuronal damage after TBI [132]. Therefore, calcium-modulated systems are
an intriguing area for study when attempting to understand the cellular changes
taking place after brain injury. One calcium-modulated enzyme that may prove
important in studies of neuronal injury is the neuronally-enriched phosphatase,
calcineurin.
Calcineurin

is

a

calcium/calmodulin-stimulated

serine/

threonine

phosphatase that is highly enriched in neuronal tissue [137]. As the only
identified

calcium-regulated

phosphatase,

calcineurin

has

an

important

physiological role. CaN regulates neuronal excitability through modulation of both
the GABA and NMDA receptors [64, 67, 68], plays a key role in the development
of learning and memory [138], and is an important modulator of neuronal
apoptosis [140, 185]. CaN also regulates the synthesis of nitric oxide, a free
radical potentially important in TBI [186], and an isoform of CaN may modulate
the formation of reactive astrocytes [187, 188]. In spite of the relevance of CaN to
many of the pathological consequences of TBI, little research has been done
detailing the effects of brain injury on calcineurin activity.
The present study investigates the effect of moderate central fluid
percussion injury on CaN activity in rat brain homogenate from the cortex,
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hippocampus and cerebellum. Both basal and maximal (cation-stimulated) CaN
activity were assayed in all three brain regions. A TBI-dependent increase in CaN
activity was observed in both the cortex and hippocampus, and this increase in
CaN activity was found to persist two to three weeks post-injury.

MATERIALS:
All materials were reagent grade and were purchased from Sigma
Chemical Co. (St. Louis, MO) unless otherwise noted. Bio-Rad protein assay
concentrate, sodium dodecyl sulfate (SDS), 2-mercaptoethanol, blotting grade
dry milk, and Mini-Protean II SDS-PAGE apparatus and power supplies were
purchased from Bio-Rad Laboratories (Richmond, CA). ABC reagents were
obtained from Vector Laboratories (Burlingame, CA). Adult male SpragueDawley rats were obtained from Harlan Laboratories (Indianapolis, IN).

METHODS:

Surgical preparation and fluid percussion injury:
All animal use procedures were in strict accordance with the Guide for the
Care and Use of Laboratory Animals described by the National Institutes of
Health and were approved by the Virginia Commonwealth University Animal Use
Committee. Adult male Sprague-Dawley rats weighing between 300 and 350g
were surgically prepared under sodium pentobarbital anesthesia (54 mg/kg
intraperitoneally). Animals were placed in a stereotactic frame and the scalp
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sagitally incised. A 4.8 mm hole was then trephined into the skull over the sagittal
suture midway between bregma and lambda. A nickel-plated screw was placed
1mm rostral to bregma, and a second screw was inserted 1mm caudal to
lambda. A modified female Luer-Loc syringe hub (2.6 mm inside diameter) was
placed over the exposed dura and bonded in place with a cyanoacrylate
adhesive. Dental acrylic was then poured around the syringe hub and screws.
The scalp was then sutured, bacitracin was applied to the wound, and the animal
was returned to its home cage.
Twenty-four hours following the surgical procedure, the rats were again
anesthetized (4% isoflurane in a carrier gas mixture of 70% N2O and 30% O2).
Rats in the sham-injury (control) group were anesthetized and connected to the
injury device, but the pendulum was not released. Rats in the injured group were
anesthetized and subjected to a moderate (2.1 ± 0.1 atm) level of fluid
percussion injury. The Luer-Loc fitting, screws, and dental cement were then
removed from the skull. Following recovery, rats were returned to their home
cages and allowed to survive for 24 hours, one week, two weeks, three weeks or
four weeks prior to being sacrificed.

Fluid percussion injury device:
The fluid percussion injury device used in these experiments is identical to
that described by Dixon et al. [189]. Briefly, the device consisted of a Plexiglas
cylinder reservoir 60cm long and 4.5cm in diameter. At one end of the cylinder
was a rubber-covered Plexiglas piston mounted on O-rings. The opposite end of

91

the cylinder had a metal housing 2cm long, containing a transducer. A 5mm tube
with a 2mm inner diameter was fitted at the end of the metal housing. The tube
terminated with a male Luer-Loc fitting. This fitting was connected to a female
Luer-Loc fitting that had been chronically implanted over the exposed dura of the
rat. The entire system was filled with isotonic saline. The injury was produced by
a metal pendulum that struck the piston of the injury device. The injury device
injected a small volume of saline into the closed cranial cavity and produced brief
displacement of brain tissue. The magnitude of injury was controlled by varying
the height from which the pendulum was released. The resulting pressure pulse
was measured externally by a pressure transducer (model EPN-0300A*-100A,
Entran Devices, Fairfield, NJ) and recorded on a storage oscilloscope (model
5111, Tektronix, Beaverton, OR).

Isolation and homogenization of brain regions:
Rats were anesthetized and decapitated 24 hours, one week, two weeks,
three weeks, and four weeks after injury. Brains were dissected on a petri dish on
ice to reduce post-mortem alteration of enzyme activity. Cortical, hippocampal,
and cerebellar brain regions were quickly isolated and immediately homogenized
with 10 strokes (up and down) at 12,000 rpm, using a motorized homogenizer
(TRI-R Instruments, Inc. Rockville Center, NY). Brain regions were homogenized
into ice-cold homogenization buffer containing 5mM HEPES (pH 7.0), 7mM
EGTA, 5mM EDTA, 1mM dithiothreitol (DTT), 0.3mM PMSF, and 300mM
sucrose. Cortical regions were homogenized into 7ml of buffer, hippocampal
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regions into 3ml of buffer, and cerebellar regions into 5ml. All brain homogenates
were normalized for protein, separated into aliquots and stored at -80°C until
used.

PNPP assay of calcineurin activity:
CaN activity was quantified using the procedure described in detail by
Kurz et al. [167]. Briefly, the reactions were performed as follows. All reaction
tubes were prepared on ice and contained the following: 25mM MOPS (pH 7.0),
1mM DTT, 2mM p-nitrophenol phosphate (pNPP). Maximal tubes contained the
same reagents as basal reactions, with the addition of 2mM MnCl2. Final reaction
volumes were 1ml. Prior to use, the protein concentration of all homogenates
was determined using the method of Bradford [144]. Reactions were initiated by
the addition of 200 µg/ml brain region homogenate. Reactions were incubated at
37°C for 15 minutes in a shaking water bath. Tubes were then removed from the
water bath and placed in ice to stop the reaction. Absorbance of the reaction
mixture was immediately measured at 405nm in a spectrophotometer.
Absorbance units were converted to nmol of pNP produced by comparison to a
pNP concentration standard absorption curve.

RII phosphopeptide assay:
Each fraction was subjected to 1% triton X-100 for 1h at 4° C. Samples
were then spun at 100,000 g in a tabletop centrifuge. The resulting supernatant
will be passed through a centrifugal filter device with a 10,000 MW cutoff
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(MicroCon filters, Amicon). These steps are necessary to remove endogenous
phosphate from the assay, otherwise background phosphate would overwhelm
the detection protocol. The final, phosphate-free solution was then balanced for
protein as above. Reaction tubes contained the following: 50 mM Tris-HCl, 6 mM
MgCl2, 0.5 mM CaCl2, 15 µM RII phosphopeptide and 5 µg of protein. Reaction
tubes were incubated for 15 min at 37°C in a shaking water bath. Reactions were
terminated by the addition of 2X the reaction volume of a malachite green-based
agent

(Calbiochem).

Reactions

were

read

at

620

nm

in

a

UV-Vis

spectrophotometer (Cary 50). Increased absorbance in this system indicates
increased phosphate release from the CaN substrate. Absorbances were
compared to a phosphate standard curve.

pNPP substrate kinetics:
Basal reaction tubes were prepared containing 25mM MOPS, 1mM DTT,
2mM EGTA, 2mM EDTA, and 150nM okadaic acid to minimize the influence of
other phosphatases on the results of the assay [167]. Maximal reaction tubes
contained 25mM MOPS, 1mM DTT, 2mM MnCl2, and 150nM okadaic acid. All
reaction tubes were prepared on ice. pNPP was added to the tubes for final
concentrations of 0, 0.1, 0.2, 0.5, 1, 2, 4, 8, 16 and 24mM. CaN reactions were
initiated by the addition of homogenate and assayed as described above. Values
for Km and Vmax were obtained via a non-linear regression analysis of the
substrate isotherm.
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Western blot analysis:
Western analysis was performed essentially as described previously [167].
Briefly, homogenates were resolved on SDS-PAGE and transferred to a
nitrocellulose membrane using the Geni blot system (Idea Scientific, Minneapolis,
MN). Nitrocellulose was then immersed for one hour in blocking solution
containing phosphate buffered saline (PBS, pH 7.4), 0.05% (v/v) polyoxyethylene
sorbitan monolaurate (tween-20), 50 g/L Bio-Rad blotting grade dry milk, and the
appropriate normal serum (Vector Laboratories Inc., diluted 50 µl/10ml). The
nitrocellulose membrane was then incubated with primary antibody in blocking
solution for one hour. Anti-CaN A antibody (clone CN-A1, mouse monoclonal
IgG, Sigma Chemical Co.) was diluted 1:10,000 for western analysis, and anti βtubulin antibody was diluted 1:1,000. Membranes were then washed three times
in a wash solution containing PBS, tween-20, and dry milk. Nitrocellulose was
then reacted with a secondary antibody in blocking solution for 45 minutes. The
membrane was then washed three times and incubated with an avidin-biotin
horseradish peroxidase complex for 30 minutes. Nitrocellulose was then washed
three times in PBS for 10 minutes per wash. Blots were developed with a solution
containing 10 ml PBS, 0.025% (v/v) H2O2, and 8 mg 4-chloro-1-napthol dissolved
in 2ml of methanol. Specific immunoreactive bands were quantified by computerassisted densitometry (Inquiry, Loats Associates, Westminster, MD).
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Statistical analysis:
All statistical analysis of data was performed using GraphPad Prism 3.0
(GraphPad Software, San Diego, CA), or Sigma Stat 2.03 (SPSS Inc, Richmond,
CA). Levels of phosphatase activity were compared to control using the Student's
t-test (two-tailed distribution, unpaired) or one-way ANOVA with Tukey post
analysis to control for type 1 errors in multiple comparisons. Values for Vmax and
Km were determined by a non-linear regression curve for single-site substrate
binding, included with the Prism software. Computer assisted densitometric
analysis was performed using Inquiry (Loats Associates Inc, Westminster, MD).

RESULTS:

Central fluid percussion injury results in an increase in calcineurin activity
in specific brain regions:
CaN activity was quantified in homogenates from the cortex, hippocampus
and cerebellum under both basal and maximal reaction conditions. In both the
cortex and hippocampus CaN activity was significantly elevated after TBI. In
hippocampal homogenates, TBI induced a significant increase in phosphatase
activity above control levels under both basal and maximal conditions (Figure
12A). Average basal CaN activity measured in sham hippocampal homogenates
was 3.63 µg pNP produced/min/mg of protein. Following TBI, this value was
elevated to 5.01 µg pNP/min/mg, an increase of 38.2% (p <0.001, n=10,
Student’s t-test). Control maximal activity in hippocampal homogenates was 7.36
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µg pNP/min/mg. After injury, activity increased 28.6% over control, to a value of
9.47 µg pNP/min/mg (p < 0.05, n=10).
TBI induced a significant increase in both basal and maximal CaN activity
in cortical homogenates. However, the increase in CaN activity was substantially
smaller than that observed in hippocampal homogentates (Figure 12B). Average
basal CaN activity in control samples was 3.49 µg pNP/min/mg. Following TBI,
this value increased to 4.11 µg pNP/min/mg, and increase of 17.8% (p<0.05,
n=6). Maximal activity in cortical homogenates isolated from sham animals was
6.99 µg pNP/min/mg. In injured animals, this value was increased by 14.6%, to a
value of 8.01 µg pNP/min/mg (p < 0.05, n=6). The increase in both the cortical
and hippocampal homogenates was present despite the addition of ion chelators
to the reaction mix (see methods).

Changes in pNPP dephosphorylation were caused by CaN:
Previous studies [167] have demonstrated a high degree of CaNspecificity in the pNPP assay. For the present study, these results were futher
confirmed by the use of gossypol, a specific CaN inhibitor (Figure 13). Under
basal

reaction

conditions,

the

addition

of

gossypol

decreased

pNPP

dephosphorylation in cortical homogenates isolated from control animals from
3.49 µg pNP produced/min/mg of protein to 1.38 µg pNP produced/min/mg, a
decrease of 60.4%. Likewise, in cortical homogenates isolated from injured
animals, pNPP dephosphorylation was reduced by 65.9% in the presence of
gossypol, from 4.11 µg pNP produced/min/mg to 1.40 µg pNP produced/min/mg.
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Under maximal reaction conditions, the addition of gossypol resulted in a 74.2%
decrease in pNPP dephosphorylation in control homogenates, from 7.36 µg pNP
produced/min/mg to 1.89 µg pNP produced/min/mg. pNPP dephosporylation was
similarly decreased in cortical homogenates isolated from injured animals, from
9.47 µg pNP produced/min/mg to 1.94 µg pNP produced/min/mg in the presence
of gossypol, a decrease of 79.5%. In the presence of gossypol, there was no
significant

difference

between

control

and

injured

values

for

pNPP

dephosporylation (p <0.01, n = 10) suggesting that any TBI-dependent
alterations in pNPP dephosphorylation were due to CaN.

The TBI-dependent increase in CaN activity persists several weeks postinjury:
CaN activity was assayed in both the cortex and hippocampus to
determine the duration of the TBI-dependent increase in enzyme activity. In
addition to the acute time-point discussed above, both basal and maximal CaN
activity were measured at one week, two weeks, three weeks, and four weeks
post-injury. The post-injury increase in CaN activity persisted two to three weeks
after the TBI event; however, the magnitude of the increase in activity decreased
with time in both hippocampal and cortical homogenates.
In cortical homogenates isolated from injured animals, basal CaN activity
was 124% of control activity at the one week time point (p <0.01, n=3). Two
weeks post-injury, basal CaN activity was 121% of control basal activity (p <

98

0.01, n=6), and three weeks post-injury, basal CaN activity was 108.6% of control
values (p < 0.05, n=3). At the four week post-TBI time point, basal CaN activity in
homogenates isolated from TBI animals was 97.6% of control basal activity, a
difference that was not significant (Figure 14A).
Similarly, at the one week time point, maximal CaN activity in cortical
homogenates from injured animals was increased to 120.4% of control activity (p
< 0.01, n=3). Two weeks post-injury, CaN activity was increased to 115.6% of
control in cortical homogenates isolated from injured animals (p < 0.05, n=6). No
significant increase in maximal CaN activity was observed at either the three or
four week time point (Figure 14B).
The time-course of increased CaN activity in hippocampal homogenates
demonstrated a pattern similar to that of cortical homogenates. Basal activity in
homogenates isolated from injured animals was 132.3% of control one week
post-injury (p < 0.01, n=3). At two weeks post-injury, basal CaN activity was
128.4% of control activity (p < 0.01, n= 6), and at three weeks post-injury, basal
CaN activity was 114.4% of control activity in hippocampal homogenates (p <
0.05, n=3). At four weeks post-injury, there was no longer a statistically
significant TBI-dependent increase in basal CaN activity (Figure 14C).
Maximal CaN activity remained elevated for two weeks post-injury in
hippocampal homogenates. One week post-injury, maximal CaN activity was
126.2% of control activity in hippocampal homogenates isolated from injured
animals (p < 0.01, n = 3). Two weeks post-injury, maximal CaN activity was
124.1% of control activity (p < 0.01, n=6). By three weeks post-injury, maximal
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CaN activity had receeded to 104% of control activity, a difference which was not
statistically significant (p > 0.05, n=3). At four weeks post injury, maximal CaN
activity in hippocampal homogenates isolated from injured animals was
indistinguishable from that of control animals (Figure 14D).

TBI induces an alteration in CaN enzyme kinetics in both the cortex and
hippocampus:
Other models of cerebral trauma have been shown to alter apparent
substrate affinity of CaN [167]. Therefore, to further characterize the effect of TBI
on CaN activity, substrate affinity (Km) and maximal dephosphorylation rate
(Vmax) were examined (see Materials and Methods). Substrate concentration
isotherms of the pNPP dephosphorylation reaction were examined in both
cortical and hippocampal homogenates, and under both basal and maximal
reaction conditions. In hippocampal homogenates, the maximal rate of pNPP
dephosphorylation was increased approximately 22% under basal reaction
conditions (Figure 15A). In homogenates from control animals, Vmax was 4.17 µg
pNP/min/mg. In TBI homogenates, this value was elevated to 5.09 µg
pNP/min/mg (p < 0.001, n=3). The apparent Km was not significantly affected by
TBI under basal conditions in the hippocampus. In control homogenates, the
apparent Km was 0.94 mM. Following TBI, the substrate affinity increased
(decreased Km) by 5.3% to 0.89 mM. However, the TBI-induced increase in
substrate affinity was not statistically significant (p>0.05, n=3).
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Under maximal CaN reaction conditions in hippocampal homogenates, the
apparent Vmax was significantly increased, while substrate affinity was not
significantly altered by TBI (Figure 15B). In hippocampal homogenates isolated
from control animals, Vmax was 8.64 µg pNP/min/mg. Following TBI, this value
increased by 14.4% to 9.88 µg pNP/min/mg (p<0.001, n=3). Substrate affinity
was

not

altered

under

maximal

dephosphorylation

conditions

in

the

hippocampus. In homogenates from both control and injured animals, the
apparent Km was approximately 0.20 mM (p>0.05, n=3).
Under both basal and maximal conditions in the cortex, Vmax, but not Km,
was significantly increased following brain injury (Figure 16A). Under basal
conditions, the apparent Vmax in homogenates isolated from control animals was
6.88 µg pNP/min/mg. In animals subjected to TBI, this value increased 11.5% to
7.67 µg pNP/min/mg (p<0.01, n=3). In control homogenates, the Km for basal
reaction conditions was 0.95 mM pNPP. Following TBI, this value decreased
slightly to 0.90 mM pNPP, a decrease of 5.3% that was not statistically
significant. (p>0.05, n=3). Under maximal conditions in the cortex (Figure 16B),
the apparent Vmax was 10.82 µg pNP/min/mg. After injury, this value was
significantly increased by 9.8% to 11.88 µg pNP/min/mg (p<0.01, n=3). Km was
not

significantly

altered

under

maximal reaction

conditions

in

cortical

homogenates. The control value for Km was 0.68 mM, following TBI, this value
decreased by 7.3% to 0.63 mM. This difference was not statistically significant
(p>0.05, n=3).
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TBI did not affect CaN activity in the cerebellum:
While significant increases in CaN activity were found in both the cortex
and hippocampus following TBI, no increase was found in cerebellar
homogenates. In fact, values for CaN activity appeared to decrease slightly
(Figure 17). Under basal reaction conditions, the average control CaN activity in
cerebellar homogenates was 3.84 µg pNP/min/mg. Following TBI, basal activity
was 3.51 µg pNP/min/mg, a decrease of 8.6% that was not statistically significant
(p>0.05, n=6). Maximal activity in sham cerebellar homogenates was 9.15 µg
pNP/min/mg. Following TBI, this value decreased by 4.1%, to 8.78 µg
pNP/min/mg (p>0.05, n=6). Although the decrease in neither basal nor maximal
activity was statistically significant, the response of the cerebellum was
remarkable due to the obvious difference from the significant increases in activity
found in the other brain regions. To determine if significant post-TBI neuronal cell
loss in the cerebellum contributed to the lack of increase and lower activities
observed in this study, homogenates were assayed for the presence of a neuronspecific marker. Western analysis of cerebellar homogenates from control and
TBI animals was performed using an antibody directed against β-tubulin (Clone
TUJ1, Covance, Richmond, CA). This method has been shown to be an accurate
assay for neuronal concentration [190, 191]. No significant difference in β-tubulin
immunoreactivity was found between cerebellar homogenates from sham injured
animals (Figure 18). This suggests that a roughly similar amount of neuronal
tissue remained in the cerebellar homogenate 24 hours post-TBI, and that
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neuronal cell loss was likely not responsible for the lower CaN activities observed
in the cerebellum.

The observed increase in CaN activity was not due to an increase in the
amount of CaN present:
A possible explanation for the increase in CaN activity observed in the
hippocampus and cortex is the increased synthesis of enzyme following TBI. To
examine this hypothesis, western analyses of homogenate from all brain regions
were performed, using an antibody directed against the catalytic A-subunit of the
enzyme (CN-1, Sigma, St. Louis, MO). In all three brain regions, a single band
with molecular weight of approximately 61 kDa was resolved. This corresponds
with the size of the CaN A subunit [8]. Computer-assisted densitometric analysis
was performed on TBI and control fractions (see Materials and Methods). Optical
density of the immunoreactive band in cortical TBI homogenate was found to be
94.8%

of

control

density

(Figure

19A).

In

the

hippocampus,

CaN

immunoreactivity in TBI homogenate was 103.4% of control (Figure 19B) and in
the cerebellum, immunoreactivity was 107.1% of control (Figure 19C). The
density of the immunoreactive bands was not significantly different in any region
tested (p>0.05, n=3 for all regions). The data suggest that an increase in CaN
synthesis was not responsible for the increase observed in the cortex and
hippocampus, nor was a decrease in the amount of CaN present responsible for
the slight decrease in CaN activity in the cerebellum.
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DISCUSSION:
The present study is the first to demonstrate a significant increase in CaN
activity following fluid percussion brain injury. TBI induced a significant increase
in both basal and maximal CaN activity in both the hippocampus and cortex,
which persisted two to three weeks after injury. No increase in CaN activity was
observed in the cerebellum. TBI-dependent increases in both substrate affinity
and maximal reaction rate were demonstrated in the hippocampus and cortex.
The significant increase in CaN activity was not due to an increase in the amount
of CaN present in the homogenate. An increase in the activity of this important
neuronal phosphatase has broad physiological implications, and may be an
important step in the development of the pathological consequences of TBI.
Several possible mechanisms exist to explain the TBI-induced elevation in
CaN activity. Significant increases in intracellular calcium concentrations have
been demonstrated following TBI in several model systems, including the fluid
percussion model used in this study [192, 193] and in hippocampal neurons in
culture [194, 195]. Calcineurin is a calcium/calmodulin-stimulated enzyme, and
would be highly sensitive to an increase in intracellular free calcium
concentrations. Therefore, it is reasonable to suspect altered intracellular calcium
levels were responsible for increased CaN activation following TBI. There is
precedent to assume that increased intracellular calcium could account for
altered enzyme activity lasting well after the event, as was the case in this study.
The study of intracellular calcium described by Fineman et al. [193] detected
increased intracellular calcium up to 4 days post TBI (the longest time-point
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used), while studies in culture have detected persistent alterations in calcium
entry and homeostatic mechanisms [194, 195].

However, under the reaction

conditions employed in the present study, any increased Ca2+ should have been
adequately buffered. In addition, increasing ion-chelator concentrations in the
reaction mix did not significantly effect calcineurin activity in this assay (Data not
shown). Therefore, increased intracellular Ca2+ alone cannot account for the
observed increase in CaN activity.
It is possible that TBI alters the expression of CaN, resulting in a greater
amount of the enzyme being present in neuronal cells after injury. An increase in
the amount of CaN would explain both the increase in the apparent pNPP
dephosphorylation rate without the alteration in substrate affinity following TBI.
However, western analyses of cortical and hippocampal homogenates did not
detect a significant change in the amount of CaN present in the tissue. This
suggests that increased synthesis of CaN is not responsible for the results
demonstrated in this study.
CaN activity may be increased after TBI due to post-translational
modification of the enzyme. There are several intriguing possible modifications of
the enzyme that could result in alterations in CaN activity similar to those
observed in this study. For example, limited proteolysis of the CaN A subunit by
the calcium-stimulated protease calpain I produces a highly active, calciumindependent form of CaN [12, 14]. Interestingly, several studies have
demonstrated a TBI-dependent increase in calpain I activity, possibly due to
increased intracellular calcium levels [154, 196]. Increased calpain activity could
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result in higher levels of the partially digested, highly active form of CaN.
However, the 43 kDa activated CaN fragment was not detected by the western
analysis performed in this study, nor was a significant reduction in CaN A
immunoreactivity detected, indicating that a large amount of the enzyme was not
broken down by calpain. This does not completely discount proteolysis as a
possible mechanism for the TBI-induced increase in CaN activity. Partially
digested CaN is reported to have a basal activity 1100% higher than that of the
holoenzyme [14]. An increase of this magnitude suggests that, if the activated 43
kDa fragment is present after TBI, it constitutes only a small amount (less than
5%) of total enzyme. A difference in protein levels of this magnitude would be
difficult to detect through western blot analysis. It is also possible that the epitope
recognized by the antibody was no longer present following proteolysis,
explaining why no small fragments appeared on the western blot.
Other post-translational regulatory mechanisms also affect CaN activity.
Phosphorylation of CaN by both PKC and CaM Kinase II has been shown to
inactivate the enzyme [197]. Additionally, the membrane-associated protein
AKAP79 binds CaN, also inactivating the enzyme [56]. A TBI-induced alteration
in any of these mechanisms could result in the observed increase in CaN activity.
The TBI-dependent increase in CaN activity described in this study was
not observed in the cerebellum. In fact, a small decrease in CaN activity was
observed in all samples. Although, this decrease was not significant, it is
interesting when considered in context of the significant increases observed in
the other tow brain regions. Central fluid percussion injury produces a large
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amount of strain on the brainstem and nearby structures, with death often
resulting from brainstem injury in severe FPI [198, 199]. Therefore, it was
possible that physical damage and death of neurons in this region may have
contributed to the lower CaN activity. Western analysis for β-tubulin, a neuronspecific marker, did not detect a significant difference between TBI and sham
homogenates. Additionally, western analysis of CaN did not detect a significant
difference in CaN A immunoreactivity. Therefore, loss of CaN protein was not a
contributing factor confounding a potential TBI-induced increase in enzyme
activity. The data suggest that TBI modulated different mechanisms in the cortex
and hippocampus than in the cerebellum.
The moderate fluid percussion injury used in this study results in
numerous cognitive deficits, including memory dysfunction [200], loss of spatial
navigation skills [201], and sensorimotor deficits [202]. These deficits are often
worst in the days and weeks immediately following TBI. Increased CaN activity
may play a role in this cognitive dysfunction. CaN plays a modulatory role in both
LTP and LTD of neurons. CaN also modulates major inhibitory receptors, such
as the GABAA receptor, and major excitatory receptors, such as the NDMA
receptor. Additionally, recent research suggests a major role for CaN in the
process of learning and memory. An increase in CaN activity could disrupt any of
these processes, playing a role in the cognitive deficits that follow TBI.
Interestingly, recent studies have shown cyclosporin A (CsA), a potent CaN
inhibitor, to be beneficial in preserving cognitive and motor function following TBI
[203, 204]. CsA has other functions as well, most notably blocking the formation
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of the mitochondrial transition pore [205], and thus it is impossible to clearly
attribute its neuroprotective function to the inhibition of CaN. However, these
results, in combination with those of the present study, clearly identify CaN as an
important area for further TBI-related research.
Among the physiological roles of CaN, modulation of the GABAA receptor
is of particular interest. The GABAA receptor is the primary inhibitory receptor in
the brain, and is essential for the control of neuronal excitability [65]. Several
recent studies have demonstrated a down modulation of GABAA receptor
function by CaN [66-68, 159]. A post-TBI elevation in CaN activity may result in
increased dephosphorylation of GABAA receptors, resulting in a net disinhibition
of cellular excitability. A loss of GABA function could produce cognitive and motor
deficits, as well as possibly being epileptogenic. It is interesting to note that a
recent study found antagonism of the GABAA receptor to be detrimental to
recovery of cognitive function after TBI [206].
Another major cellular mechanism modulated by calcineurin is apoptosis.
Several studies have shown CaN to be an essential link in apoptotic pathways
[140, 185]. Additionally, artificially high levels of CaN activity predisposes
neuronal cells to apoptosis [207]. When a truncated, highly active form of the
enzyme was overexpressed in neuronal cells, even normally sub-lethal stimuli
were capable of inducing apoptotic cell death. The increased CaN activity
demonstrated in the present study, particularly the larger increases in the
hippocampus, may make neurons in these regions more likely to undergo
apoptosis. Recent literature suggests that apoptotic cell death may play an
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important role in the pathology of TBI, making this mechanism an intriguing area
for further study [208-210].
The results presented in this study describe a TBI-induced increase in
CaN activity that persists up to three weeks post-injury. The relatively persistent
nature of this increase suggests a major role for CaN in TBI-related pathologies,
with the enzyme playing a role in both immediate neuronal dysfunction and
possibly inducing chronic neurological changes. Further research into the role of
CaN in TBI may provide a new avenue for clinical treatment of brain injury. For
example, the calcineurin inhibitors cyclosporin A and FK506 have both shown
promise as neuroprotective agents in several models of TBI, although debate
exists about their mechanism of action [93, 94, 211]. Future research is needed
to detail the physiological role of calcineurin in TBI and the mechanism
responsible for the observed increase in CaN activity. This research will offer
useful insight into the biochemical mechanisms occurring during traumatic brain
injury.
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Figure 12. TBI resulted in a significant increase in basal and maximal CaN
activity. Basal (white) and maximal (black) calcineurin activity were assayed in
hippocampal and cortical homogenates isolated 24 h after moderate fluidpercussion injury. (A) Hippocampal homogenates isolated from injured animals
displayed a significant increase in both basal (52.2%) and maximal (34.3%) CaN
activity. (B) A TBI-dependent increase in CaN activity was also observed in
cortical homogenates, although this increase was smaller than that observed in
the hippocampus. Basal CaN activity was elevated by 44.9% and maximal CaN
activity was increased by 39.1% when compared to control homogenates (***p <
0.001, *p < 0.05, n =10, Student’s t-test).
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Figure 13. The observed increase in pNPP dephosphorylation is CaNspecific. Cortical homogenates from injured and control animals 24 h post-injury
were subjected to basal (white bars) and maximal (black bars) reaction
conditions in the presence and absence of gossypol, a CaN-specific inhibitor. In
the presence of gossypol, both basal and maximal pNPP dephosphorylation
were significantly reduced in control and injured homogenates (***p < 0.001, n =
10, Student’s t-test). When gossypol was added to the reaction, basal pNPP
dephosphorylation

was

not

significantly

different

from

maximal

pNPP

dephosphorylation in either control or TBI homogenates (p > 0.05, n = 10).
Finally, control and TBI pNPP dephosphorylation were not significantly different
in the presence of gossypol (p > 0.05, n = 10), indicating that the observed
injury-dependent increase in pNPP dephosphorylation was due to CaN activity.
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Figure 14. The TBI-induced increase in CaN activity lasts several weeks
post-injury. Cortical and hippocampal homogenates from injured and control
animals were isolated at 1, 2, 3, and 4 weeks post-injury. Under basal reaction
conditions, CaN activity remained significantly elevated in cortical homogenates
(A) at 1 and 2 weeks post-injury. At 3 and 4 weeks post-injury, basal CaN activity
was not significantly different from control values. Under maximal conditions,
CaN activity in cortical homogenates (B) was significantly elevated at 1 and 2
weeks post-injury. At 3 and 4 weeks post-injury, maximal CaN activity was not
significantly different from control. In hippocampal homogenates, CaN activity
was significantly elevated under basal conditions (C) post-injury at 1, 2, and 3
weeks post-injury. At 4 weeks post-injury, basal CaN activity was not significantly
different from control. Under maximal reaction conditions, CaN activity was
elevated in hippocampal homogenates (D) at 1, 2, and 3 weeks postinjury. At 4
weeks post-injury, maximal CaN activity was not significantly different from
control (**p < 0.01, *p < 0.05, n = 8 for all groups, one-way ANOVA with Tukey
post-hoc analysis).
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Figure

15.

TBI
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CaN

enzyme

concentration

kinetics

isotherms

were

in

hippocampal
constructed

in

hippocampal homogenates isolated from control and TBI animals. (A) Basal CaN
reactions were performed in control (open circles) and TBI (closed circles)
homogenates. TBI resulted in a 27.4% increase in apparent Vmax (p < 0.001, n
= 3). However, substrate affinity was not significantly affected (5.0% decrease in
Km, p

> 0.05, n = 3). (B) Maximal CaN reactions were performed in

homogenates isolated from control (open circles) and TBI (closed circles)
animals. Like basal CaN reactions, TBI resulted in a significant (20.2%, p <
0.001, n = 3) increase in apparent Vmax, without a significant increase in
substrate affinity (Km not changed).
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Figure 16. TBI modulated CaN enzyme kinetics in cortical homogenates.
Substrate concentration isotherms were constructed in cortical homogenates
isolated from control and TBI animals. Cortical homogenates displayed a
significant increase in CaN activity. (A) Basal CaN reactions were performed in
control (closed circles) and TBI (open circles) homogenates. TBI resulted in a
22.3% increase in apparent Vmax (p < 0.01, n = 3). However, substrate affinity
was not significantly affected (5.3% difference in Km, p > 0.05, n = 3). (B)
Maximal CaN reactions were performed in homogenates isolated from control
(open circles) and TBI (closed circles) animals. Like basal CaN reactions, TBI
resulted in a significant (15.2%, p < 0.01, n = 3) increase in apparent Vmax,
without a significant increase in substrate affinity (6.7%, p > 0.05, n = 3).
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Figure 17. TBI did not affect CaN activity in the cerebellum.
Basal (white) and maximal (black) CaN activity was assayed in cerebellar
homogenates 24 h post-TBI. Both basal and maximal activity appeared to
decrease slightly; however values were not found to be significantly different from
those observed in control homogenates (p < 0.05, n =10, Student’s t-test).
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Figure 18. TBI did not induce significant neuronal loss in the cerebellum at
the acute time-point.
(A) Western analysis for the neuron-specific protein β-tubulin was used to
determine relative concentrations of neuronal tissue in TBI and control cerebellar
homogenates. (B) Computer-assisted densitometry demonstrated that β-tubulin
immunoreactivity was not significantly different between TBI homogenate and
control, suggesting a roughly similar amount of neuronal tissue was present in
the homogenate before and after injury. β-Tubulin immunoreactivity in TBI
cerebellum was 106. ± 9.4% of control (p > 0.05, n > 6, Student’s t-test).
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Figure 19. The post-TBI alteration in CaN activity was not due to a TBIinduced increase in CaN protein expression.
To determine if TBI resulted in increased CaN enzyme levels, homogenates from
all brain regions were subjected to western analysis for the catalytic CaN A
subunit. Immunoreactivity in the hippocampus (A), cortex (B), and cerebellum (C)
was quantified with computer-assisted densitometry (D), and found not
significantly different from control (p < 0.05, n = 3 for all brain regions, Student’s
t-test). Blots shown are representative from samples utilized for biochemical
characterization.

CHAPTER IV
A PERSISTENT CHANGE IN SUBCELLULAR DISTRIBUTION OF
CALCINEURIN FOLLOWING FLUID PERCUSSION INJURY IN
THE RAT.

INTRODUCTION:

Traumatic brain injury (TBI) remains a major cause of death and disability
in the United States today [183]. Although the initial injury often involves
irreversible destruction of tissue, secondary, potentially preventable injury
processes take place in the days and weeks after injury. This secondary damage
causes pathological change in cells over a much greater area than the primary
injury, and is often responsible for many of the lasting neurological deficits
associated with TBI [183, 184] The delayed nature of this secondary injury offers
a potential window for treatment, making it an exciting area for both basic
research and clinical trials. Fluid percussion brain injury provides an excellent
model for this type of secondary, generalized injury; moderate fluid percussion
does very little immediate damage to the brain tissue, but animals are left with
pathologically altered neuronal cells and lasting neurological deficits [212].
Central fluid percussion, in particular, is associated with reduced cell death when
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compared with lateral fluid percussion [213].
Many of the mechanisms associated with secondary neuronal injury in TBI
are associated with calcium and calcium-modulated systems [132]. A calciumregulated enzyme of current interest is the neuronally enriched phosphatase,
calcineurin (CaN). Expression of CaN mRNA is elevated after injury in at least
one model [214]. Additionally, the CaN inhibitors cyclosporin A and FK-506 have
both shown promise as neuroprotective agents in several models of TBI [93, 94,
215, 216], although only cyclosporin A has been evaluated in the specific model
used in this study [94]. In the case of cyclosporin A, the neuroprotective effect
may be due to CaN inhibition, but most studies suggest neuroprotection is due to
the drug's effects on mitochondria. On the other hand, for FK-506, the
neuroprotective action is more likely due to CaN inhibition [93, 216]. Finally,
recent research has characterized a TBI-dependent increase in CaN activity in
the fluid percussion model, further implicating CaN in brain trauma-induced
pathology [217].
The present study expands on our previous study of CaN in TBI, further
characterizing the effects of fluid percussion TBI on CaN in rat forebrain. CaN
immunoreactivity was increased in synaptoplasmic membrane-enriched fractions
from both the cortex and hippocampus. This elevation in CaN immunoreactivity
persisted for 2 weeks in the cortex, and up to 4 weeks in the hippocampus.
Additionally, immunohistochemical studies of the hippocampus demonstrated a
TBI-dependent elevation in CaN immunoreactivity in dendritic processes of the
CA1 region. The data suggest a long-lasting post-injury translocation of CaN to
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the post-synaptic region of neurons, where it may play a role in pathologically
altering synaptic activity.

METHODS:

Surgical preparation and fluid percussion injury:
All animal use procedures were in strict accordance with the Guide for the
Care and Use of Laboratory Animals described by the National Institutes of
Health and were approved by the Virginia Commonwealth University Institutional
Animal Care and Use Committee. Adult male Sprague–Dawley rats weighing
between 300 and 350 g were surgically prepared under sodium pentobarbital
anesthesia (54 mg/kg intraperitoneally). Animals were placed in a stereotactic
frame and the scalp was sagitally incised. A 4.8-mm hole was then trephined into
the skull over the sagittal suture midway between bregma and lambda. A nickelplated screw was placed 1 mm rostral to bregma, and a second screw was
inserted 1 mm caudal to lambda. A modified female Luer-Loc syringe hub (2.6
mm inside diameter) was placed over the exposed dura and bonded in place with
a cyanoacrylate adhesive. Dental acrylic was then poured around the syringe
hub and screws. The scalp was then sutured, bacitracin was applied to the
wound, and the animal was returned to its home cage.
Twenty-four hours following the surgical procedure, the rats were again
anesthetized (4% isoflurane in a carrier gas mixture of 70% N2O and 30% O2).
Rats in the sham-injury (control) group were anesthetized and connected to the
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injury device, but the pendulum was not released. Rats in the injured group were
anesthetized and subjected to a moderate (2.1 ± 0.1 atm) level of fluid
percussion injury. The Luer-Loc fitting, screws, and dental cement were then
removed from the skull. Following recovery, rats were returned to their home
cages and allowed to survive for 24 h, 1 week, 2 weeks, 3 weeks, or 4 weeks
prior to being sacrificed. Six injured and six sham-injured animals were obtained
for each post-injury time point for Western analysis. An additional three injured
and three sham-injured animals were obtained for immunohistochemical studies
from the 24-h and 4-week time points.

Fluid percussion injury device:
The fluid percussion injury device used in these experiments is identical to
that described by Dixon et al. [189]. Briefly, the device consisted of a Plexiglas
cylinder reservoir 60 cm long and 4.5 cm in diameter. At one end of the cylinder
was a rubber-covered Plexiglas piston mounted on O-rings. The opposite end of
the cylinder had a metal housing 2 cm long, containing a transducer. A 5-mmlong tube with a 2-mm inner diameter was fitted at the end of the metal housing.
The tube terminated with a male Luer-Loc fitting. This fitting was connected to a
female Luer-Loc fitting that had been chronically implanted over the exposed
dura of the rat. The entire system was filled with isotonic saline. The injury was
produced by a metal pendulum that struck the piston of the injury device. The
injury device injected a small volume of saline into the closed cranial cavity and
produced brief displacement of brain tissue. The magnitude of injury was
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controlled by varying the height from which the pendulum was released. The
resulting pressure pulse was measured externally by a pressure transducer
(model EPN-0300A*-100A, Entran Devices, Fairfield, NJ) and recorded on a
storage oscilloscope (model 5111, Tektronix, Beaverton, OR).

Isolation and homogenization of brain regions:
Rats were anesthetized and decapitated 24 h, 1 week, 2 weeks, 3 weeks,
and 4 weeks after injury or sham-injury. No obvious contusion or gross signs of
injury were noted. Brains were dissected on a petri dish on ice to reduce
postmortem alteration of enzyme activity. Cortical and hippocampal brain regions
were quickly isolated and immediately homogenized with 10 strokes (up and
down) at 12,000 rpm using a motorized homogenizer (TRI-R Instruments, Inc.,
Rockville Center, NY). Brain regions were homogenized into ice-cold
homogenization buffer containing 5 mM HEPES (pH 7.0), 7 mM EGTA, 5 mM
EDTA, 1 mM dithiothreitol, 0.3 mM phenylmethylsulfonylfloride, and 300 mM
sucrose. Cortical regions were homogenized into 7 ml of buffer and hippocampal
regions into 3 ml of buffer. Cortical homogenates consisted of both left and right
hemispheres, while hippocampal homogenates consisted of both the left and
right hippocampus. Subcellular fractions were then isolated by a differential
centrifugation procedure [168] with modifications described previously [217].
Brain region homogenate was first centrifuged at 5000 × g for 10 min to produce
a crude nuclear pellet (P1) and a supernatant (S1). The P1 pellet was
resuspended in homogenization buffer, separated into aliquots, and stored at −80
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°C until used. The S1 was centrifuged for 30 min at 18,000 × g to produce the
crude synaptoplasmic membrane/mitochondiral pellet (P2) and a supernatant
(S2). The S2 was separated into aliquots and stored at −80 °C. The P2 pellet
was resuspended in homogenization buffer (1 ml for cortex, 500 µl for
hippocampus), then separated into aliquots and stored at −80 °C until used.

CaN immunoblotting procedure:
Western analysis was performed essentially as described previously [146].
Briefly, homogenate protein concentrations were measured and balanced.
Homogenates were then resolved on SDS-PAGE (5 µg/lane, 5 well, 1.5 mm thick
gels, Mini-Protean II system, Bio-Rad, Hercules, CA) and transferred to a
nitrocellulose membrane using the Geni blot system (Idea Scientific, Minneapolis,
MN). Anti-CaN A antibody (clone CN-A1, mouse monoclonal IgG, Sigma
Chemical Co.) was diluted 1:10,000 for Western analysis, and stained using the
Vectastain Elite anti-mouse IgG kit (Vector Laboratories Inc., Burlingame, CA).
Blots were developed with a solution containing 10 ml PBS, 0.025% (v/v) H2O2,
and 8 mg 4-chloro-1-napthol dissolved in 2 ml of methanol. Specific
immunoreactive bands were quantified by computer-assisted densitometry (GS800 Calibrated Densitometer, BioRad).

Immunohistochemical analysis:
Immunohistochemical studies were carried out as described previously
[146, 217]. At 24 h and 4 weeks post-injury, rats were anesthetized with
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halothane

and

transcardially

perfused

with

a

solution

containing

4%

paraformaldehyde and 0.1% glutaraldehyde. Brains were then removed and
allowed to post-fix in the perfusion fixative for 24 h. Brains were then blocked to
allow sectioning of the dorsal hippocampus, embedded in agar and coronally
sectioned into serial 40-µm sections on a Leica VT1000S vibratome (Leica
Microsystems, Bannockburn, IL). Sections were stored in 12-well culture plates
until used.
For immunohistochemical staining, sections were incubated for 30 min in
normal serum at 37 °C. Sections were then incubated overnight with a polyclonal
anti-CaN A antibody at a dilution of 1:50,000. Following incubation with the
primary antibody, sections were then washed 4× with phosphate-buffered saline
(PBS, pH 7.4) for 15 min per wash. The tissue was then incubated in secondary
antibody for 1 h at 37 °C. Sections were washed 3× in PBS, then placed in
Vectastain ABC reagent for 2 h. The first hour of incubation in ABC was
performed at 37 °C, the second hour at room temperature. Sections were then
washed 2× in PBS for 10 min per wash, and 1× in Tris–Base (pH 7.6). The tissue
was then stained with a glucose oxidase-DAB-nickel preparation.

RESULTS:

TBI resulted in a long-lasting increase of CaN immunoreactivity in both the
cortex and hippocampus
Western analysis was performed for homogenate and subcellular fractions
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for both cortex and hippocampus. No significant post-TBI difference in CaN
immunoreactivity was found in homogenate from either cortical or hippocampal
tissues, indicating that there was no overall increase in the amount of CaN
present in this tissue (Fig 20). Additionally, no difference in CaN immunoreactivity
was detected in the P1 (nuclear-enriched) or S2 fractions (data not shown).
Crude synaptoplasmic membrane (SPM) fractions were isolated from the
cortex and hippocampus at several time points post-injury to assess the duration
of the increase in CaN immunoreactivity. All SPM fractions were compared with
fractions isolated from sham-operated controls at identical time points postsham-injury. At 24 h post-injury, a significant increase in CaN immunoreactivity
was observed (257.9 ± 32.0% of control, Fig. 21 and Fig. 22) in the P2 (crude
SPM) fraction isolated from post-TBI cortical tissue. CaN immunoreactivity
remained increased to 218.1 ± 25.4% of control 1 week post-TBI (Figs. 21 and
22), and 202.1 ± 23.1% of control 2 weeks post TBI (Fig. 21C). At 3 weeks postinjury, CaN immunoreactivity had returned to baseline, and was indistinguishable
from that of sham-operated animals (Figs. 21 and 22).
Similarly, a TBI-dependent increase in CaN immunoreactivity to
261.3 ± 24.8% of control was observed 24 h post-injury in hippocampal crude
SPM (Figs. 23 and 24). CaN immunoreactivity remained elevated to
261.6 ± 26.2% of control 1 week post-TBI (Figs. 23 and 24), 259.2 ± 20.1% of
control 2 weeks post-TBI (Figs. 23 and 24), and 138.7 ± 10.3% of control 3
weeks post-TBI (Figs 23 and 24). At 4 weeks post-injury, CaN immunoreactivity
in hippocampal SPM-enriched fractions was 130.4 ± 12.5% of control (Figs. 23
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and 24). Although the elevation in CaN immunoreactivity decreased over time in
the hippocampus, it remained significantly higher than that of sham-operated
control animals for the entire 4 weeks of this study, suggesting a persistent
alteration in the CaN content of the SPM fraction.

TBI resulted in a long-lasting increase in CaN A immunoreactivity in apical
dendrites of hippocampal CA1 neurons
To

further

characterize

the

TBI-dependent

increase

in

CaN

immunoreactivity observed in the crude SPM fraction, immunohistochemical
studies were performed on paraformaldehyde-fixed coronal sections from TBI
and control animals, both at 24 h (Fig. 25A, B) and 4 weeks (Fig. 25C, D) postinjury. Hippocampal sections from sham-control animals demonstrated no
noticeable histological differences between 24-h and 4-week post-sham
treatment

(Fig.

25A,

C).

Hippocampal

sections

from

control

animals

demonstrated diffuse staining throughout the pyramidal cell layer, with the
exception of the pyramidal cell nuclei. Faint CaN immunoreactivity was observed
in the surrounding cortex (data not shown). This diffuse cortical staining
remained unchanged following TBI. Therefore, the intensity of cortical staining
was used as a background value to compare control and TBI images. Individual
hippocampal pyramidal neurons could be visualized in sham animals; the
cytoplasm of these cells demonstrated very diffuse CaN-reactive staining. The
darkest staining was seen around the plasma membrane of these neurons.
Occasional dendritic processes demonstrated CaN immunoreactivity; however,
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many apical dendrites could not be individually visualized in control sections.
These

histological

findings

were

in

agreement

with

previous

studies

demonstrating the presence of CaN in the hippocampal formation, particularly in
the plasma membrane and in neurites [217].
Hippocampal sections from TBI animals demonstrated several qualitative
changes when compared to sham-control sections (Fig. 25B, D). Similar to the
control sections, diffuse CaN-reactive staining was present throughout the
hippocampus. However, this staining was noticeably more intense in the 24-h
post-injury sections. Staining was still relatively poor in the surrounding cortex in
the TBI sections. Intense staining was found to be present around the plasma
membranes and throughout the apical dendrites of pyramidal neurons. Unlike the
control sections, where few processes could be seen, many apical dendrites
were easily visualized and intensely stained in the TBI sections. It was not
possible to visualize any axonal processes leading from the pyramidal cells, nor
were any darkly stained processes observed in axonal layers of the
hippocampus, suggesting that the increased CaN immunoreactivity was postrather than presynaptic. Finally, no interneurons were detected in control or SE
sections, suggesting an absence of CaN in these neurons that is in agreement
with previous research. Although these changes were most intense in the 24-h
post-injury sections, they remained noticeably different from control in the 4-week
post-injury samples, a finding which corresponds well with the subcellular fraction
data presented above.
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DISCUSSION:

The present study identified an increase in CaN immunoreactivity in the
P2 fraction isolated from hippocampal and cortical tissue that lasted for a
significant amount of time post-injury. This study did not identify any significant
increase in CaN immunoreactivity in homogenate from these tissues. This
suggests that the increase in CaN content in the crude SPM fraction was due to
translocation,

rather

than

new

protein

synthesis.

Additionally,

immunohistochemical staining of hippocampal tissue revealed increased CaN
staining in the apical dendrites of the CA1 region that persisted at least 4 weeks
post-injury. These data suggest a TBI-induced translocation of CaN into specific
synaptic membrane-rich compartments, and also indicate that this translocation
remains in effect during the critical weeks immediately following brain injury.
Recent studies have suggested that CaN participates in the biochemical
mechanisms leading to neuronal pathology following traumatic brain injury.
Additionally, inhibitors of CaN, including cyclosporin A and FK506, can be
neuroprotective if administered within a short time of the injury event. However, it
is important to note that FK506 has not been specifically studied in the fluid
percussion model of TBI, and caution should be used when applying results from
these inhibitor studies across injury models. A great deal remains to be
understood about the exact physiological role played by CaN in these
pathological processes, and a better understanding of CaN activity post-TBI may
allow more effective targeting of these treatments. Previous studies in our
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laboratory described an increase in CaN activity beginning acutely post-injury
and persisting for several weeks post-injury [218]. Since CaN regulates a diverse
group of neuronal processes, understanding how this increase in activity relates
to specific subcellular compartments is important in determining the role of CaN
in TBI-induced pathology.
The P2 fraction described in this study is highly enriched in both crude
synaptoplasmic membrane and mitochondria [168]. Previous studies have not
detected significant amounts of CaN in purified mitochondrial preparations [171];
however, it is possible that TBI induces a translocation of the enzyme to these
organelles. CaN plays an essential role in several apoptotic pathways [91, 166],
and movement of the enzyme to the mitochondria would likely facilitate these
apoptotic mechanisms, resulting in increased cell death. While this is an
intriguing hypothesis, the lack of significant amounts of CaN in mitochondrial
preparations from other studies, coupled with the immunohistochemical data in
this study, makes mitochondrial translocation of CaN an unlikely explanation for
the data presented.
CaN has been detected in purified synaptoplasmic membranes by several
researchers [171, 219]. The increased immunoreactivity of CaN in the P2 fraction
observed in this experiment could be due to a translocation of enzyme to the
synaptic membrane. Immunohistochemical data presented in this study
described a significant increase in CaN immunoreactivity in the pyramidal cell
layers of the hippocampus, especially in the CA1 region. The fact that this
increase in immunoreactivity was confined primarily to the apical dendrites
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supports the hypothesis that TBI leads to a translocation of the enzyme to the
post-synaptic membrane. This would place double the control amount of CaN in
a region rich in substrates highly relevant to the pathology of TBI. This
translocation is an especially intriguing possibility when considered along with
prior observations that TBI induces an increase in CaN activity.
The fluid percussion model of TBI used in this study has been shown to
lead to numerous cognitive deficits in the animals studied, including poor
performance in tasks known to rely on new memory formation and hippocampal
processing [202, 220-222]. Interestingly, the duration of some of the major
deficits in learning and memory in the fluid percussion model correlates well with
the duration of increased CaN immunoreactivity [221-223]. CaN plays an
important role in learning and memory through its regulation of LTP and LTD [41,
224]. Through its actions leading to dephosphorylation of NMDA receptors, CaN
activity is generally thought to be associated with weakening synaptic strength,
i.e., LTD [69, 180, 225]. The translocation of CaN noted in this study would
greatly increase the amount of CaN in the vicinity of these receptors, possibly
increasing LTD of neurons important in memory formation and decreasing overall
cognitive function. Additionally, CaN has been shown to cause depotentiation of
neurons that have undergone LTP, also weakening relative synaptic strength
[226]. A recent study has shown that fluid percussion TBI leads to an inability to
maintain LTP in hippocampal CA1 neurons [227]. Interestingly, both the post-TBI
translocation of CaN and the increase in its activity are present long after the
initial injury in the hippocampus, a structure essential for memory formation and
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highly vulnerable to TBI-induced damage.
Conversely, CaN has also been shown to decrease GABAergic
neurotransmission by dephosphorylating an essential phosphorylation site on the
GABA receptor [66, 68]. Additionally, CaN-mediated dephosphorylation is the
rate-limiting step in dynamin-mediated vesicle endocytosis [228] such as occurs
in GABAA receptor internalization [229]. Thus, an increase of CaN concentration
in the vicinity of GABAA receptors could decrease inhibitory neurotransmission
both by decreasing receptor function and decreasing the number of available
receptors. A decrease in inhibitory neurotransmission could lead to pathologically
hyperexcitable neuronal tissue, such as occurs in the epileptic activity and
hippocampal hyperexcitability associated with the fluid percussion injury model
[230-232]. Understanding the exact physiological role of CaN in TBI clearly
depends on discovering which elements of the post-synaptic membrane CaN
associates with after the injury, providing an intriguing area for future research.
This study is the first to describe a TBI-dependent increase in CaN
concentration in the post-synaptic region of neurons. This increase persists well
after the acute injury, suggesting that it may play a role in the development of
TBI-associated pathologies. Discovery of TBI-associated effects on this important
enzyme is especially relevant in light of the recent interest in the neuroprotective
effects of CaN inhibitors. Further research into the effects of TBI on CaN will help
lead to a better understanding of the biochemical processes occurring in the days
and weeks post-injury, and will hopefully lead to more effective treatment options
for these devastating injuries.
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Figure 20: TBI did not alter total CaN A expression in hippocampal and
cortical homogenates
Western analysis of cortical (A) and hippocampal (C) homogenates did not
demonstrate a TBI-dependent change in CaN A immunoreactivity 24h post-injury
when compared to sham animals. In cortical homogenates (B) from injured
animals, CaN immunoreactivity was 98.7 % of control as determined by
calibrated densitometry (p > 0.05, n = 6, Student’s t-test). In hippocampal
homogenates (D), CaN immunoreactivity was 103.2 % of control (p > 0.05, n=6).
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Figure 21: CaN immunoreactivity in crude SPM isolated from cortical tissue
was elevated for 2 weeks post-TBI
In crude SPM isolated from the cortex of injured animals, a marked increase in
CaN immunoreactivity was present 24h (A), one week (B), and two weeks post
injury (C). CaN A immunoreactivity returned to baseline at three weeks postinjury
(D) and remained similar to control values at four weeks post-injury (not shown).
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Figure 22: Calibrated densitometry of cortical crude SPM westerns reveals
a significant increase in CaN A immunoreactivity
Optical

density

was

calculated

using a

calibrated

densitometer.

CaN

immunoreactivity was significantly increased over sham-control values at 24h (p
< 0.01, n=6, Student’s t-test), one week (p < 0.01, n = 6), and two weeks postinjury (p < 0.01, n=6). At both three and four weeks post-TBI, CaN
immunoreactivity was indistinguishable from sham-control values (p > 0.05, n=6).
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Figure 23: CaN immunoreactivity in crude SPM isolated from hippocampal
tissue was elevated up to 4 weeks post-injury
In

crude

SPM

isolated

from

hippocampal

tissue,

increased

CaN

A

immunoreactivity was observed in injured animals 24h (A), one week (B), two
weeks (C), three weeks (D) and four weeks (E) post-injury. Although the
alteration in CaN A immunoreactivity decreased with time, CaN A levels in the
hippocampus did not return to control values during the span of this study.
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Figure 24: Calibrated densitometry of hippocampal crude SPM westerns
demonstrates a significant increase in CaN A immunoreactivity
Optical

density

was

calculated

using a

calibrated

densitometer.

CaN

immunoreactivity was significantly increased over their respective sham-control
values at 24h (p < 0.001, n = 6, Student’s t-test), one week (p < 0.01, n = 6), two
weeks (p < 0.01, n=6), three weeks (p < 0.05, n = 6), and four weeks post-injury
(p < 0.05, n = 6). The increase in hippocampal CaN A immunoreactivity trended
toward control values over time.
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Figure 25: TBI induced an increase in CaN A immunoreactivity in apical
dendrites of hippocampal CA1 neurons
Immunohistochemistry of sham-operated animals revealed diffuse CaN A
immunoreactivity around the cell bodies of CA1 neurons at both 24h (A) and four
weeks (C). In injured animals, CaN A immunoreactivity was far more intense than
control in the apical dendrites of these neurons 24h post-injury, allowing
numerous dendritic processes to be visualized (B). The injury-induced alteration
in CaN A staining remained present four weeks post-injury, although qualitatively
less intense (D). (representative slices shown, n=3).

CHAPTER V
A CELLULAR MECHANISM FOR DENDRITIC SPINE LOSS IN THE
PILOCARPINE MODEL OF STATUS EPILEPTICUS

INTRODUCTION:
Status epilepticus (SE) is a severe neurological emergency characterized
by persistent, continuous seizure activity [233]. In addition to an immediate risk of
mortality, patients experiencing SE are at risk for a number of chronic
neurological pathologies as a consequence of the seizure episode, including
cognitive impairment, focal neurological deficits, and the development of chronic
epilepsy [105,

116, 124]. A number of

SE-induced biochemical and

morphological changes in the brain have been investigated as possible causes of
this long-term pathology. One recent finding that may have relevance to this
subject is the SE-induced loss of dendritic spines [234].
Dendritic spines are small, dynamic protuberances from the dendritic shaft
that are critical for synaptic transmission throughout the CNS, representing the
primary location of excitatory glutamatergic neurotransmission [235]. The
presence of dendritic spines is thought to aid neurotransmission in several ways,
both by increasing the surface area for synaptic contact and by providing a
specialized compartment for the excitatory postsynaptic machinery [236]. The
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importance of these spines to excitatory neurotransmisson, and the apparent
ability of neurons to alter spine density, size and shape in response to synaptic
input, makes them an ideal location for regulation of synaptic strength. In fact,
spine plasticity has been noted as a possible mechanism of long-term
potentiation/depression [80] and has been implicated in several models of
learning and memory [237-239].
Interestingly, profound decreases in dendritic spine density, as well as
alterations in spine shape and size, have been detected in both SE and several
models of chronic epilepsy [234, 240-242]. Although the precise physiological
consequence of this pathological spine plasticity has not yet been elucidated,
several possible theories have been proposed. SE and epilepsy have both been
associated with long-term cognitive deficiencies [116], and a widespread and
chronic loss of dendritic spine density could certainly play a major role in this
pathology, especially considering the importance of spines in learning and
memory models [237]. On the other hand, SE-induced spine plasticity may also
represent a potential mechanism of epileptogenesis, in which the loss of dendritic
spines is part of a pathological reorganization of synaptic networks leading to an
overall increase in neuronal excitability [243]. In spite of the uncertainty about the
pathological consequences of SE-induced spine plasticity, such a widespread
alteration in the structure of excitatory synapses remains an important and highly
interesting consequence of SE and certainly merits continued investigation.
Unfortunately, the biological mechanisms responsible for this SE-induced
spine plasticity remain poorly understood as well. One potential mechanism
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involves the calcium-regulated phosphatase, calcineurin (CaN). The cytoskeleton
of spines is composed primarily of actin filaments, and CaN has been shown to
regulate actin stability in a number of neuronal settings, including axonal growth
cones and dendrites. Additionally, activation of CaN by NMDA-receptor
associated calcium influx has been shown to destabilize F-actin in dendritic
spines, and CaN and F-actin are co-localized in dendritic spines under these
conditions [79]. Finally, recent research has demonstrated an SE-induced
increase in CaN activity and enzyme concentration in post-synaptic regions of
neurons [167, 217]. Thus an enzyme capable of regulating the structure of
dendritic spines is both activated and localized into the vicinity of the spines in
SE, placing CaN in an ideal position to play a role in SE-induced spine plasticity.
The present study investigated the CaN-dependent regulation of actin
stability in the context of SE-induced dendritic spine loss. We demonstrate an
SE-dependent dephosphorylation of cofilin, an actin-depolymerizing factor that is
activated by dephosphorylation. We also show a subsequent increase in cofilinactin binding and actin depolymerization. All of these SE-induced cytoskeletal
events are shown to be blocked by pre-administration of the CaN inhibitors,
FK506 (tacrolimus) and cyclosporin A, strongly suggesting a CaN-dependent
mechanism. Finally, SE-induced dendritic spine loss was demonstrated
histologically in several brain regions, this spine loss was also blocked by the
administration of CaN inhibitors. These findings implicate CaN in a widespread,
SE-induced alteration in the structure of synaptic contacts, potentially furthering
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our understanding of the cellular mechanisms underlying chronic SE-induced
neurological pathology.

METHODS:

Pilocarpine model of status epilepticus:
All animal-use procedures were in strict accordance with the National
Institutes of Health Guide for the Care and Use of Laboratory Animals and were
approved by the Virginia Commonwealth University Institutional Animal Care
and Use Committee. Adult Sprague-Dawley rats were handled after arrival from
Harlan Laboratories, for acclimation to handling before drug treatment. One
week before the induction of SE, four surface electrodes were implanted into
the skulls of rats under ketamine anesthesia, as described previously [244].
Two frontal electrodes were implanted over frontal cortex [3.5 mm anterior to
bregma, ±2.5 mm L/R (F1/F2)]. Two posterior electrodes were implanted over
parietal cortex and hippocampus [2.0 mm posterior to bregma, ±2.5 mm L/R
(P1/P2)]. A fifth electrode was fixed onto the surface of the skull as a ground.
The electrodes were secured in place with dental acrylate, and the animals
were allowed ≥5 days to recover from surgery before experiments were
performed.
Twenty minutes before the injection of pilocarpine, methylscopolamine,
a muscarinic antagonist, was administered i.p. (1 mg/kg) to reduce adverse
peripheral affects of the pilocarpine. Where appropriate, 10 mg/kg cyclosporin A
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(Sigma) or 5 mg/kg FK506 (Fujisawa) was administered i.v. (tail vein) 3 hours
prior to the induction of SE. Control and sham-surgery animals were attached
to video-EEG machines (BMSI 5000; Nicolet, Madison, WI), and baseline EEG
recordings were obtained for ≥10 min after scopolamine injection. SE was
induced in experimental animals by i.p. injection of 375 mg/kg pilocarpine HCl,
a muscarinic agonist. Behavioral and encephalographic activities were
recorded throughout the procedure [244]. Once initial seizure activity was
observed, the time was noted, and rats were allowed to seize for specific
amounts of time before the animals were processed. These time points
consisted of 10, 15, 20, 30, 40, 50, 60, and 70 min after the first discrete
seizure. Since our laboratory has previously characterized SE onset as being
10 min after the first discrete seizure [244], these times approximate 0, 5, 10,
20, 30, 40, 50, and 60 min of SE, respectively. Behavioral seizures were
assessed according to the scale of Racine [142].

Brain region isolation and subcellular fractionation:
Rats were rapidly decapitated after specific durations of SE. Brains were
rapidly dissected on a petri dish on ice to preserve postmortem enzyme activity.
Cortical and hippocampal brain regions were quickly isolated and immediately
homogenized with 10 strokes (up and down) at 12,000 rpm, using a motorized
homogenizer (TRI-R Instruments, Inc., Rockville Center, NY). Brain regions were
homogenized into an ice-cold isotonic homogenization buffer containing 10 mM
Tris-HCl (pH 7.0), 7 mM EGTA, 5 mM EDTA, 1 mM dithiothreitol (DTT), 0.3 mM
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PMSF, and 187 mM sucrose. Cortical regions were homogenized into 7 ml of
buffer and hippocampal regions into 3 ml. All brain homogenates were then
subjected to the differential centrifugation procedure described below.
Isolation of crude synaptoplasmic membrane fractions was achieved using
a differential centrifugation procedure [168] modified as described previously
[217, 245]. Briefly, brain region homogenates were centrifuged at 5000g for 10
min to produce a crude nuclear pellet (P1) and a supernatant (S1). The P1 pellet
was resuspended in homogenization buffer, separated into aliquots, and stored
at -80°C. The S1 was centrifuged for 30 min at 18,000g to produce the crude
synaptoplasmic membrane/ mitochondrial pellet (P2) and a supernatant (S2).
The P2 pellet was resuspended in 1/10 the original volume of the homogenate
(700 µl for cortex, 300 µl for hippocampus), separated into aliquots, and stored at
-80°C until used.

Western analysis:
Western analysis was performed in a manner similar to that described
previously [217]. Briefly, fractions were balanced for protein using the Bradford
method [144], resolved on SDS-PAGE, and transferred to a nitrocellulose
membrane using the Trans-blot system with the plates in the high-intensity field
configuration (BioRad, Richmond, CA). Nitrocellulose was then immersed for 1 h
in blocking solution, containing phosphate buffered saline (PBS, pH 7.4), 0.05%
(v/v) polyoxyethylene sorbitan monolaurate (Tween 20), and 2.5% Bio-Rad
blotting grade dry milk. The nitrocellulose membrane was then incubated with the
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appropriate primary antibody in blocking solution for 1 h. Anti-CaN A antibody
(clone CN-A1, mouse monoclonal IgG, Sigma Chemical Co.) was diluted
1:10,000, anti-actin antibody was diluted 1:5000, DARRP-32 antibody was
diluted 1:1000, and anti-cofilin (Chemicon) and anti-phosphocofilin (Chemicon)
were diluted 1:500 for western analysis. Membranes were then washed three
times in a wash solution containing PBS, Tween 20, and dry milk. Next,
nitrocellulose was reacted with the appropriate HRP-conjugated secondary
antibody in blocking solution for 30 min, then washed 3X in PBS/Tween for 10
minutes each wash. Finally, blots were reacted with a luminol reagent for 5
minutes (Pierce Pico-sensitive reagent for CaN A and actin studies, Pierce
Femto-sensitive reagent for cofilin and phospho-cofilin staining). Blots were
immediately exposed to x-ray film (Kodak X-OMAT). Films were developed using
a Kodak X-OMAT developer. Specific immunoreactive bands were quantified by
computer-assisted densitometry (GS-800 calibrated densitometer and Quantity
One software, BioRad) and compared to a linear concentration curve as
described previously [146].

Immunoprecipitation:
Homogenates were spun at 5000 x g for 5 min to clear large insoluble
material. All samples were balanced to ensure equivalent protein content, 500 µg
of protein was incubated on a rotating rack with anti-cofilin antibody diluted 1:50
(Chemicon) overnight at 4º C. 30 µL of protein-A agarose beads were then
added to the sample and incubated (rotating) for 3h at 4º C. The beads were then
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precipitated by spinning the samples at 2000 x g for 2 minutes. The resulting
pellet was washed 3X in phosphate buffered saline with 1% triton X-100. The
pellet was then suspended in SDS sample buffer, placed in a boiling water bath
for 5 minutes, and subjected to SDS-PAGE.

Actin polymerization assay:
Actin polymerization was assayed using the differential solubility of F-actin
and G-actin in 1% triton. Samples were incubated in 1% triton for 1h at 4° C, then
subjected to a 1h centrifugation at 100,000 x g. The resulting supernatant and
pellet were balanced for protein concentration, then run on a 10% SDS-PAGE
gel and subjected to western analysis as described previously. The ratio of the
amounts of actin present in these two fractions was used to provide an estimate
of the actin polymerization state in different brain region isolates.

Rapid Golgi impregnation:
Visualization of dendritic spines was accomplished via a modification of
the single-section rapid Golgi procedure described previously [246]. After 1h of
SE, animals were anesthetized with an overdose of sodium pentobarbital and
transcardially perfused with 10% neutral buffered formalin. Brains were removed
and postfixed overnight in 10% neutral buffered formalin, then sectioned into
deionized water at 100 µm on a vibratome (Leica VT-1000S). Sections were then
incubated 30 min at room temperature in a solution containing 0.5% osmium
tetroxide, followed by a 2h incubation in a solution of 3.5% potassium
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dichromate. Sections were removed from the dichromate solution and placed on
a glass slide with a few drops of dichromate surrounding the section. A second
slide was placed on top of the section, and the two slides were spaced apart from
one another by a glass coverslip. The entire assembly was held together with
cyanoacrylate-based glue. This assembly was placed in a solution of 1% silver
nitrate and kept in the dark on a shaker for 6-12h. The slide/coverslip assembly
was then disassembled and the slides rinsed in deionized water. Sections were
then dehydrated through a series of increasing ethanol concentrations, cleared
with xylene, and mounted on slides with glass coverslips using Permount. Slides
were examined under 40X and 100X oil immersion objectives (400X and 1000X
final magnification). A minimum of 3 neurons were studied per slide, and at least
3 slides were examined per animal. Photographic images were obtained with an
Olympus Q-fire camera and processed with Adobe Photoshop CS.

Statistical analysis:
EEG review and analysis was performed using Insight II software
(Persyst, Prescott, AZ). All statistical analysis was performed using GraphPad
Prism 4.0 (GraphPad Software, San Diego, CA). For multiple group comparisons,
ANOVA with Tukey post-hoc analysis was used with a minimum significance
level of p < 0.05. All data is presented as mean ± SEM unless otherwise noted.
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RESULTS:
SE induces a rapid increase in CaN activity and concentration in postsynaptic regions:
Previous studies in our laboratory described a dramatic increase in CaN
immunoreactivity in post-synaptic neuronal regions after 1 hour of SE [217]. This
places highly elevated amounts of CaN in an ideal location to regulate synaptic
transmission through a number of post-synaptic mechanisms, including alteration
of the dendritic cytoskeleton. The present study expands upon these results
through the use of video-EEG monitoring, which allowed us to obtain tissue at
highly precise time-points during SE, thus providing a temporal profile of SEinduced alterations in CaN activity and distribution.
Crude SPM fractions were isolated at specific times after the first discrete
seizure as described previously [244], and western analysis for CaN was carried
out to determine the CaN content of SPM isolated from both control and SE
animals at several time-points. Fractions were analyzed from both cortical and
hippocampal tissues, as these were the brain regions previously shown to
demonstrate an increase in SPM CaN immunoreactivity. In both cortical and
hippocampal samples, SPM CaN immunoreactivity was not significantly different
from control at 10 minutes post-first discrete seizure (a time-point corresponding
to the onset of status epilepticus). However, at 15 minutes post-first discrete
seizure and all subsequent time points, CaN immunoreactivity was significantly
increased over control values in both cortical and hippocampal SPM (Fig 26).
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Using a pNPP-based phosphatase assay as described previously [167],
we also examined CaN phosphatase activity at the above time-points in cortical
and hippocampal crude SPM fractions (Fig 27). Similar to the increase in CaN
concentration, CaN activity approximately doubled shortly after the onset of
continuous seizure activity in both cortical and hippocampal crude SPM. This
increase in activity is of roughly the same magnitude as the increase in CaN
concentration described above, and is likely due to the increased quantity of the
enzyme present in this fraction after the onset of SE. Interestingly, an additional
increase in CaN activity – beyond the 2-fold increase observed at 10 minutes –
was observed in cortical and hippocampal SPM fractions 30 minutes after the
first discrete seizure. This increase in activity did not correspond to a further
increase in CaN immunoreactivity in the crude SPM fraction. A similar increase in
CaN activity is also observed in homogenates at this later time point [247]; we
have previously hypothesized that this further increase in CaN activity represents
a post-translational modification of the enzyme brought on by SE [167].
To further characterize the SE-induced increase in synaptic CaN
concentration and activity, we examined the phosphorylation state of a known
neuronal CaN substrate, DARRP-32 (Fig 28). In both cortical and hippocampal
fractions, SE induced a profound dephosphorylation of DARRP-32. This
dephosphorylation could be blocked by administration of FK506 or cyclosporin A
prior to the induction of SE, indicating that SE-induced dephosphorylation of
these substrates was CaN-dependent.

In cortical SPM, phospho-DARRP-32

immunoreactivity was 12.3 ± 10.2% of control after SE, while immunoreactivity
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was 62.1 ± 7.3% of control in animals that were treated with FK506 and 45.8 ±
9.1% of control in animals that were treated with cyclosporin A. Similar results
were achieved in hippocampal tissue (data not shown). The CaN-dependent, SEinduced dephosphorylation of this substrate further demonstrates the dramatic
increase in synaptic CaN activity that is present in SE, and confirms the efficacy
of the CaN inhibitors used in this study.
Finally, the SE-induced increase in CaN enzyme activity in crude SPM
was examined using an RII phosphopeptide-based assay. This assay allows the
detection of phosphate released from a CaN-specific peptide substrate.
Increases in CaN activity similar to those described with the pNPP assay were
present in this assay as well. CaN activity increased after 1 hour of SE in both
cortical (Fig 29A) and hippocampal (Fig 29B) crude SPM fractions.
The above results, taken together with our previous studies, demonstrate
a significant increase in CaN activity and concentration in the post-synaptic
regions of neurons shortly after the onset of continuous seizure activity.

CaN-dependent cofilin dephosphorylation in SE:
To determine the cellular consequences of the SE-induced increase in
post-synaptic CaN activity, we examined the effect of SE on the stability of the
dendritic cytoskeleton, and consequently on dendritic spine plasticity. CaN may
regulate the stability of dendritc actin via cofilin, a CaN-regulated actin
depolymerization factor. Through the use of a phospho-specific cofilin antibody
we were able to assess the phosphorylation state of cofilin after SE, both with
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and without the administration of CaN inhibitors. In both homogenates and crude
SPM

fractions

isolated

from

SE

animals,

we

found

a

significant

dephosphorylation of cofilin in cortical and hippocampal samples. In cortical
SPM, phospho-cofilin immunoreactivity was decreased 54.2 ± 12.3 % from
control after 1h of SE (Fig 30A), while in hippocampal SPM phospho-cofilin levels
decreased 74.1 ± 13.2 % from control (Fig 30B). A similar SE-induced decrease
in cofilin phosphorylation was observed in homogenates from these brain
regions, indicating that the effect was not an artifact of the SPM isolation
procedure (data not shown). Overall cofilin immunoreactivity was not significantly
affected by SE in any fraction tested (Fig 30 C, D), indicating that the observed
decrease in phospho-cofilin was likely due to dephosphorylation of the protein
rather than a decrease in the amount of cofilin present in the neuron.
To determine if the SE-induced dephosphorylation of cofilin was CaNdependent, we administered CaN inhibitors, FK506 or cyclosporin A, to animals
prior to induction of SE. In FK506-treated animals, SE decreased phospho-cofilin
immunoreactivity by 18.2 ± 13.0% in cortical SPM (Fig 30A), and 37.1 ± 14.6% in
hippocampal

SPM

dephosphorylation

(Fig
in

30B).
these

While

SE

FK506-treated

still

induced

animals,

some

cofilin

phospho-cofilin

immunoreactivity was significantly greater in SPM samples from FK506-treated
animals than in untreated SE animals, indicating that SE-induced cofilin
dephosphorylation was at least partially CaN-dependent. Similar results were
achieved by treating animals with cyclosporin A prior to SE. Phosphocofilin
immunoreactivity was decreased 32.9 ± 9.7% in cortical SPM and 38.6 ± 11.7%
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in hippocampal SPM isolated from cyclosporin A animals when compared to
control (Fig 30 A, B). These values were significantly greater than the cofilin
phosphorylation levels in untreated SE animals. The fact that two different CaN
inhibitors (with different mechanisms of action) were effective in preventing SEinduced cofilin dephosphorylation provides a strong argument that CaN inhibition
was indeed the important factor in preventing cofilin dephosphorylation, rather
than some side-effect of the inhibitors. This data suggests that increased
dendritic CaN activity leads to cofilin dephosphorylation after SE. While this study
is the first to present such a finding, the data corresponds well with previous
research detailing CaN’s effects on cofilin and actin stability.

Time-course of cofilin dephosphorylation:
Western blot analysis was used to determine the phosphocofilin
immunoreactivity by western blot at specific time-points post-first discrete
seizure. Both cortical and hippocampal crude SPM isolates were examined,
using control and pilocarpine-treated animals. In both cortical and hippocampal
samples, cofilin phosphorylation levels decreased significantly from control levels
after just 10 minutes of seizures, a time point which generally corresponded with
the onset of continuous seizure activity. At 10 minutes post-first discrete seizure,
phosphocofilin immunoreactivity was decreased 40.2 ± 6.7% from control in
cortical samples (Fig 31A) and 60.1 ± 8.3% in hippocampal samples (Fig 31B).
At the 20 and 40 minute time points, phosphocofilin immunoreactivity was
indistinguishable from the 70 minute time point presented earlier. It is interesting
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to note the speed with which cofilin phosphorylation responds to seizure activity,
suggesting that even a few minutes of continuous seizure activity may be
sufficient to induce widespread activation of this protein. We also noted that the
temporal profile of cofilin dephosphorylation correlates with the timing of the
increase in dendritic CaN activity, providing further support for the idea that CaN
is partially responsible for SE-induced cofilin activation.

SE increases cofilin-actin binding:
Upon activation by dephosphorylation, cofilin binds tightly to F-actin at
specific sites, leading to actin depolymerization. To study this binding, we utilized
a co-immunoprecipitation protocol. Cofilin-associated actin was then measured
via western analysis of the precipitate.
After one hour of SE, there was a profound increase in cofilin-actin coimmunoprecipitation. In cortical samples, actin immunoreactivity was 167.0 ±
20.1% of control values in the precipitate (Fig 32A, B), suggesting an
approximately 1.5-fold increase in cofilin-actin binding. Similar results were
achieved in hippocampal samples, with actin immunoreactivity increased by
201.3 ±17.6% in cofilin immunoprecipitates from SE animals (Fig 32C, D). When
the precipitation procedure was carried out in the absence of anti-cofilin antibody,
a minimal amount of actin was present in the precipitate, indicating that the
primary source of actin immunoreactivity was actin that was bound to cofilin and
co-precipitated with it.
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Both FK506 and cyclosporin A significantly reduced cofilin-actin coimmunoprecipitation. Pretreatment of animals with FK506 resulted in a SEinduced cofilin-actin co-immunoprecipitation that was 102.9 ± 3% of control in
cortical samples (Fig 32A, B) and 121.3 ± 8.2% of control in hippocampal
samples (Fig 32C, D). Both of these values are significantly lower than those of
untreated SE animals, suggesting that CaN inhibition prevents cofilin-actin
binding. Similar results were achieved with cyclosporin A. This data complements
our finding that CaN inhibition prevents SE-induced cofilin dephosphorylation,
since dephosphorylation of cofilin is required for the protein to bind to actin.

SE induced actin depolymerization is CaN-dependent:
Following

dephosphorylation

and

actin

binding,

cofilin

induces

depolymerization of F-actin to G-actin. To study this next step in our
hypothesized pathway of SE-induced, CaN-mediated spine loss, we quantified
the relative amounts of F and G-actin present in cortical and hippocampal SPM
after SE. To accomplish this, we made use of the fact that F-actin is insoluble in
1% Triton X-100, while G-actin remains soluble. SPM fractions were treated with
Triton and centrifuged to precipitate insoluble material, thus separating F-actin
from G-actin. Both the pellet and supernatant were subjected to SDS-PAGE and
western analysis to quantify the amount of actin present.
In

crude

SPM

isolated

from

SE

cortex,

Triton-soluble

actin

immunoreactivity was 123.2 ± 8.1 % of control (Fig 33A), while Triton-insoluble
actin immunoreactivity was 79.3 ± 6.7 % of control (Fig 33B), indicating an SE-
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induced shift from F-actin to G-actin in the crude SPM. A similar change was
noted in hippocampal samples, with Triton-soluble actin immunoreactivity 121.9 ±
7.4% of control (Fig 33C), while insoluble actin immunoreactivity was 71.3 ±
5.4% of control (Fig 33D), again demonstrating a decrease in F-actin and an
increase in G-actin. Overall actin immunoreactivity in this fraction was unchanged
by SE. In both cortical and hippocampal homogenates, FK506 significantly
reduced this actin depolymerization, partially preventing the SE-induced
increases in Triton-soluble actin immunoreactivity (G-actin) and the decreases in
Triton-insoluble actin immunoreactivity (F-actin). Thus, by blocking the first step
in this pathway – the CaN-induced dephosphorylation of cofilin – we prevented
the final biochemical step of actin depolymerization.

CaN inhibitors prevent dendritic spine loss in SE:
The

preceding

results

demonstrate

that

CaN-mediated

cofilin

dephosphorylation leads to actin depolymerization in SE. Actin is the primary
component of the dendritic spine cytoskeleton, and spine morphogenesis and
retraction require actin depolymerization. CaN-mediated actin depolymerization,
therefore, may likely lead to dendritic spine loss in SE. We studied dendritic spine
density in SE via a modification of the rapid Golgi impregnation procedure (Fig
34). This procedure has the advantage of staining neuronal processes in their
entirety, allowing excellent visualization of dendritic arbors and spines. We
examined neurons in frontal cortex, parietal cortex, and several hippocampal
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subfields, including CA1, CA3 and dentate gyrus in sections from control
animals, SE animals, and FK506-treated SE animals.
Previous studies have demonstrated a significant SE-induced loss of
dendritic spines in the granule cells of the dentate gyrus. These results were
confirmed in the present study with the Golgi technique. In control animals,
numerous spines could be observed on all dendritic branches of the DG granule
cells (Fig 34B). Following SE, spine density decreased remarkably, with few
spines observed on any dendrites in the DG, a result consistent with previous
studies (Fig 34C). Administration of the CaN inhibitor FK506 prevented SEinduced spine loss (Fig 34D). In dentate gyrus granule cells, FK506-treated
animals had an observed spine density that was qualitatively far greater than that
of untreated SE animals, and appeared similar to control. This data strongly
suggests a CaN-dependent mechanism of spine loss in SE, such as the CaNdependent activation of cofilin described above.

DISCUSSION:
The results presented in this study demonstrate a CaN-dependent
mechanism of dendritic spine loss in the pilocarpine model of SE. A dramatic
increase in CaN activity and concentration occurs in the crude SPM fraction of
hippocampal and cortical tissues at or near the onset of continuous seizure
activity. Coupled with our previous histochemical results [217], this demonstrates
an increase in the effective amount of CaN phosphatase activity in dendritic
regions of neurons. This study elucidated one pathological consequence of this
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increased post-synaptic CaN activity by examining CaN’s effects on dendritic
actin stability. First, we have shown a CaN-dependent dephosphorylation of the
actin-depolymerizing factor, cofilin. Like the increase in CaN concentration and
activity, this dephosphorylation develops shortly after the onset of SE. The
expected biochemical consequences of an SE-induced activation of cofilin were
also found to occur in a CaN-mediated manner, with a SE-dependent increase in
cofilin-actin binding and a subsequent SE-induced depolymerization of dendritic
actin. Finally, the CaN-dependent depolymerization of dendritic actin led to SEinduced dendritic spine loss, which was demonstrated histologically in several
brain regions and was blocked with the CaN inhibitor FK506. These findings
implicate CaN in a widespread, SE-induced alteration in the structure of synaptic
contacts, proving our hypothesis that SE-induced dendritic spine loss is CaNdependent via cofilin. These findings also potentially further our understanding of
the cellular mechanisms underlying chronic SE-induced neurological pathology.

SE, Epilepsy and Spine Loss:
The observed SE-induced reduction in dendritic spine density may be part
of the long-term neurological pathology that is associated with SE. As the primary
site of excitatory neuronal synapses, and given their importance in models of
learning and memory, spines appear to be critical for normal cognition. Studies in
animal models have documented cognitive difficulties associated with SE, both in
adult and developing animals [116]. While SE-induced neuronal death
undoubtedly accounts for some of this loss of cognitive function, other, more
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subtle, mechanisms – such as spine loss – are likely responsible as well.
Depending on the duration of the SE-induced decrease in dendritic spine density,
the mechanism described in this study could be a mechanism underlying SEinduced cognitive dysfunction. In one previous study, dendritic spine density
rebounded in the weeks following SE, although with significant alterations in
spine morphology and location. Spine density then decreased again – possibly
through a different mechanism – once chronic seizure activity ensued
(spontaneous recurrent seizures are a common consequence of the pilocarpine
model of SE) [240]. These findings tend to argue against the acute mechanism of
spine loss described in this study as the cause of long-term cognitive dysfunction
(although it may cause short-term deficits); however, they do suggest that it may
be part of another chronic SE-associated pathology, epileptogenesis.
In the pilocarpine model of SE, spontaneous recurrent seizures typically
begin approximately 2 weeks after the prolonged seizure episode. No epileptic
activity is seen during this quiescent period, but there is a great deal happening
on a cellular level. It is thought that the biochemical and structural changes that
lead to recurrent seizure activity are being completed during this time. While the
exact mechanisms responsible for epileptogenesis remain the subject of intense
study and debate, dendritic spine plasticity certainly is a promising candidate for
this role. The loss and subsequent regrowth of dendritic spines could represent a
pathological reorganization of synaptic networks leading to the formation of
epileptic foci in the brain. It is especially interesting that spine loss has been
documented in the dentate gyrus of the hippocampus. Network reorganization
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and neuronal hyperexcitability in this region are frequently proposed as possible
mechanisms of epileptogenesis. Furthermore, after the SE-associated loss of
spines, it has been shown that their regrowth in this region is colocalized with
sites of mossy fiber sprouting [242]. Thus an outgrowth of axonal structures that
has been previously implicated in epileptogenesis seems to coincide with a
reorganization of post-synaptic structures, all of which is occurring in a region
that seems to be critical in the development of temporal lobe epilepsy.
Considered in the context of epileptogenesis, the CaN-mediated mechanism of
spine loss presented in this paper may help explain the results of several other
studies. FK506 ameliorated spine loss in the present study, while other
researchers have documented that CaN inhibitors can prevent epileptogenesis in
both a kainic acid model of SE [121] and a kindling model of epilepsy [122, 248].
Further research may determine if these two effects are related.

Cellular Mechanism of Spine Plasticity
Spine plasticity has long been observed in both chronic epilepsy and
acute SE models [234], although the mechanisms that underlie this spine loss
have not yet been determined. Like the increase in SPM CaN observed in this
study, dendritic spine loss does not seem to occur with isolated, discrete seizure
activity. Instead, spine loss only occurs in models that involve continuous seizure
activity or chronic recurrent seizures, a characteristic that certainly fits with the
observed behavior of CaN. Additionally, a great deal of research suggests that
CaN modulates neuronal spine density and morphology under normal conditions,

164

with the enzyme having been previously shown to cause calcium-stimulated
spine plasticity in several non-pathological model systems. Halpain et al.
demonstrated a loss of spines in cultured hippocampal neurons in response to
NMDA application. CaN was shown to co-localize with F-actin at synapses, and
CaN inhibitors blocked NMDA-mediated spine loss in these neurons, strongly
suggesting a CaN-mediated spine loss [79]. Simlarly, Zhou et al. described an
LTD-associated spine shrinkage that required both NMDA and CaN to occur [80].
Under physiological conditions, it is highly probable that CaN-mediated spine
plasticity is part of a learning and memory mechanism, considering the
importance of both CaN and spines to learning models. However, with the
profound increase in CaN levels at the synapse that we have observed in SE,
this regulation of spine plasticity may become pathologically active, resulting in a
detrimental reorganization of synaptic contacts.
The present study documented a profound increase in CaN concentration
and activity in the crude SPM fraction of neuronal tissue of animals that had
undergone as little as 5-10 minutes of continuous seizure activity. As we have
described previously, continuous seizure activity typically began approximately
10 minutes after the first discrete seizure in this model [244]. No detectable
increase was seen, however, in animals that experienced discrete, but not
continuous, seizure activity, indicating that the onset of SE was essential for
significant changes in CaN to occur. Such a translocation of CaN to the synapse
may initially be a physiological defense mechanism for the neuron in the face of
excessive excitation, as CaN is known to negatively modulate neurotransmission
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through the AMPA and NMDA subtypes of glutamate receptor. Perhaps such a
mechanism, occurring near the onset of continuous seizures, represents a
pathway by which seizure activity can be terminated in brains that are not prone
to SE. However, as SE progresses and worsens, this sustained increase in
synaptic CaN activity also could play a pathological role in neurons. A number of
recent studies support such a hypothesis. For example, it has long been known
that administration of CaN inhibitors prior to SE prevents chronic SE-related
behavioral pathologies, such as a SE-induced loss of cognitive abilities and the
development of spontaneous continuous seizures [121]. Several mechanisms
have been proposed as pathological roles for CaN in seizure disorders, including
negative modulation of the GABA receptor [123, 249] and – the focus of the
current study – modulation of dendritic spines.
CaN may perform this pathological modulation of spine morphology via its
regulation of the actin-depolymerizing factor, cofilin. Cofilin is a small peptide
that, when dephosphorylated, binds to F-actin and causes its depolymerization
[250, 251]. Cofilin has been shown to regulate the structure of dendritic spines by
inducing the depolymerization of their actin cytoskeleton [80, 82, 252]. Recent
studies have shown that CaN induces cofilin dephosphorylation (and thus
subsequent actin depolymerization) either directly [253], or, more likely, indirectly
via an intermediary phosphatase known as slingshot [81], thus making a
mechanism involving CaN activation of cofilin and subsequent spine loss quite
plausible. In fact, one recent study has already shown spine loss in long-term
depression through a mechanism dependent on both CaN and cofilin [80].
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The data described in this study clearly indicate a CaN-dependent
regulation of cofilin in SE. First, the SE-induced dephosphorylation of cofilin
required the onset of continuous seizure activity, a requirement shared with the
increase in SPM CaN and SE-induced dendritic spine loss. In fact, the timing of
this loss of SPM cofilin phosphorylation coincides perfectly with the increase in
SPM CaN concentration and activity. Furthermore, both of the CaN inhibitors
cyclosporin A and FK506 blocked SE-induced cofilin dephosphorylation. The fact
that two different CaN inhibitors blocked SE-induced cofilin dephosphorylation
strongly argues in favor of a CaN-dependent mechanism, although some modest
SE-induced dephosphorylation did occur in the presence of effective doses of
each inhibitor. This is not in itself surprising, as a number of other mechanisms
exist for the regulation of cofilin phosphorylation. Activation of these pathways in
SE is certainly possible, and merits future study. However, CaN-mediated
dephosphorylation represented a major portion of the observed decrease in
phosphocofilin immunoreactivity. This CaN-dependent dephosphorylation of
cofilin did indeed activate the molecule, as SE was also shown to lead to a CaNdependent

increase

in

cofilin-actin

binding

and

a

CaN-dependent

depolymerization of actin. While the observed change in the F/G actin ratio was
relatively modest, when one considers the prevalence of actin in all cell types
and cellular structures in the brain, even a 20% difference in the relative amounts
of F- and G- actually represents a quite profound structural change. This
structural change manifested itself in a CaN-dependent loss of dendritic spines.
As other researchers have previously, we observed a SE-dependent loss of
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dendritic spines after 1 hour of SE. Considering the timing of the CaN-induced
cofilin dephosphorylation, this loss of spines may, in fact, have occurred even
earlier in SE, and future studies should certainly explore synaptic changes at
these earlier time-points.
The novel findings presented in this study describe a cellular mechanism
for actin depolymerization and dendritic spine loss in the pilocarpine model of SE.
This spine loss is widespread throughout the forebrain after SE, and is CaNdependent, involving the actin depolymerizing factor, cofilin. Further research in
this area may help elucidate the role of dendritic spine plasticity in SE-associated
neuronal pathologies, potentially provide insight into some of the mechanisms
underlying epileptogenesis and providing the basis for future treatment options.
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Figure

26:

The

seizure-induced

increase

in

crude

SPM

CaN

immunoreactivity occurs near the onset of SE. CaN immunoreactivity was
measured in crude SPM fractions isolated from cortex (A) and hippocampus (B).
In both fractions, CaN immunoreactivity was found to be increased significantly
above control values at 15 minutes post-first discrete seizure, or approximately 5
minutes after the onset of continuous seizure activity. CaN immunoreactivity
doubled at this time-point in both cortical and hippocampal SPM, and remained
similarly elevated at all subsequent time-points. (** p < 0.01, n = 3 per timepoint, student’s t-test).
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Figure 27: Temporal profile of basal and cation-stimulated CaN activity in
cortical and hippocampal crude SPM. In both cortex (A, B) and hippocampus
(C, D) CaN activity (as measured by the pNPP assay) in the SPM increased with
a temporal profile similar to the SE-induced increase in CaN immunoreactivity
noted above. Both basal (A, C) and cation-stimulated (B, D) activity increased
significantly by 20 minutes post-first discrete seizure, with the magnitude of the
increase being roughly similar to the magnitude of the increase in CaN
immunoreactivity via western blot. As SE continued, a further increase in CaN
activity was observed in all fractions and in all reaction conditions (although this
increase is most noticeable in under the basal reaction conditions). The timing of
this later increase corresponds to an increase in CaN activity that is observed in
the overall homogenate and is discussed previously (* p < 0.05, ** p < 0.01, *** p
<0.001).
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Figure 28: SE leads to increased CaN-dependent dephosphorylation of
DARRP-32. Phospho-DARRP-32 immunoreactivity was determined via western
analysis. SE was found to induce a significant dephosphorylation of the protein (p
<0.05, n=3), a finding that is consistent with increased CaN activity. Pretreatment
of animals with either CaN inhibitor reduced DARRP dephosphorylation
significantly (p < 0.05 compared to SE, n=3), indicating that the inhibitors were
reaching the brain in sufficient concentrations to inhibit CaN activity.
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Figure 29: RII phosphopeptide assay for CaN activity. To further expand
upon our previous results, we examined CaN activity in the crude SPM of cortex
and hippocampus using an additional enzyme assay procedure. Phosphate
released from RII phosphopeptide, a specific CaN substrate, was assayed using
a malachite-green based reaction and read in a spectrophotometer at 620nm. In
both cortex (A) and hippocampus (B) a significant increase in CaN activity was
observed after 1h of SE. This increase was of similar magnitude to that observed
with the pNPP assay. (p < 0.05, n=3).
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Figure 30: SE induces a CaN-dependent dephosphorylation of cofilin. In
both cortical (A) and hippocampal (B) crude SPM, SE induced a significant (p <
0.01, n=10 in both regions) dephosphorylation of cofilin, as measured by
immunoreactivity on western analysis using a phosphocofilin antibody.
Administration of one of the immunosuppressant CaN inhibitors (FK506 or
cyclosporin A) prior to SE partially blocked this dephosphorylation (p < 0.05 when
compared to SE, n = 6 in both cortex and hippocampus). Changes in
phosphocofilin immunoreactivity were not due to changes in overall cofilin
concentration, as western analysis with a cofilin antibody revealed no change in
overall levels of the protein in either cortical (C) or hippocampal (D) SPM.
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Figure 31: Temporal profile of cofilin dephosphorylation in the pilocarpine
model of SE. (A) Western analysis for phosphocofilin in cortical (left) and
hippocampal (right) crude SPM at 10, 20 and 40 minutes post-first discrete
seizure. Cofilin phosphorylation was detected as early as 10 minutes post-first
discrete seizure in both brain regions. This time point corresponds approximately
to the onset of continuous seizure activity in this model. (B) Calibrated
densitometry of phosphocofilin western blots in cortical (left) and hippocampal
(right) crude SPM fractions. Cofilin phosphorylation was significantly decreased
at 10 minutes and all subsequent time points (* p < 0.05, ** p < 0.01, *** p
<0.001)
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Figure 32: SE induces a CaN-dependent binding of cofilin to actin as
detected by coimmunoprecipitation. Cofilin was immunoprecipitated from
cortical (A, B) and hippocampal (C,D) homogenates, then the actin content of the
precipitate was determined by western analysis. Very little actin was precipitated
in the absence of cofilin primary antibody (A, far left), confirming the specificity of
the assay procedure. In both cortical (A, B) and hippocampal (C,D) samples, SE
led to a significant (p < 0.05) increase in cofilin-actin coprecipitation. This
association of the two proteins was significantly blocked by calcineurin inhibitors
(p < 0.05 when compared to SE value).
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Figure 33: SE induces CaN dependent actin depolymerization. F-actin and
G-actin were separated by solubility in 1% triton, then assayed by western
analysis in cortical (A, B) and hippocampal (C,D) crude SPM. In cortical SPM, SE
caused a significant (p < 0.05) increase in the amount of actin present in the
triton-soluble fraction (A). G-actin is soluble in triton while F-actin is not, and thus
this increase in soluble actin likely represents an SE-induced depolymerization of
actin. A similar decrease in triton-insoluble actin (F-actin) was observed in
cortical homogenates following SE (B). The CaN inhibitor FK506 blocked the shift
of actin from the soluble to insoluble fraction, suggesting that the observed actin
depolymerization was CaN-dependent. Similar effects were observed in
hippocampal triton-soluble (C) and triton-insoluble (D) fractions isolated from
crude SPM (n = 3 for all groups).
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Figure 34: FK506 blocks SE-induced dendritic spine loss in granule cells of
the dentate gyrus. Coronal sections were blocked for dorsal hippocampus and
sectioned at 150 microns on a vibratome, then stained using a single-section
variant of the rapid Golgi method. Granule cells with numerous processes were
easily visualized in control sections (A). Under higher magnification, numerous
dendritic spines were visualized in control dendrites (B), while relatively few
spines were observed in dendrites of SE animals (C). In SE animals pre-treated
with FK506, spine density appeared qualitatively to be preserved. (representative
sections shown, n = 3 animals per group)

DISCUSSION

The present study examined the effects of two different models of
neuronal injury on the activity and distribution of CaN. In chapter one, we
demonstrated an SE-dependent increase in both basal and maximal CaN activity
and a corresponding change in CaN substrate kinetics. This change was
dependent on NMDA-mediated calcium influx, and not due to an increase in the
overall amount of CaN present in the cell after SE. In chapter two, through the
use of western and immunohistochemical analysis, we showed an SE-dependent
increase in the amount of CaN present in the post-synaptic region of neurons.
This

SE-induced

increase

in

synaptoplasmic

CaN

concentration

was

accompanied by a dramatic increase in CaN activity in this fraction. We suspect
that the SE-induced increase in synaptic CaN is due to a translocation of the
enzyme, as the results of chapter one indicated that no new CaN synthesis had
taken place. Taken together, the results presented in the first two chapters of this
study describe a profound increase in post-synaptic CaN concentration and
activity after one hour of SE, changes that could have major implications in the
pathology of SE. In chapters three and four we demonstrated a similar increase
in CaN activity and post-synaptic increase in CaN concentration in the moderate
fluid percussion model of traumatic brain injury. These changes in CaN activity
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and subcellular distribution persisted for several weeks post-injury, a time-course
which corresponds to a number of TBI-associated pathologies Finally, in chapter
five, we examined one potential physiological consequence of SE-induced
increases in post-synaptic CaN activity and concentration. CaN was shown to be
part of a cellular mechanism of SE-induced dendritic spine loss, possibly
implicating the enzyme in SE-induced chronic neurological pathology. Altogether,
the results presented in this study provide compelling evidence that CaN is
involved in neuronal damage in two disparate models of injury, and provide at
least one cellular mechanism for this damage in the pilocarpine model of SE.
Ideally, further research in this topic will provide a basis for future neuroprotective
and therapeutic treatments.
The presence of injury-dependent changes in CaN activity in both models
may be explained by the importance of glutamate-mediated excitotoxic
mechanisms to the pathology of both conditions. In fact, this alteration in CaN
activity and distribution would not be the first pathologic mechanism shared
between TBI and SE. For example, MK801, a non-competitive NMDA channel
blocker, is neuroprotective in animal models of both conditions [254, 255]. Both
TBI and SE lead to neuronal hyperexcitability, particularly in the hippocampus.
Additionally, both TBI and SE are epileptogenic in animal models and clinical
studies (in fact, TBI represents one of the major causes of epilepsy in the United
States). Thus, while TBI and SE are clearly different types of neuronal injury, it is
just as clear that they share some pathological mechanisms and long-term
consequences. The identification of these common pathological pathways, such
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as CaN activation and redistribution, may allow for the development of multi-use
treatment modalities.

Increased forebrain homogenate CaN activity in SE and TBI:
In both SE and TBI, a significant increase in basal and Mn-stimulated CaN
activity was observed. Western analysis in homogenates from both models
revealed no significant increase in CaN concentration, suggesting that this
increase in activity was not due to injury-stimulated synthesis of new enzyme. A
number of other possibilities exist to explain this increase in activity. First of all,
glutamate-induced calcium influx could directly stimulate the enzyme, resulting in
the observed increase in activity. This explanation is unlikely for several reasons.
First, the levels of free calcium achieved inside neurons during toxic glutamate
stimulation are well above the concentration range commonly associated with
CaN activation. In fact, high calcium concentrations have actually been shown to
inactivate the enzyme, rather than activating it. Second, the timing of the
increase in CaN activity in homogenate correlates poorly with calcium entry as a
mechanism. In SE, homogenate CaN activity increased after approximately 30
minutes of continuous seizure activity, although cellular free calcium levels rise
much sooner. Finally, addition of excess chelator to the reaction mix did not
eliminate the observed increase in activity. On the other hand, local calcium
concentrations in some portions of the neuron could certainly be within the
appropriate range, due to the separation of specialized compartments within the
cell. When CaN activity is considered on a finer scale than that provided by
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tissue homogenization, direct activation by glutamate-induced calcium influx is
certainly possible, however we belive it is not likely to explain the wholesale
increase in activity observed in the homogenates after both injuries.
While direct activation of the enzyme by glutamate-induced calcium influx
does not seem to explain the increase in CaN activity, NMDA-receptor
associated calcium influx still was essential for the enzyme activation to occur.
This tends to implicate other calcium-regulated systems in the activation of the
enzyme in homogenate. Phosphorylation of the enzyme by a calcium-stimulated
kinase is one such explanation, although significant regulation of the enzyme
through such a mechanism has not been conclusively demonstrated. Another
possible mechanism involves partial proteolysis of the enzyme by calcium
stimulated proteases. Such proteolysis has been shown to activate the enzyme
via removal of the autoinhibitory domain. Interestingly, the calcium stimulated
protease, calpain, has been shown to be activated in both SE and TBI, and this
mechanism of CaN activation has been demonstrated in an in vitro model of
glutamate excitotoxicity. Further research is needed to determine if calpainmediated activation of CaN is responsible for the delayed increase in CaN
activity observed in SE, and the similar increase in homogenate CaN activity
observed in TBI. Interestingly, the increase in CaN activity persisted for several
weeks in TBI, and it is possible that this sustained increase is due to some
combination of post-translational modification and increased resting calcium
levels.
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Increased synaptoplasmic CaN concentration in SE and TBI:
In both model systems, a profound increase in the amount of CaN present
in the crude synaptoplasmic membrane fraction was noted in hippocampal and
cortical isolates. Additionally, immunohistochemistry confirmed this increase in
post-synaptic CaN immunoreactivity in hippocampal slices from both SE and TBI
animals.

Two

possible

explanations

exist

for

this

increased

CaN

immunoreactivity in SPM fractions and on IHC; either new CaN has been
synthesized or existing CaN has been translocated to the membrane.
Regardless of the cause of the increased CaN immunoreactivity, the result
is functionally the same. Both injury processes result in a dramatic increase in
the amount of CaN present at the synapse. In SE, this increase was determined
to be very rapid, occurring shortly after the onset of continuous seizure activity (in
contrast to the increase in homogenate activity, which was delayed until 20-30
minutes of continuous seizures had occurred). A proportional increase in activity
accompanied this increase in CaN concentration in both models. At least in the
SE model, this increase in activity was determined to be mechanistically distinct
from the increase in homogenate activity discussed above. A careful analysis of
the temporal profile of SE-induced CaN activity changes in SPM reveals an
immediate increase in CaN activity that corresponds in timing and magnitude
with the increase in SPM CaN concentration, and a separate, later increase in
activity that corresponds temporally with the increase in homogenate activity.
Thus two events appear to be taking place: increased CaN concentration post-
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synaptically shortly after the onset of continuous seizure activity, and a later
increase in CaN activity caused by post-translational modification of the enzyme.
There are numerous possible implications of this increased post-synaptic
CaN activity and concentration for the observed pathologies of both models. As
described previously, CaN regulates a number of neurotransmitter receptors.
Disregulation of the GABAA receptor has been observed as a pathological
mechanism in both TBI and SE [161, 256-258]. A number of studies have
demonstrated negative modulation of GABAA function by CaN [66, 67], and at
least one study has shown a direct CaN-mediated dephosphorylation of a GABAA
subunit [69]. Additionally, an injury-induced modulation of the receptor by CaN
has already been observed in a model of hypoxic injury in immature rats [123].
The dramatically increased SPM CaN activity observed in the two model systems
in this study could result in increased GABAA receptor dephosphorylation (or
increased receptor internalization), decreased GABAergic neurotransmission,
and increased neuronal excitability. Post-injury hyperexcitability and eventual
epileptogenesis are hallmarks of both TBI and SE [230], pathologies that could
be explained by a negative modulation of GABAA receptors by the increased
post-synaptic CaN. Futhermore, one study has demonstrated a loss of
GABAergic inhibition that was NMDA-dependent, like the increase in CaN activity
described in this study [259]. This mechanism of neuronal disinhibition merits
future research in both of these conditions.
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CaN and cognitive function:
A second potential implication of increased post-synaptic CaN is
decreased cognitive function. This is of particular interest in TBI, where cognitive
deficits are a common and unfortunate consequence of the injury. A great deal of
evidence suggests that CaN exerts a negative modulation on learning and
memory. Studies in rats have revealed that CaN inhibition increases performance
in associative memory-related tasks. For example, Ikegami et al. demonstrated
an increase in conditioned fear memory in rats treated with CaN antisense
oligonucleotides or FK506 [260]. Similarly Lin et al. demonstrated that application
of CaN inhibitors to the amygdala in vivo prevented the extinction of fear memory
[261, 262]. A number of studies have examined the effects of genetically reduced
CaN activity on learning and memory, either via overexpression of a calcineurin
autoinhibitory peptide or by CaN knockout. Conditional (doxycycline-dependent)
overexpression of the CaN autoinhibitory peptide in adult mouse brain resulted in
enhanced short- and long-term memory in an object recognition task [5].
Additionally, overexpression of the autoinhibitory peptide enhanced performance
in the Morris water maze (MWM) task. Mutant mice treated with doxycycline
learned the position of the platform in the maze more rapidly and retained this
information longer (the platform was removed and the number of times the
mouse crossed the prior location on successive days measured), indicating a
positive effect of CaN inhibition on learning and memory [5]. Finally, several
studies have investigated the effects of conditional overexpression of calcineurin,
often using a doxycycline-sensitive mutant mouse that overexpresses a
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truncated, active form of calcineurin (see calpain proteolysis, above). Mansuy
and colleagues demonstrated that calcineurin overexpressing mice had deficient
long-term memory and deficient spatial learning as tested by the Barnes maze
task, but normal short term memory. These deficits could be entirely rescued by
“turning off” the calcineurin overexpression. Additionally, the mice in this study
had difficulty with an object-recognition task when tested at long (but not short)
intervals [224]. The researchers theorized that CaN was essential for the
transition from short-term to long term memory; on a cellular level, they
hypothesized that this was due to CaN’s negative effects on an intermediatelength form of LTP [224, 263, 264]. In a later study by the same laboratory, the
mutant mice also exhibited impaired spatial learning on the MWM task. When
conditional mutants were allowed to train on the MWM task with CaN
overexpression suppressed (normal CaN levels) their performance was the same
as control mice; however, if CaN overexpression was then induced after the
training phase, the performance of the mice declined and they could no longer
remember the position of the platform. This seems to indicate that CaN
overexpression also interferes with memory retrieval. Interestingly, if CaN levels
were subsequently restored to normal, memory of platform position was
recovered [264]. The results of these CaN overexpression studies correspond
well with the inhibitor and autoinhibitory peptide-based studies, suggesting that
within a certain range, CaN activity generally acts to prevent memory formation
and retrieval while promoting memory extinction. Thus a dramatic increase in
post-synaptic CaN, such as that observed in SE and TBI in this study, could be
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responsible for decreased cognition after the injury event. Interestingly, the
duration of increased CaN activity and post-synaptic concentration correlates
with previous results documenting the duration of cognitive deficits after TBI.
Future research into this cellular mechanism may provide clinical options for
preserving cognitive abilities after brain injury.

SE, epilepsy and spine loss:
Finally, injury-induced increases in post-synaptic CaN may lead to
negative modulation of dendritic spines. Decreased spine density has been
previously observed in SE [240], and is postulated to be involved in chronic postseizure pathology. As discussed above, CaN negatively modulates spine density
in several model systems [79, 80]. Thus, an SE (or TBI)-mediated increase in
CaN activity and concentration in the immediate vicinity of dendritic spines could
account for decreased spine density in these conditions. We investigated this
intriguing cellular mechanism in the pilocarpine model of SE, and discovered a
profound CaN-dependent loss of dendritic spines.
There are several potential physiological roles of the CaN-dependent loss
of spines described in this study. In the pilocarpine model of SE, spontaneous
recurrent seizures typically begin approximately 2 weeks after the prolonged
seizure episode [265]. No epileptic activity is seen during this quiescent period,
but there is a great deal happening on a cellular level. It is thought that the
biochemical and structural changes that lead to recurrent seizure activity are
being completed during this time. While the exact mechanisms responsible for
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epileptogenesis remain the subject of intense study and debate, dendritic spine
plasticity certainly is a promising candidate for this role. The loss and subsequent
regrowth of dendritic spines could represent a pathological reorganization of
synaptic networks leading to the formation of epileptic foci in the brain. It is
especially interesting that spine loss has been documented in the dentate gyrus
of the hippocampus [242]. Network reorganization and neuronal hyperexcitability
in

this

region

are

frequently

proposed

as

possible

mechanisms

of

epileptogenesis. Furthermore, after the SE-associated loss of spines, it has been
shown that their regrowth in this region is colocalized with sites of mossy fiber
sprouting [242]. Thus an outgrowth of axonal structures that has been previously
implicated in epileptogenesis seems to coincide with a reorganization of postsynaptic structures, all of which is occurring in a region that seems to be critical
in the development of temporal lobe epilepsy.

Conclusion:
These studies describe a novel increase in CaN activity after both TBI and
SE, and demonstrate an increase in CaN in crude SPM fractions after both
conditions. In TBI, these changes were shown to persist for 2 weeks in cortical
samples and up to 4 weeks in hippocampal samples. Immunohistochemical
studies confirmed that this increase in SPM CaN represented an increase in the
amount of enzyme in hippocampal dendrites. The pathological implications of
these changes include potential mechanisms for decreased cognitive function
and epileptogenesis. Finally, we presented one physiological consequence of
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increased dendritic CaN in SE: dendritic spine loss. We demonstrated a CaNdependent cellular mechanism for this decrease in spine density involving the
actin-depolymerizing factor, cofilin. These results help further our understanding
of the pathologies set in motion by these two models of neuronal injury, and may
provide the basis for future clinical treatments, ideally decreasing the impact of
neuronal injury on patient’s quality of life.
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